<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/css" href="gpml.css" ?>
<!DOCTYPE set SYSTEM "gpml.dtd">
<set>

<import resource="GENIAontology.daml" prefix="G"></import>


<article>
<articleinfo>
<bibliomisc>MEDLINE:96025779</bibliomisc>
</articleinfo>
<title>
<sentence>Mutually exclusive interaction of a novel <cons lex="matrix_attachment_region_binding_protein" sem="G#protein_family_or_group">matrix attachment region binding protein</cons> and the <cons lex="NF-muNR_enhancer_repressor" sem="G#protein_molecule">NF-muNR enhancer repressor</cons>.</sentence>
<sentence>Implications for regulation of <cons lex="immunoglobulin_heavy_chain_expression" sem="G#other_name"><cons lex="immunoglobulin_heavy_chain" sem="G#protein_subunit">immunoglobulin heavy chain</cons> expression</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="immunoglobulin_heavy_chain" sem="G#protein_subunit">immunoglobulin heavy chain</cons> (<cons lex="IgH" sem="G#protein_subunit">IgH</cons>) intronic enhancer stimulates transcription from functional promoters in <cons lex="B_lymphocyte" sem="G#cell_component">B lymphocytes</cons> but not other cell types.</sentence>
<sentence>The observation that binding sites for the <cons lex="nuclear_factor-mu_negative_regulator_(NF-muNR)_enhancer_repressor_overlap_nuclear_matrix_attachment_regions" sem="G#protein_domain_or_region"><cons lex="nuclear_factor-mu_negative_regulator" sem="G#protein_molecule">nuclear factor-mu negative regulator</cons> (<cons lex="NF-muNR" sem="G#protein_molecule">NF-muNR</cons>) enhancer repressor overlap <cons lex="nuclear_matrix_attachment_region" sem="G#protein_domain_or_region">nuclear matrix attachment regions</cons></cons> (<cons lex="MAR" sem="G#protein_domain_or_region">MARs</cons>) in this <cons lex="enhancer" sem="G#DNA_domain_or_region">enhancer</cons> has lead to the hypothesis that the cell type specificity of the <cons lex="enhancer" sem="G#DNA_domain_or_region">enhancer</cons> might be controlled by regulating <cons lex="nuclear_matrix_attachment" sem="G#other_name">nuclear matrix attachment</cons> (Scheuermann, R. H., and Chen, U. (1989) Genes &amp; Dev. 3, 1255-1266).</sentence>
<sentence>To understand the role of <cons lex="MAR" sem="G#protein_domain_or_region">MARs</cons> in <cons lex="IgH_enhancer_regulation" sem="G#other_name"><cons lex="IgH_enhancer" sem="G#DNA_domain_or_region"><cons lex="IgH" sem="G#protein_subunit">IgH</cons> enhancer</cons> regulation</cons>, we have identified a novel <cons lex="MAR-binding_protein" sem="G#protein_molecule">MAR-binding protein</cons>, <cons lex="MAR-BP1" sem="G#protein_molecule">MAR-BP1</cons>, from soluble <cons lex="nuclear_matrix_preparation" sem="G#other_name">nuclear matrix preparations</cons> based on its ability to bind to the <cons lex="MAR" sem="G#protein_domain_or_region">MARs</cons> associated with the <cons lex="IgH_enhancer" sem="G#DNA_domain_or_region"><cons lex="IgH" sem="G#protein_subunit">IgH</cons> enhancer</cons>.</sentence>
<sentence>Purified <cons lex="MAR-BP1" sem="G#protein_molecule">MAR-BP1</cons> migrates as a <cons lex="33-kDa_protein" sem="G#protein_molecule">33-kDa protein</cons>, and it can be found in nuclear matrix preparations from a number of different types of <cons lex="lymphoid_cell_line" sem="G#cell_line">lymphoid cell lines</cons>.</sentence>
<sentence>Although specific binding sites have been difficult to localize by chemical or <cons lex="enzymatic_footprinting_procedure" sem="G#other_name">enzymatic footprinting procedures</cons>, <cons lex="NF-muNR" sem="G#protein_molecule">NF-muNR</cons> binding sites are critical for efficient <cons lex="MAR-BP1_binding" sem="G#other_name"><cons lex="MAR-BP1" sem="G#protein_molecule">MAR-BP1</cons> binding</cons>.</sentence>
<sentence>Indeed, binding of the <cons lex="IgH_enhancer" sem="G#DNA_domain_or_region"><cons lex="IgH" sem="G#protein_subunit">IgH</cons> enhancer</cons> to either intact <cons lex="nuclear_matrix_preparation" sem="G#cell_component">nuclear matrix preparations</cons> or to <cons lex="MAR-BP1" sem="G#protein_molecule">MAR-BP1</cons> is mutually exclusive to <cons lex="NF-muNR_binding" sem="G#other_name"><cons lex="NF-muNR" sem="G#protein_molecule">NF-muNR</cons> binding</cons>.</sentence>
<sentence>These results are consistent with a model for cell-type specific regulation in which binding of the <cons lex="NF-muNR_repressor" sem="G#protein_molecule"><cons lex="NF-muNR" sem="G#protein_molecule">NF-muNR</cons> repressor</cons> to the <cons lex="IgH_enhancer" sem="G#DNA_domain_or_region"><cons lex="IgH" sem="G#protein_subunit">IgH</cons> enhancer</cons> prevents <cons lex="nuclear_matrix_attachment" sem="G#other_name"><cons lex="nuclear_matrix" sem="G#cell_component">nuclear matrix</cons> attachment</cons> in inappropriate cells by interfering with <cons lex="MAR-BP1/enhancer_interaction" sem="G#other_name"><cons lex="MAR-BP1" sem="G#protein_molecule">MAR-BP1</cons><cons lex="enhancer" sem="G#DNA_domain_or_region">/enhancer</cons> interaction</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96009612</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> (<cons lex="Spi-1" sem="G#protein_molecule">Spi-1</cons>) and <cons lex="C/EBP_alpha" sem="G#protein_molecule">C/EBP alpha</cons> regulate expression of the <cons lex="granulocyte-macrophage_colony-stimulating_factor_receptor_alpha_gene" sem="G#DNA_domain_or_region"><cons lex="granulocyte-macrophage_colony-stimulating_factor_receptor" sem="G#protein_molecule">granulocyte-macrophage colony-stimulating factor receptor</cons> alpha gene</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="growth_factor_receptor" sem="G#protein_family_or_group">Growth factor receptors</cons> play an important role in <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons>.</sentence>
<sentence>In order to further understand the mechanisms directing the expression of these key regulators of <cons lex="hematopoiesis" sem="G#other_name">hematopoiesis</cons>, we initiated a study investigating the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> activating the expression of the <cons lex="granulocyte-macrophage_colony-stimulating_factor_(GM-CSF)_receptor_alpha_gene" sem="G#DNA_domain_or_region"><cons lex="granulocyte-macrophage_colony-stimulating_factor" sem="G#protein_molecule">granulocyte-macrophage colony-stimulating factor</cons> (<cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons>) receptor alpha gene</cons>.</sentence>
<sentence>Here, we demonstrate that the <cons lex="human_GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region">human <cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> directs <cons lex="reporter_gene_activity" sem="G#other_name"><cons lex="reporter_gene" sem="G#DNA_family_or_group">reporter gene</cons> activity</cons> in a <cons lex="tissue-specific_fashion" sem="G#other_name">tissue-specific fashion</cons> in <cons lex="myelomonocytic_cell" sem="G#cell_type">myelomonocytic cells</cons>, which correlates with its expression pattern as analyzed by <cons lex="reverse_transcription_PCR" sem="G#other_name">reverse transcription PCR</cons>.</sentence>
<sentence>The <cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> contains an important functional site between positions -53 and -41 as identified by deletion analysis of <cons lex="reporter_construct" sem="G#DNA_family_or_group">reporter constructs</cons>.</sentence>
<sentence>We show that the myeloid and <cons lex="B_cell_transcription_factor" sem="G#protein_family_or_group">B cell transcription factor</cons> <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> binds specifically to this site.</sentence>
<sentence>Furthermore, we demonstrate that a <cons lex="CCAAT_site" sem="G#DNA_domain_or_region">CCAAT site</cons> located upstream of the <cons lex="PU.1_site" sem="G#DNA_domain_or_region"><cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> site</cons> between positions -70 and -54 is involved in <cons lex="positive-negative_regulation" sem="G#other_name">positive-negative regulation</cons> of the <cons lex="GM-CSF_receptor_alpha_promoter_activity" sem="G#other_name"><cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> activity</cons>.</sentence>
<sentence><cons lex="C/EBP_alpha" sem="G#protein_molecule">C/EBP alpha</cons> is the major <cons lex="CCAAT/enhancer-binding_protein" sem="G#protein_family_or_group"><cons lex="CCAAT/enhancer" sem="G#DNA_domain_or_region">CCAAT/enhancer</cons>-binding protein</cons> (<cons lex="C/EBP" sem="G#protein_family_or_group">C/EBP</cons>) form binding to this site in <cons lex="nuclear_extract" sem="G#cell_component">nuclear extracts</cons> of <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons>.</sentence>
<sentence>Point mutations of either the <cons lex="PU.1_site" sem="G#DNA_domain_or_region"><cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> site</cons> or the <cons lex="C/EBP_site" sem="G#DNA_domain_or_region"><cons lex="C/EBP" sem="G#protein_molecule">C/EBP</cons> site</cons> that abolish the binding of the respective factors result in a significant decrease of <cons lex="GM-CSF_receptor_alpha_promoter_activity" sem="G#other_name"><cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> activity</cons> in <cons lex="myelomonocytic_cell" sem="G#cell_type">myelomonocytic cells</cons> only.</sentence>
<sentence>Furthermore, we demonstrate that in <cons lex="(AND myeloid_extract B_cell_extract)" sem="(AND G#other_name G#other_name)"><cons lex="myeloid*">myeloid</cons> and <cons lex="B_cell*">B cell</cons> <cons lex="*extract">extracts</cons></cons>, <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> forms a novel, specific, more slowly migrating complex (<cons lex="PU-SF" sem="G#protein_complex">PU-SF</cons>) when binding the <cons lex="GM-CSF_receptor_alpha_promote" sem="G#DNA_substructure"><cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> <cons lex="PU.1_site" sem="G#DNA_domain_or_region"><cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> site</cons>.</sentence>
<sentence>This is the first demonstration of a specific interaction with <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> on a <cons lex="myeloid_PU.1_binding_site" sem="G#DNA_domain_or_region">myeloid <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> binding site</cons>.</sentence>
<sentence>The novel complex is distinct from that described previously as binding to <cons lex="B_cell_enhancer_site" sem="G#DNA_domain_or_region">B cell enhancer sites</cons> and can be formed by addition of <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> to extracts from certain <cons lex="nonmyeloid_cell_type" sem="G#cell_type">nonmyeloid cell types</cons> which do not express <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons>, including <cons lex="T_cell" sem="G#cell_type">T cells</cons> and <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons>, but not from <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons>.</sentence>
<sentence>Furthermore, we demonstrate that the <cons lex="PU-SF_complex" sem="G#protein_complex"><cons lex="PU-SF" sem="G#protein_complex">PU-SF</cons> complex</cons> binds to <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> sites found on a number of <cons lex="myeloid_promoter" sem="G#DNA_family_or_group">myeloid promoters</cons>, and its formation requires an intact <cons lex="PU.1_site" sem="G#DNA_domain_or_region"><cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> site</cons> adjacent to a single-stranded region.</sentence>
<sentence>Expression of <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> in <cons lex="nonmyeloid_cell" sem="G#cell_type">nonmyeloid cells</cons> can activate the <cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha promoter</cons>.</sentence>
<sentence>Deletion of the <cons lex="amino-terminal_region" sem="G#protein_domain_or_region">amino-terminal region</cons> of <cons lex="PU.1" sem="G#protein_molecule">PU.1</cons> results in a failure to form the <cons lex="PU-SF" sem="G#protein_complex">PU-SF</cons> complex and in a concomitant loss of transactivation, suggesting that formation of the <cons lex="PU-SF_complex" sem="G#protein_complex"><cons lex="PU-SF" sem="G#protein_complex">PU-SF</cons> complex</cons> is of functional importance for the activity of the <cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha promoter</cons>.</sentence>
<sentence>Finally, we demonstrate that <cons lex="C/EBP_alpha" sem="G#protein_molecule"><cons lex="C/EBP" sem="G#protein_molecule">C/EBP</cons> alpha</cons> can also active the <cons lex="GM-CSF_receptor_alpha_promoter" sem="G#DNA_domain_or_region"><cons lex="GM-CSF_receptor_alpha" sem="G#protein_molecule"><cons lex="GM-CSF" sem="G#protein_molecule">GM-CSF</cons> receptor alpha</cons> promoter</cons> in <cons lex="nonmyeloid_cell" sem="G#cell_type">nonmyeloid cells</cons>.</sentence>
<sentence>(ABSTRACT TRUNCATED AT 400 WORDS)</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96024587</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> binds to <cons lex="GATA_motif" sem="G#DNA_domain_or_region">GATA motifs</cons>: implications for an <cons lex="HPFH_syndrome" sem="G#other_name">HPFH syndrome</cons>.</sentence>
</title>
<abstract>
<sentence>We have examined binding of the <cons lex="nuclear_protein" sem="G#protein_family_or_group">nuclear protein</cons> <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> to the <cons lex="human_gamma-globin_promoter" sem="G#DNA_domain_or_region">human gamma-globin promoter</cons>.</sentence>
<sentence>We find that <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> binds preferentially to the more 3' of a pair of <cons lex="GATA_motif" sem="G#DNA_domain_or_region">GATA motifs</cons> in the <cons lex="gamma-globin_promoter" sem="G#DNA_domain_or_region">gamma-globin promoter</cons>; this paired motif is bound by the <cons lex="erythroid_factor_GATA-1" sem="G#protein_family_or_group">erythroid factor <cons lex="GATA-1" sem="G#protein_molecule">GATA-1</cons></cons>.</sentence>
<sentence>A naturally occurring <cons lex="mutation" sem="G#other_name">mutation</cons> (-175 T-C) in the area bound by <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> results in overexpression of <cons lex="gamma-globin" sem="G#protein_family_or_group">gamma-globin</cons> in <cons lex="adult_red_blood_cell" sem="G#cell_type">adult red blood cells</cons> (<cons lex="HPFH" sem="G#cell_type">HPFH</cons>) and up-regulation of the <cons lex="gamma-globin_promoter" sem="G#DNA_domain_or_region"><cons lex="gamma-globin" sem="G#protein_family_or_group">gamma-globin</cons> promoter</cons> in <cons lex="in_vitro_expression_assay" sem="G#other_name">in vitro expression assays</cons>; <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> does not bind to this <cons lex="mutant_sequence" sem="G#DNA_domain_or_region">mutant sequence</cons>.</sentence>
<sentence>A survey of <cons lex="GATA_motif" sem="G#DNA_domain_or_region">GATA motifs</cons> from other <cons lex="globin_cis-element" sem="G#DNA_domain_or_region">globin cis-elements</cons> demonstrates <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> binding to most of them.</sentence>
<sentence>These findings implicate <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> in the <cons lex="HPFH_phenotype" sem="G#other_name"><cons lex="HPFH" sem="G#cell_type">HPFH</cons> phenotype</cons>; we speculate that it may participate in the formation of <cons lex="multiprotein_complex" sem="G#protein_complex">multiprotein complexes</cons> that regulate <cons lex="globin_gene_expression" sem="G#other_name">globin <cons lex="gene_expression" sem="G#other_name">gene expression</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95386713</bibliomisc>
</articleinfo>
<title>
<sentence>Constitutive activation of different <cons lex="Jak_tyrosine_kinase" sem="G#protein_family_or_group">Jak <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> kinases</cons> in <cons lex="human_T_cell_leukemia_virus_type_1_(HTLV-1)_tax_protein" sem="G#protein_molecule"><cons lex="human_T_cell_leukemia_virus_type_1" sem="G#virus">human T cell leukemia virus type 1</cons> (<cons lex="HTLV-1" sem="G#virus">HTLV-1</cons>) tax protein</cons> or <cons lex="virus-transformed_cell" sem="G#cell_line">virus-transformed cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="HTLV-1_infection" sem="G#other_name"><cons lex="HTLV-1" sem="G#virus">HTLV-1</cons> infection</cons> causes an <cons lex="adult_T_cell_leukemia" sem="G#other_name">adult T cell leukemia</cons> in <cons lex="human" sem="G#multi_cell">humans</cons>.</sentence>
<sentence>The <cons lex="viral_encoded_protein" sem="G#protein_family_or_group">viral encoded protein</cons> <cons lex="tax" sem="G#protein_molecule">tax</cons>, is thought to play an important role in <cons lex="oncogenesis" sem="G#other_name">oncogenesis</cons>.</sentence>
<sentence>Our previous data obtained from a <cons lex="tax_transgenic_mouse_model" sem="G#other_artificial_source"><cons lex="tax" sem="G#protein_molecule">tax</cons> transgenic mouse model</cons> revealed that <cons lex="tax" sem="G#protein_molecule">tax</cons> transforms <cons lex="mouse_fibroblast" sem="G#cell_type">mouse fibroblasts</cons> but not <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons>, despite comparable levels of <cons lex="tax_expression" sem="G#other_name"><cons lex="tax" sem="G#protein_molecule">tax</cons> expression</cons> in both tissues.</sentence>
<sentence>Constitutive <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of a <cons lex="130-kD_protein" sem="G#protein_family_or_group">130-kD protein</cons>(s) was observed in the <cons lex="tax" sem="G#protein_molecule">tax</cons> <cons lex="transformed_fibroblast_B_line" sem="G#cell_line">transformed fibroblast B line</cons> and in <cons lex="HTLV-1_transformed_human_lymphoid_line" sem="G#cell_line"><cons lex="HTLV-1" sem="G#virus">HTLV-1</cons> transformed human lymphoid lines</cons>, but not in <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons> from <cons lex="Thy-tax_transgenic_mice" sem="G#other_artificial_source">Thy-tax transgenic mice</cons>.</sentence>
<sentence><cons lex="Phosphotyrosine_immunoprecipitation" sem="G#other_name">Phosphotyrosine immunoprecipitation</cons> followed by <cons lex="Western_blot_analysis" sem="G#other_name">Western blot analysis</cons> with a set of <cons lex="Jak_kinase_specific_antibody" sem="G#protein_family_or_group"><cons lex="Jak_kinase" sem="G#protein_family_or_group">Jak kinase</cons> specific antibodies</cons>, identified p130 as <cons lex="Jak2" sem="G#protein_molecule">Jak2</cons> in the <cons lex="tax" sem="G#protein_molecule">tax</cons> transformed <cons lex="mouse_fibroblastic_cell_line" sem="G#cell_line">mouse fibroblastic cell line</cons> and <cons lex="Jak3" sem="G#protein_molecule">Jak3</cons> in <cons lex="HTLV-1_transformed_human_T_cell_line" sem="G#cell_line"><cons lex="HTLV-1" sem="G#virus">HTLV-1</cons> transformed human T cell lines</cons>.</sentence>
<sentence>Phosphorylation of <cons lex="Jak2" sem="G#protein_molecule">Jak2</cons> in <cons lex="tax_transformed_cell" sem="G#cell_line"><cons lex="tax" sem="G#protein_molecule">tax</cons> transformed cells</cons> resulted from high expression of <cons lex="IL-6" sem="G#protein_N/A">IL-6</cons>.</sentence>
<sentence><cons lex="tyrosine" sem="G#amino_acid_monomer">Tyrosine</cons> phosphorylation of this protein could also be induced in <cons lex="Balb/c3T3_cell" sem="G#cell_line">Balb/c3T3 cells</cons> using a supernatant from the <cons lex="B_line" sem="G#cell_line">B line</cons>, which was associated with induction of <cons lex="cell_proliferation" sem="G#other_name">cell proliferation</cons>.</sentence>
<sentence>Both <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> and <cons lex="proliferation" sem="G#other_name">proliferation</cons> were inhibited by <cons lex="IL-6_neutralizing_antibody" sem="G#protein_family_or_group"><cons lex="IL-6" sem="G#protein_N/A">IL-6</cons> neutralizing antibodies</cons>.</sentence>
<sentence>Constitutive phosphorylation of <cons lex="Jak_kinase" sem="G#protein_family_or_group">Jak kinases</cons> may facilitate <cons lex="tumor_growth" sem="G#other_name">tumor growth</cons> in both <cons lex="HTLV-1_infected_human_T_cell" sem="G#cell_type"><cons lex="HTLV-1" sem="G#virus">HTLV-1</cons> infected human <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> and the <cons lex="transgenic_mouse_model" sem="G#other_artificial_source">transgenic mouse model</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95367587</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="c-jun_mRNA_expression" sem="G#other_name"><cons lex="c-jun_mRNA" sem="G#RNA_molecule"><cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> mRNA</cons> expression</cons> by <cons lex="hydroxyurea" sem="G#other_organic_compound">hydroxyurea</cons> in <cons lex="human_K562_cell" sem="G#cell_line">human K562 cells</cons> during <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons> [published erratum appears in Biochim Biophys Acta 1995 Dec 27;1264(3):409]</sentence>
</title>
<abstract>
<sentence><cons lex="hydroxyurea" sem="G#other_organic_compound">Hydroxyurea</cons> (<cons lex="HU" sem="G#other_organic_compound">HU</cons>) is an <cons lex="antitumor_agent" sem="G#other_name">antitumor agent</cons> which also induces <cons lex="hemoglobinization" sem="G#other_name">hemoglobinization</cons> during <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>.</sentence>
<sentence>In addition, <cons lex="HU" sem="G#other_organic_compound">HU</cons> stimulates the synthesis of <cons lex="fetal_hemoglobin_in_sickle_cell_anemia" sem="G#other_name"><cons lex="fetal_hemoglobin" sem="G#protein_complex">fetal hemoglobin</cons> in sickle cell anemia</cons> <cons lex="patient" sem="G#multi_cell">patients</cons>.</sentence>
<sentence>To further understand its mechanism of action, we investigated the effects of <cons lex="HU" sem="G#other_organic_compound">HU</cons> on regulation of <cons lex="c-jun_expression" sem="G#other_name"><cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> expression</cons> prior to the onset of <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons> of <cons lex="K562_cell" sem="G#cell_line">K562 cells</cons>.</sentence>
<sentence><cons lex="HU" sem="G#other_organic_compound">HU</cons> induced a dose-dependent stimulation of <cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> synthesis.</sentence>
<sentence>The levels of <cons lex="c-jun_mRNA" sem="G#RNA_molecule"><cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> mRNA</cons> was elevated 4 to 7.5-fold by <cons lex="HU" sem="G#other_organic_compound">HU</cons> within 2 h.</sentence>
<sentence>This was followed by a gradual decline to the basal level by 24 h.</sentence>
<sentence>Both nuclear run-on and <cons lex="actinomycin_D_pulse_experiments" sem="G#other_name"><cons lex="actinomycin_D" sem="G#other_organic_compound">actinomycin D</cons> pulse experiments</cons> strongly indicate that <cons lex="HU" sem="G#other_organic_compound">HU</cons> regulates <cons lex="c-jun_mRNA_expression" sem="G#other_name"><cons lex="c-jun_mRNA" sem="G#RNA_molecule">c-jun mRNA</cons> expression</cons> by increasing the rate of synthesis as well as stabilizing the <cons lex="c-jun_mRNA" sem="G#RNA_molecule"><cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> mRNA</cons>.</sentence>
<sentence>In addition, the level of <cons lex="jun_protein" sem="G#protein_family_or_group">jun protein</cons> was elevated by 2 to 5-fold within 4 h in <cons lex="HU_treated_cell" sem="G#cell_line"><cons lex="HU" sem="G#other_organic_compound">HU</cons> treated cells</cons>.</sentence>
<sentence>Furthermore, concentrations of <cons lex="HU" sem="G#other_organic_compound">HU</cons> below 250 microM slightly increased the 5X <cons lex="AP-1/CAT_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons><cons lex="CAT" sem="G#protein_molecule">/CAT</cons> activity</cons>.</sentence>
<sentence>These results strongly suggest that <cons lex="HU" sem="G#other_organic_compound">HU</cons> induces both <cons lex="(AND transcriptional_regulation post-transcription_regulation)" sem="(AND G#other_name G#other_name)"><cons lex="transcriptional*">transcriptional</cons> and <cons lex="post-transcription*">post-transcription</cons> <cons lex="*regulation">regulation</cons></cons> of <cons lex="c-jun" sem="G#DNA_domain_or_region">c-jun</cons> during <cons lex="erythroid_differentiation" sem="G#other_name">erythroid differentiation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:92187059</bibliomisc>
</articleinfo>
<title>
<sentence>In vivo and in vitro effects of <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> on <cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> in <cons lex="man" sem="G#multi_cell">man</cons>: relationship to <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptors</cons>.</sentence>
</title>
<abstract>
<sentence>Interrelations between the <cons lex="hypothalamic-pituitary-adrenal_system" sem="G#body_part">hypothalamic-pituitary-adrenal system</cons> (<cons lex="HPA" sem="G#body_part">HPA</cons>) and the <cons lex="immune_system" sem="G#body_part">immune system</cons> represent a well-documented <cons lex="biological_phenomenon" sem="G#other_name">biological phenomenon</cons>.</sentence>
<sentence>While in vitro administration of <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> may inhibit <cons lex="(AND concanavalin_A_(Con_A)-induced_T-cell_proliferation phytohemagglutinin_(PHA)-induced_T-cell_proliferation)" sem="(AND G#other_name G#other_name)"><cons lex="concanavalin_A_(Con_A)-*">concanavalin A (Con A)-</cons> and <cons lex="phytohemagglutinin_(PHA)-*">phytohemagglutinin (PHA)-</cons><cons lex="*induced_T-cell_proliferation">induced T-cell proliferation</cons></cons>, <cons lex="pokeweed_mitogen_(PWM)-driven_B-cell_mitogenesis" sem="G#other_name"><cons lex="pokeweed_mitogen" sem="G#protein_molecule">pokeweed mitogen</cons> (<cons lex="PWM" sem="G#protein_molecule">PWM</cons>)-driven B-cell mitogenesis</cons> is relatively resistant to <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons>.</sentence>
<sentence>To further explore the link between the <cons lex="HPA" sem="G#body_part">HPA</cons> and the <cons lex="immune_system" sem="G#body_part">immune system</cons> in relation to <cons lex="glucocorticoid_receptor_function" sem="G#other_name"><cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptor</cons> function</cons>, dose-response curves were obtained for <cons lex="Con_A" sem="G#other_organic_compound">Con A</cons> -and <cons lex="PHA-induced_T-cell_mitogenesis" sem="G#other_name"><cons lex="PHA" sem="G#protein_molecule">PHA</cons>-induced T-cell mitogenesis</cons>, <cons lex="PWM-generated_B-cell_mitogenesis" sem="G#other_name"><cons lex="PWM" sem="G#protein_molecule">PWM</cons>-generated B-cell mitogenesis</cons> and spontaneous <cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> in 13 <cons lex="healthy_control" sem="G#multi_cell">healthy controls</cons>.</sentence>
<sentence>Glucocorticoid effects were assessed in vivo by depletion of <cons lex="endogenous_glucocorticoid" sem="G#lipid">endogenous <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons></cons> after <cons lex="oral_administration" sem="G#other_name">oral administration</cons> of <cons lex="1.5_g_metyrapone" sem="G#other_organic_compound">1.5 g metyrapone</cons> (<cons lex="MET" sem="G#other_organic_compound">MET</cons>) and subsequent <cons lex="glucocorticoid_replacement" sem="G#other_name"><cons lex="glucocorticoid" sem="G#lipid">glucocorticoid</cons> replacement</cons>, and in vitro by incubation of the cells with different doses of <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> (<cons lex="DEX" sem="G#lipid">DEX</cons>).</sentence>
<sentence>There was a significant decrease in <cons lex="PWM-induced_B-cell_mitogenesis" sem="G#other_name"><cons lex="PWM" sem="G#protein_molecule">PWM</cons>-induced B-cell mitogenesis</cons> and a more pronounced effect of <cons lex="DEX" sem="G#lipid">DEX</cons> administered in vitro on spontaneous <cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> after <cons lex="MET_treatment" sem="G#other_name"><cons lex="MET" sem="G#other_organic_compound">MET</cons> treatment</cons> when compared with the <cons lex="DEX" sem="G#lipid">DEX</cons> plus <cons lex="MET" sem="G#other_organic_compound">MET</cons> pretreated condition in vivo.</sentence>
<sentence>These data suggest that the inhibition of spontaneous <cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> by <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> in vitro is related to <cons lex="glucocorticoid_receptor_function" sem="G#other_name"><cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group"><cons lex="glucocorticoid" sem="G#lipid">glucocorticoid</cons> receptor</cons> function</cons>.</sentence>
<sentence>The decrease in <cons lex="PWM-generated_B-cell_proliferation" sem="G#other_name"><cons lex="PWM" sem="G#protein_molecule">PWM</cons>-generated B-cell proliferation</cons> following <cons lex="cortisol_depletion" sem="G#other_name"><cons lex="cortisol" sem="G#lipid">cortisol</cons> depletion</cons> by <cons lex="MET" sem="G#other_organic_compound">MET</cons> may be seen in connection with impaired <cons lex="glucocorticoid-mediated_induction" sem="G#other_name"><cons lex="glucocorticoid" sem="G#lipid">glucocorticoid</cons>-mediated induction</cons> of <cons lex="interleukin-1_receptor_synthesis" sem="G#other_name"><cons lex="interleukin-1_receptor" sem="G#protein_family_or_group">interleukin-1 receptor</cons> synthesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96356325</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcription_specific_difference" sem="G#other_name">Transcription specific differences</cons> visualized by <cons lex="fluorescence" sem="G#other_name">fluorescence</cons> in <cons lex="situ_hybridization_pattern" sem="G#other_name">situ hybridization pattern</cons> on <cons lex="interphase_nuclei" sem="G#cell_component">interphase nuclei</cons> of different cell types.</sentence>
</title>
<abstract>
<sentence>Application of a "formamide free" and thus "material preserving" in <cons lex="situ_hybridization_technique" sem="G#other_name">situ hybridization technique</cons> using the <cons lex="cDNA" sem="G#DNA_family_or_group">cDNA</cons> of the <cons lex="myf3_gene" sem="G#DNA_domain_or_region">myf3 gene</cons> revealed the following results: <cons lex="human_rhabdomyosarcoma_cell" sem="G#cell_type">Human rhabdomyosarcoma cells</cons>, characterized by a high expression of <cons lex="myf3" sem="G#DNA_domain_or_region">myf3</cons> show intensive <cons lex="hybridization_signal" sem="G#other_name">hybridization signals</cons> in their <cons lex="interphase" sem="G#other_name">interphase</cons>.</sentence>
<sentence><cons lex="RNase_treatment" sem="G#other_name"><cons lex="RNase" sem="G#protein_molecule">RNase</cons> treatment</cons> prior to <cons lex="hybridization" sem="G#other_name">hybridization</cons> considerably reduces the size of this signals.</sentence>
<sentence>In comparison, <cons lex="isolated_nuclei" sem="G#cell_component">isolated nuclei</cons> of <cons lex="human_lymphocyte" sem="G#cell_type">human lymphocytes</cons> in which no need for the expression of this gene exists, show barely <cons lex="hybridization_signal" sem="G#other_name"><cons lex="hybridization" sem="G#other_name">hybridization</cons> signals</cons>.</sentence>
<sentence>Correspondingly, <cons lex="RNase_treatment" sem="G#other_name"><cons lex="RNase" sem="G#protein_molecule">RNase</cons> treatment</cons> had no effect on <cons lex="hybridization_pattern" sem="G#other_name"><cons lex="hybridization" sem="G#other_name">hybridization</cons> pattern</cons> at all.</sentence>
<sentence>In conclusion an increased <cons lex="transcription_efficiency" sem="G#other_name">transcription efficiency</cons> of a cell type specific gene is accompanied by a higher <cons lex="hybridization_accessibility" sem="G#other_name"><cons lex="hybridization" sem="G#other_name">hybridization</cons> accessibility</cons> in the corresponding <cons lex="cell_nuclei" sem="G#cell_component">cell nuclei</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96079009</bibliomisc>
</articleinfo>
<title>
<sentence>Oncogenicity of <cons lex="(OR human_papillomavirus-transformed_cell human_adenovirus-transformed_cell)" sem="(OR G#cell_line G#cell_line)"><cons lex="human*">human</cons> <cons lex="*papillomavirus-*">papillomavirus-</cons> or <cons lex="*adenovirus-*">adenovirus-</cons><cons lex="*transformed_cell">transformed cells</cons></cons> correlates with resistance to lysis by <cons lex="natural_killer_cell" sem="G#cell_type">natural killer cells</cons>.</sentence>
</title>
<abstract>
<sentence>The reasons for the dissimilar oncogenicities of <cons lex="human_adenovirus" sem="G#virus">human adenoviruses</cons> and <cons lex="human_papillomavirus" sem="G#virus">human papillomaviruses</cons> (<cons lex="HPV" sem="G#virus">HPV</cons>) in <cons lex="human" sem="G#multi_cell">humans</cons> are unknown but may relate to differences in the capacities of the <cons lex="E1A" sem="G#protein_molecule">E1A</cons> and <cons lex="E7_protein" sem="G#protein_molecule">E7 proteins</cons> to <cons lex="target_cell" sem="G#cell_type">target cells</cons> for rejection by the <cons lex="host_natural_killer_(NK)_cell_response" sem="G#other_name"><cons lex="host_natural_killer_(NK)_cell" sem="G#cell_type">host natural killer (NK) cell</cons> response</cons>.</sentence>
<sentence>As one test of this hypothesis, we compared the abilities of <cons lex="E1A" sem="G#protein_molecule">E1A</cons> -and <cons lex="E7" sem="G#protein_molecule">E7</cons>-expressing <cons lex="(OR human_fibroblastic_cell keratinocyte-derived_human_cell)" sem="(OR G#cell_line G#cell_line)"><cons lex="human_fibroblastic*">human fibroblastic</cons> or <cons lex="keratinocyte-derived_human*">keratinocyte-derived human</cons> <cons lex="*cell">cells</cons></cons> to be selectively killed by either <cons lex="unstimulated_NK_cell" sem="G#cell_type">unstimulated</cons> or <cons lex="interferon_(IFN)-activated_NK_cell" sem="G#cell_line">interferon (IFN)-activated NK cells</cons>.</sentence>
<sentence>Cells expressing the <cons lex="E1A_oncoprotein" sem="G#protein_molecule"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> oncoprotein</cons> were selectively killed by <cons lex="unstimulated_NK_cell" sem="G#cell_line">unstimulated NK cells</cons>, while the same <cons lex="parental_cell" sem="G#cell_type">parental cells</cons> but expressing the <cons lex="HPV_type_16" sem="G#virus"><cons lex="HPV" sem="G#virus">HPV</cons> type 16</cons> (<cons lex="HPV-16" sem="G#virus">HPV-16</cons>) or <cons lex="HPV-18" sem="G#virus">HPV-18</cons> <cons lex="E7_oncoprotein" sem="G#protein_molecule"><cons lex="E7" sem="G#protein_molecule">E7</cons> oncoprotein</cons> were resistant to <cons lex="NK_cell_lysis" sem="G#other_name">NK cell lysis</cons>.</sentence>
<sentence>The ability of <cons lex="IFN-activated_NK_cell" sem="G#cell_line">IFN-activated NK cells</cons> to selectively kill virally transformed cells depends on <cons lex="IFN" sem="G#protein_molecule">IFN</cons>'s ability to induce resistance to <cons lex="NK_cell_lysis" sem="G#other_name">NK cell lysis</cons> in normal (i.e., <cons lex="non-viral_oncogene-expressing_cell" sem="G#cell_line">non-viral oncogene-expressing</cons>) but not <cons lex="virally_transformed_cell" sem="G#cell_line">virally transformed cells</cons>.</sentence>
<sentence><cons lex="E1A" sem="G#protein_molecule">E1A</cons> blocked <cons lex="IFN" sem="G#protein_molecule">IFN</cons>'s induction of <cons lex="cytolytic_resistance" sem="G#other_name">cytolytic resistance</cons>, resulting in the selective lysis of <cons lex="adenovirus-transformed_cell" sem="G#cell_line">adenovirus-transformed cells</cons> by <cons lex="IFN-activated_NK_cell" sem="G#cell_line"><cons lex="IFN" sem="G#protein_molecule">IFN</cons>-activated NK cells</cons>.</sentence>
<sentence>The extent of <cons lex="IFN-induced_NK_cell_killing" sem="G#other_name"><cons lex="IFN" sem="G#protein_molecule">IFN</cons>-induced NK cell killing</cons> of <cons lex="E1A-expressing_cell" sem="G#cell_line"><cons lex="E1A" sem="G#protein_molecule">E1A</cons>-expressing cells</cons> was proportional to the level of <cons lex="E1A_expression" sem="G#other_name"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> expression</cons> and correlated with the ability of <cons lex="E1A" sem="G#protein_molecule">E1A</cons> to block <cons lex="IFN-stimulated_gene_expression" sem="G#other_name"><cons lex="IFN" sem="G#protein_molecule">IFN</cons>-stimulated gene expression</cons> in <cons lex="target_cell" sem="G#cell_type">target cells</cons>.</sentence>
<sentence>In contrast, <cons lex="E7" sem="G#protein_molecule">E7</cons> blocked neither <cons lex="IFN-stimulated_gene_expression" sem="G#other_name"><cons lex="IFN" sem="G#protein_molecule">IFN</cons>-stimulated gene expression</cons> nor <cons lex="IFN" sem="G#protein_molecule">IFN</cons>'s induction of <cons lex="cytolytic_resistance" sem="G#other_name">cytolytic resistance</cons>, thereby precluding the selective lysis of <cons lex="HPV-transformed_cell" sem="G#cell_line"><cons lex="HPV" sem="G#virus">HPV</cons>-transformed cells</cons> by <cons lex="IFN-activated_NK_cell" sem="G#cell_line"><cons lex="IFN" sem="G#protein_molecule">IFN</cons>-activated NK cells</cons>.</sentence>
<sentence>In conclusion, <cons lex="E1A_expression" sem="G#other_name"><cons lex="E1A" sem="G#protein_molecule">E1A</cons> expression</cons> marks cells for destruction by the <cons lex="host_NK_cell_response" sem="G#other_name">host <cons lex="NK_cell" sem="G#cell_type">NK cell</cons> response</cons>, whereas the <cons lex="E7_oncoprotein" sem="G#protein_molecule"><cons lex="E7" sem="G#protein_molecule">E7</cons> oncoprotein</cons> lacks this activity.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96062284</bibliomisc>
</articleinfo>
<title>
<sentence>Regulation of <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons> by <cons lex="(AND PKC-dependent_signal_transduction_pathway Ca(2+)-dependent_signal_transduction_pathway)" sem="(AND G#other_name G#other_name)"><cons lex="PKC-*">PKC-</cons> and <cons lex="Ca(2+)-*">Ca(2+)-</cons><cons lex="*dependent_signal_transduction_pathway">dependent signal transduction pathways</cons></cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="Ca(2+)-dependent_phosphatase" sem="G#protein_family_or_group"><cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent phosphatase</cons> <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons>, a target of <cons lex="FK506" sem="G#other_organic_compound">FK506</cons> and <cons lex="CsA" sem="G#other_organic_compound">CsA</cons>, synergizes with <cons lex="PKC-induced_activation" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-induced activation</cons> of <cons lex="nuclear_factor_(NF)-kappa_B" sem="G#protein_molecule">nuclear factor (NF)-kappa B</cons> in <cons lex="T_cell_line" sem="G#cell_line">T cell lines</cons>.</sentence>
<sentence>We have investigated whether this synergy is present in other cell types and the mechanism(s) by which these two pathways lead to <cons lex="NF-kappa_B_activation" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activation</cons>.</sentence>
<sentence>While this synergy is present in other cell types, in the <cons lex="monocytic_cell_line_U937" sem="G#cell_line">monocytic cell line U937</cons> <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons> is also sufficient to activate <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>.</sentence>
<sentence>Having previously shown that <cons lex="(AND Ca(2+)-dependent_pathway PKC-dependent_pathway)" sem="(AND G#other_name G#other_name)"><cons lex="Ca(2+)-*">Ca(2+)-</cons> and <cons lex="PKC-*">PKC-</cons><cons lex="*dependent_pathway">dependent pathways</cons></cons> synergize by accelerating the degradation of <cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons>, we focused on the regulation of <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons>.</sentence>
<sentence>While <cons lex="PKC-dependent_pathway" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-dependent pathways</cons> sequentially result in the phosphorylation and in an incomplete degradation of <cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> in <cons lex="T_cell_line" sem="G#cell_line">T cell lines</cons>, co-activation of <cons lex="Ca(2+)-dependent_pathway" sem="G#other_name"><cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent pathways</cons> accelerates the rate of <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons> and results in its complete degradation.</sentence>
<sentence>Activation of <cons lex="Ca(2+)-dependent_pathway" sem="G#other_name"><cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent pathways</cons> alone do not result in the <cons lex="phosphorylation" sem="G#other_name">phosphorylation</cons> and/or degradation of <cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> in <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T</cons> or in <cons lex="U937_cell" sem="G#cell_line">U937 cells</cons>.</sentence>
<sentence>Treatment of <cons lex="T_cell" sem="G#cell_type">T cells</cons> with the selective <cons lex="PKC_inhibitor" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons> inhibitor</cons> <cons lex="GF109203X" sem="G#other_organic_compound">GF109203X</cons> abrogates the <cons lex="PMA-induced_IkB_alpha_phosphorylation/degradation" sem="G#other_name"><cons lex="PMA" sem="G#other_organic_compound">PMA</cons>-induced <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons>/degradation</cons> irrespective of activation of <cons lex="Ca(2+)-dependent_pathway" sem="G#other_name"><cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent pathways</cons>, but not the phosphorylation and degradation of <cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> induced by <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>, a <cons lex="PKC-independent_stimulus" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-independent stimulus</cons>.</sentence>
<sentence>Contrary to the interaction with <cons lex="PKC,_Ca(2+)-dependent_pathway" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>, <cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent pathways</cons> synergize with <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> not at the level of <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons>, but at the level of its degradation.</sentence>
<sentence>These results indicate that <cons lex="Ca(2+)-dependent_pathway" sem="G#other_name"><cons lex="Ca(2+)" sem="G#atom">Ca(2+)</cons>-dependent pathways</cons>, including the <cons lex="phosphatase" sem="G#protein_family_or_group">phosphatase</cons> <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons>, participate in the regulation of <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> in a cell specific fashion and synergize with <cons lex="PKC-dependent_pathway" sem="G#other_name"><cons lex="PKC" sem="G#protein_molecule">PKC</cons>-dependent</cons> and <cons lex="-independent_pathway" sem="G#other_name">-independent pathways</cons> at the level of <cons lex="IkB_alpha_phosphorylation" sem="G#other_name"><cons lex="IkB_alpha" sem="G#protein_molecule">IkB alpha</cons> phosphorylation</cons> and <cons lex="degradation" sem="G#other_name">degradation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96054968</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="Vitamin_E_therapy" sem="G#other_name"><cons lex="Vitamin_E" sem="G#lipid">Vitamin E</cons> therapy</cons> of <cons lex="acute_CCl4-induced_hepatic_injury" sem="G#other_name">acute <cons lex="CCl4" sem="G#other_organic_compound">CCl4</cons>-induced hepatic injury</cons> in <cons lex="mice" sem="G#multi_cell">mice</cons> is associated with inhibition of <cons lex="nuclear_factor_kappa_B_binding" sem="G#other_name"><cons lex="nuclear_factor_kappa_B" sem="G#protein_molecule">nuclear factor kappa B</cons> binding</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="oxidative_stress" sem="G#other_name">Oxidative stress</cons>, with <cons lex="reactive_oxygen_intermediate_formation" sem="G#other_name"><cons lex="reactive_oxygen_intermediate" sem="G#inorganic">reactive oxygen intermediate</cons> formation</cons>, may represent a common mechanism by which <cons lex="liver_injury" sem="G#other_name"><cons lex="liver" sem="G#body_part">liver</cons> injury</cons> is induced by diverse etiologies.</sentence>
<sentence>Oxidative stress enhances <cons lex="nuclear_factor_kappa_B_(NF-kappa_B)_activity" sem="G#other_name"><cons lex="nuclear_factor_kappa_B" sem="G#protein_molecule">nuclear factor kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>) activity</cons>, and <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activity</cons> has been shown to enhance the expression of <cons lex="cytotoxic_cytokine" sem="G#protein_family_or_group">cytotoxic cytokines</cons>.</sentence>
<sentence>Acute hepatic injury caused by <cons lex="reactive_oxygen_intermediate_production" sem="G#other_name"><cons lex="reactive_oxygen_intermediate" sem="G#other_organic_compound">reactive oxygen intermediate</cons> production</cons> was induced by an intraperitoneal injection of <cons lex="CCl4" sem="G#other_organic_compound">CCl4</cons> in <cons lex="mice" sem="G#multi_cell">mice</cons>.</sentence>
<sentence>This injury was significantly inhibited by intravenous pretreatment of the <cons lex="mice" sem="G#multi_cell">mice</cons> with a water-soluble emulsion of <cons lex="alpha-tocopherol" sem="G#other_organic_compound">alpha-tocopherol</cons>.</sentence>
<sentence><cons lex="alpha-tocopherol_treatment" sem="G#other_name">Alpha-tocopherol treatment</cons> of the <cons lex="mice" sem="G#multi_cell">mice</cons> given the <cons lex="CCl4" sem="G#other_organic_compound">CCl4</cons> also reduced the <cons lex="NF-kappa_B_binding" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> binding</cons> to levels approaching those found in <cons lex="normal_mice" sem="G#multi_cell">normal <cons lex="mice" sem="G#multi_cell">mice</cons></cons>.</sentence>
<sentence>In vitro treatment of a monocyte/macrophage cell line with <cons lex="CCl4" sem="G#other_organic_compound">CCl4</cons> led to enhanced <cons lex="NF-kappa_B_binding" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> binding</cons> and an increase in <cons lex="tumor_necrosis_factor-alpha_(TNF-alpha)_messenger_RNA_levels" sem="G#other_name"><cons lex="tumor_necrosis_factor-alpha_(TNF-alpha)_messenger_RNA" sem="G#RNA_molecule"><cons lex="tumor_necrosis_factor-alpha" sem="G#protein_molecule">tumor necrosis factor-alpha</cons> (<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>) messenger RNA</cons> levels</cons>.</sentence>
<sentence>Liver specimens taken from patients with <cons lex="acute_fulminant_hepatitis" sem="G#other_name">acute fulminant hepatitis</cons> had markedly increased <cons lex="NF-kappa_B_binding_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> binding activity</cons> in comparison with the binding of <cons lex="normal_liver" sem="G#body_part">normal livers</cons>.</sentence>
<sentence>These data demonstrate that abolishing <cons lex="acute_hepatic_injury" sem="G#other_name">acute hepatic injury</cons> with <cons lex="alpha-tocopherol" sem="G#other_organic_compound">alpha-tocopherol</cons>, a free <cons lex="radical_scavenger" sem="G#other_name">radical scavenger</cons>, also eliminated increased <cons lex="NF-kappa_B_binding" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> binding</cons>.</sentence>
<sentence>It is tempting to speculate that enhanced <cons lex="NF-kappa_B_expression" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> expression</cons> caused by <cons lex="free_radical_production/oxidative_stress" sem="G#other_name">free radical production/oxidative stress</cons> may modulate <cons lex="liver_injury" sem="G#other_name"><cons lex="liver" sem="G#body_part">liver</cons> injury</cons>, perhaps through an effect on <cons lex="cytotoxic_cytokine_synthesis" sem="G#other_name"><cons lex="cytotoxic_cytokine" sem="G#protein_family_or_group">cytotoxic cytokine</cons> synthesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96026328</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="immunosuppression" sem="G#other_name">Immunosuppression</cons> by <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons>: inhibition of <cons lex="NF-kappa_B_activity" sem="G#other_name"><cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activity</cons> through induction of <cons lex="I_kappa_B_synthesis" sem="G#other_name"><cons lex="I_kappa_B" sem="G#protein_molecule">I kappa B</cons> synthesis</cons> [see comments]</sentence>
</title>
<abstract>
<sentence><cons lex="glucocorticoid" sem="G#lipid">Glucocorticoids</cons> are among the most potent <cons lex="(AND anti-inflammatory_agent immunosuppressive_agent)" sem="(AND G#other_name G#other_name)"><cons lex="anti-inflammatory*">anti-inflammatory</cons> and <cons lex="immunosuppressive*">immunosuppressive</cons> <cons lex="*agent">agents</cons></cons>.</sentence>
<sentence>They inhibit synthesis of almost all known <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> and of several <cons lex="cell_surface_molecule" sem="G#protein_family_or_group">cell surface molecules</cons> required for <cons lex="immune_function" sem="G#other_name">immune function</cons>, but the mechanism underlying this activity has been unclear. Here it is shown that <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons> are potent <cons lex="inhibitor" sem="G#other_name">inhibitors</cons> of <cons lex="nuclear_factor_kappa_B_(NF-kappa_B)_activation" sem="G#other_name"><cons lex="nuclear_factor_kappa_B" sem="G#protein_molecule">nuclear factor kappa B</cons> (<cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>) activation</cons> in <cons lex="mice" sem="G#multi_cell">mice</cons> and <cons lex="cultured_cell" sem="G#cell_line">cultured cells</cons>.</sentence>
<sentence>This inhibition is mediated by induction of the <cons lex="I_kappa_B" sem="G#protein_molecule">I kappa B</cons> alpha inhibitory protein, which traps activated <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> in <cons lex="inactive_cytoplasmic_complex" sem="G#protein_complex">inactive cytoplasmic complexes</cons>.</sentence>
<sentence>Because <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> activates many <cons lex="immunoregulatory_gene" sem="G#DNA_domain_or_region">immunoregulatory genes</cons> in response to pro-inflammatory stimuli, the inhibition of its activity can be a major component of the <cons lex="anti-inflammatory_activity" sem="G#other_name">anti-inflammatory activity</cons> of <cons lex="glucocorticoid" sem="G#lipid">glucocorticoids</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96009608</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcriptional_repression" sem="G#other_name">Transcriptional repression</cons> of the <cons lex="interleukin-2_gene" sem="G#DNA_domain_or_region">interleukin-2 gene</cons> by <cons lex="vitamin_D3" sem="G#lipid">vitamin D3</cons>: direct inhibition of <cons lex="NFATp/AP-1_complex_formation" sem="G#other_name"><cons lex="NFATp/AP-1_complex" sem="G#protein_complex">NFATp/AP-1 complex</cons> formation</cons> by a <cons lex="nuclear_hormone_receptor" sem="G#protein_family_or_group">nuclear hormone receptor</cons>.</sentence>
</title>
<abstract>
<sentence>T-<cons lex="lymphocyte_proliferation" sem="G#other_name">lymphocyte proliferation</cons> is suppressed by <cons lex="1,25-dihydroxyvitamin_D3" sem="G#lipid">1,25-dihydroxyvitamin D3</cons> [<cons lex="1,25(OH)2D3" sem="G#lipid">1,25(OH)2D3</cons>], the active metabolite of <cons lex="vitamin_D3" sem="G#lipid">vitamin D3</cons>, and is associated with a decrease in <cons lex="(AND interleukin_2_(IL-2)_mRNA_level gamma_interferon_mRNA_level granulocyte-macrophage_colony-stimulating_factor_mRNA_level)" sem="(AND G#other_name G#other_name G#other_name)"><cons lex="interleukin_2_(IL-2)*">interleukin 2 (IL-2)</cons>, <cons lex="gamma_interferon*">gamma interferon</cons>, and <cons lex="granulocyte-macrophage_colony-stimulating_factor*">granulocyte-macrophage colony-stimulating factor</cons> <cons lex="*mRNA_level">mRNA levels</cons></cons>.</sentence>
<sentence>We report here that <cons lex="1,25(OH)2D3-mediated_repression" sem="G#other_name"><cons lex="1,25(OH)2D3" sem="G#lipid">1,25(OH)2D3</cons>-mediated repression</cons> in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> is <cons lex="cycloheximide_resistan" sem="G#other_name"><cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons> resistant</cons>, suggesting that it is a direct transcriptional repressive effect on <cons lex="IL-2_expression" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> expression</cons> by the <cons lex="vitamin_D3_receptor" sem="G#protein_family_or_group"><cons lex="vitamin_D3" sem="G#lipid">vitamin D3</cons> receptor</cons> (<cons lex="VDR" sem="G#protein_family_or_group">VDR</cons>).</sentence>
<sentence>We therefore examined <cons lex="vitamin_D3-mediated_repression" sem="G#other_name"><cons lex="vitamin_D3" sem="G#lipid">vitamin D3</cons>-mediated repression</cons> of <cons lex="activated_IL-2_expression" sem="G#other_name">activated <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> expression</cons> by cotransfecting <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> with <cons lex="IL-2_promoter/reporter_construct" sem="G#DNA_family_or_group"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> promoter/reporter constructs</cons> and a <cons lex="VDR_overexpression_vector" sem="G#DNA_molecule"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> overexpression vector</cons> and by <cons lex="DNA_binding" sem="G#other_name">DNA binding</cons>.</sentence>
<sentence>We delineated an element conferring both DNA binding by the receptor in vitro and <cons lex="1,25(OH)2D3-mediated_repression" sem="G#other_name"><cons lex="1,25(OH)2D3" sem="G#lipid">1,25(OH)2D3</cons>-mediated repression</cons> in vivo to a short <cons lex="40-bp_region" sem="G#DNA_domain_or_region">40-bp region</cons> encompassing an important <cons lex="positive_regulatory_element" sem="G#DNA_domain_or_region">positive regulatory element</cons>, <cons lex="NF-AT-1" sem="G#DNA_domain_or_region">NF-AT-1</cons>, which is bound by a <cons lex="T-cell-specific_transcription_factor" sem="G#protein_family_or_group">T-cell-specific transcription factor</cons>, <cons lex="NFATp" sem="G#protein_molecule">NFATp</cons>, as well as by <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>.</sentence>
<sentence><cons lex="VDR_DNA-binding_mutant" sem="G#protein_family_or_group"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> DNA-binding mutants</cons> were unable to either bind to this element in vitro or repress in vivo; the <cons lex="VDR_DNA-binding_domain" sem="G#protein_domain_or_region"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> DNA-binding domain</cons> alone, however, bound the element but also could not repress <cons lex="IL-2_expression" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> expression</cons>.</sentence>
<sentence>These results indicate that DNA binding by <cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> is necessary but not sufficient to mediate <cons lex="IL-2_repression" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> repression</cons>.</sentence>
<sentence>By combining <cons lex="partially_purified_protein" sem="G#protein_family_or_group">partially purified proteins</cons> in vitro, we observed the loss of the bound <cons lex="NFATp/AP-1-DNA_complex" sem="G#protein_complex"><cons lex="NFATp" sem="G#protein_molecule">NFATp</cons>/AP-1-DNA complex</cons> upon inclusion of <cons lex="VDR" sem="G#protein_family_or_group">VDR</cons> or <cons lex="VDR-retinoid_X_receptor" sem="G#protein_molecule"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons>-retinoid X receptor</cons>.</sentence>
<sentence>Order of addition and off-rate experiments indicate that the <cons lex="VDR-retinoid_X_receptor_heterodimer" sem="G#protein_molecule"><cons lex="VDR" sem="G#protein_family_or_group">VDR</cons>-retinoid X receptor heterodimer</cons> blocks <cons lex="NFATp/AP-1_complex_formation" sem="G#other_name"><cons lex="NFATp/AP-1_complex" sem="G#protein_complex"><cons lex="NFATp" sem="G#protein_molecule">NFATp</cons>/<cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> complex</cons> formation</cons> and then stably associates with the <cons lex="NF-AT-1_element" sem="G#DNA_domain_or_region"><cons lex="NF-AT-1" sem="G#DNA_domain_or_region">NF-AT-1</cons> element</cons>.</sentence>
<sentence>This direct inhibition by a nuclear hormone receptor of <cons lex="transcriptional_activator" sem="G#protein_family_or_group">transcriptional activators</cons> of the <cons lex="IL-2_gene" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> gene</cons> may provide a mechanistic explanation of how vitamin derivatives can act as potent <cons lex="immunosuppressive_agents" sem="G#other_name">immunosuppressive agents</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96017769</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="tissue-specific_regulation" sem="G#other_name">Tissue-specific regulation</cons> of the <cons lex="rabbit_15-lipoxygenase_gene" sem="G#DNA_domain_or_region"><cons lex="rabbit" sem="G#multi_cell">rabbit</cons> <cons lex="15-lipoxygenase" sem="G#protein_molecule">15-lipoxygenase</cons> gene</cons> in <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons> by a <cons lex="transcriptional_silencer" sem="G#DNA_domain_or_region">transcriptional silencer</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="15-lipoxygenase_(lox)_gene" sem="G#DNA_domain_or_region">15-lipoxygenase (lox) gene</cons> is expressed in a <cons lex="tissue-specific_manner" sem="G#other_name">tissue-specific manner</cons>, predominantly in <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons> but also in <cons lex="airway_epithelial_cell" sem="G#cell_type">airway epithelial cells</cons> and <cons lex="eosinophil" sem="G#cell_type">eosinophils</cons>.</sentence>
<sentence>We demonstrate in this report that the <cons lex="5'_flanking_DNA" sem="G#DNA_domain_or_region">5' flanking DNA</cons> of the <cons lex="15-lox_gene" sem="G#DNA_domain_or_region">15-lox gene</cons> contains sequences which down-regulate its activity in a variety of <cons lex="non-erythroid_cell_line" sem="G#cell_line">non-erythroid cell lines</cons> but not in two <cons lex="erythroid_cell_line" sem="G#cell_line">erythroid cell lines</cons>.</sentence>
<sentence>The element has characteristics of a <cons lex="transcriptional_'silencer'" sem="G#DNA_family_or_group">transcriptional 'silencer'</cons> since it functions in both orientations.</sentence>
<sentence>The main activity of the <cons lex="silencer" sem="G#DNA_family_or_group">silencer</cons> has been mapped to the first 900 bp of <cons lex="5'_flanking_DNA" sem="G#DNA_domain_or_region">5' flanking DNA</cons>, which contains nine binding sites for a <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factor</cons> present in non-<cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons> but not in <cons lex="erythroid_cell" sem="G#cell_type">erythroid cells</cons>.</sentence>
<sentence>These binding sites have similar sequences and multiple copies of the <cons lex="binding_site" sem="G#DNA_domain_or_region">binding sites</cons> confer <cons lex="tissue-specific_down-regulation" sem="G#other_name">tissue-specific down-regulation</cons> when attached to a <cons lex="minimal_lox_promoter_fragment" sem="G#DNA_molecule">minimal <cons lex="lox_promoter" sem="G#DNA_domain_or_region">lox promoter</cons> fragment</cons>.</sentence>
<sentence>The <cons lex="5'_flanking_DNA" sem="G#DNA_domain_or_region">5' flanking DNA</cons> also contains a cluster of three <cons lex="binding_site" sem="G#DNA_domain_or_region">binding sites</cons> for the <cons lex="GATA_family" sem="G#protein_family_or_group">GATA family</cons> of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95386516</bibliomisc>
</articleinfo>
<title>
<sentence>Phosphorylation of the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NFATp" sem="G#protein_molecule">NFATp</cons> inhibits its <cons lex="DNA_binding_activity" sem="G#other_name">DNA binding activity</cons> in <cons lex="cyclosporin_A-treated_human_B_cell" sem="G#cell_line">cyclosporin A-treated human B</cons> and <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="cyclosporin_A" sem="G#other_organic_compound">Cyclosporin A</cons> (<cons lex="CsA" sem="G#other_organic_compound">CsA</cons>) exerts its immunosuppressive effect by inhibiting the activity of <cons lex="nuclear_factor" sem="G#protein_family_or_group">nuclear factor</cons> of activated <cons lex="T_cell" sem="G#cell_type">T cells</cons> (<cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons>), thus preventing transcriptional induction of several cytokine genes.</sentence>
<sentence>This effect is thought to be largely mediated through inactivation of the phosphatase <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons>, which in turn inhibits translocation of an <cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons> component to the nucleus.</sentence>
<sentence>Here we report that <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> treatment of <cons lex="Raji_B" sem="G#cell_line">Raji B</cons> and <cons lex="Jurkat_T_cell_line" sem="G#cell_line">Jurkat <cons lex="T_cell_line" sem="G#cell_line">T cell lines</cons></cons> yields a phosphorylated form of <cons lex="NFATp" sem="G#protein_molecule">NFATp</cons> that is inhibited in DNA-binding and in its ability to form an <cons lex="NFAT_complex" sem="G#protein_complex">NFAT complex</cons> with <cons lex="Fos" sem="G#protein_family_or_group">Fos</cons> and <cons lex="Jun" sem="G#protein_family_or_group">Jun</cons>.</sentence>
<sentence><cons lex="Immunoblot_analysis" sem="G#other_name">Immunoblot analyses</cons> and metabolic labeling with <cons lex="[32P]orthophosphate" sem="G#other_organic_compound">[32P]orthophosphate</cons> show that <cons lex="CsA" sem="G#other_organic_compound">CsA</cons> alters <cons lex="NFATp_migration" sem="G#other_name"><cons lex="NFATp" sem="G#protein_molecule">NFATp</cons> migration</cons> on <cons lex="SDS-polyacrylamide_gel_electrophoresis" sem="G#other_name">SDS-polyacrylamide gel electrophoresis</cons> by increasing its <cons lex="phosphorylation_level" sem="G#other_name">phosphorylation level</cons> without affecting subcellular distribution.</sentence>
<sentence>Dephosphorylation by <cons lex="in_vitro_treatment" sem="G#other_name">in vitro treatment</cons> with <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons> or <cons lex="alkaline_phosphatase" sem="G#protein_molecule">alkaline phosphatase</cons> restores <cons lex="NFATp" sem="G#protein_molecule">NFATp</cons> <cons lex="DNA_binding_activity" sem="G#other_name">DNA binding activity</cons> and its ability to reconstitute an <cons lex="NFAT_complex" sem="G#protein_complex">NFAT complex</cons> with <cons lex="Fos" sem="G#protein_family_or_group">Fos</cons> and <cons lex="Jun" sem="G#protein_family_or_group">Jun</cons> proteins.</sentence>
<sentence>These data point to a new mechanism for <cons lex="CsA-sensitive_regulation" sem="G#other_name"><cons lex="CsA" sem="G#other_organic_compound">CsA</cons>-sensitive regulation</cons> of <cons lex="NFATp" sem="G#protein_molecule">NFATp</cons> in which <cons lex="dephosphorylation" sem="G#other_name">dephosphorylation</cons> is critical for DNA binding.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95367586</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="transcription_factor" sem="G#protein_family_or_group">Transcription factors</cons> as targets for oxidative signalling during <cons lex="lymphocyte_activation" sem="G#other_name">lymphocyte activation</cons>.</sentence>
</title>
<abstract>
<sentence>We previously have demonstrated a requirement for oxidative events during cell cycle entry in <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons> and have hypothesised that <cons lex="reactive_oxygen_specie" sem="G#inorganic">reactive oxygen species</cons> may act as <cons lex="intracellular_signalling_agents" sem="G#other_name">intracellular signalling agents</cons> during <cons lex="lymphocyte_activationp" sem="G#other_name">lymphocyte activation</cons>.</sentence>
<sentence>In the current study, <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons>, an <cons lex="aminothiol_compound" sem="G#other_organic_compound">aminothiol compound</cons> with <cons lex="antioxidant_activity" sem="G#other_name">antioxidant activity</cons>, has been used to further investigate the role of <cons lex="oxidative_signalling" sem="G#other_name">oxidative signalling</cons> during <cons lex="lymphocyte_activation" sem="G#other_name">lymphocyte activation</cons>.</sentence>
<sentence>Treatment of normal <cons lex="human_peripheral_blood_lymphocyte" sem="G#cell_type">human peripheral blood lymphocytes</cons> with <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> in vitro was found to inhibit <cons lex="proliferation" sem="G#other_name">proliferation</cons> in a <cons lex="dose-dependent_manner" sem="G#other_name">dose-dependent manner</cons>, with essentially complete inhibition occurring at a dose of 400 microM.</sentence>
<sentence>This inhibitory effect was limited to the first 2 h after <cons lex="mitogenic_activation" sem="G#other_name">mitogenic activation</cons>, localizing the time-frame of action of <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> to within the <cons lex="commitment_period" sem="G#other_name">commitment period</cons>.</sentence>
<sentence>It therefore was of interest to establish which, if any, commitment events were affected by <cons lex="oxidative_signalling" sem="G#other_name">oxidative signalling</cons> during <cons lex="cell_cycle_entry" sem="G#other_name">cell cycle entry</cons>.</sentence>
<sentence>Taking the <cons lex="IL-2_gene" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> gene</cons> as a candidate, we examined the effect of <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> treatment on <cons lex="early_gene_expression" sem="G#other_name"><cons lex="early_gene" sem="G#DNA_family_or_group">early gene</cons> expression</cons> during <cons lex="lymphocyte_activation" sem="G#other_name">lymphocyte activation</cons>, and on the activity of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>, <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons>, <cons lex="NF-AT" sem="G#protein_molecule">NF-AT</cons> and <cons lex="Oct1" sem="G#protein_molecule">Oct1</cons>, whose functions are required for expression of the <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> mRNA.</sentence>
<sentence><cons lex="c_treatment" sem="G#other_name"><cons lex="cysteamine" sem="G#other_organic_compound">Cysteamine</cons> treatment</cons> inhibited both expression of the <cons lex="IL-2_mRNA" sem="G#RNA_molecule"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> mRNA</cons> and secretion of <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> into the <cons lex="culture_medium" sem="G#other_organic_compound">culture medium</cons>.</sentence>
<sentence>The inhibitory effect of <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> may be mediated at least in part by an effect on <cons lex="transcription_factor_function" sem="G#other_name"><cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> function</cons>, as the DNA <cons lex="binding_activity" sem="G#other_name">binding activities</cons> of <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> and <cons lex="NF-kappa_B" sem="G#protein_molecule">NF-kappa B</cons> extracted from <cons lex="mitogen-stimulated_cell" sem="G#cell_type">mitogen-stimulated cells</cons> were significantly inhibited by <cons lex="cysteamine_treatment" sem="G#other_name"><cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> treatment</cons>.</sentence>
<sentence>Interestingly, <cons lex="(AND Oct1_DNA_binding_activity NF-AT_DNA_binding_activity)" sem="(AND G#other_name G#other_name)"><cons lex="Oct1*">Oct1</cons> and <cons lex="NF-AT*">NF-AT</cons> <cons lex="*DNA_binding_activity">DNA binding activity</cons></cons> were not affected by <cons lex="cysteamine" sem="G#other_organic_compound">cysteamine</cons> treatment, suggesting that <cons lex="oxidative_signalling_process" sem="G#other_name">oxidative signalling processes</cons> operate in a selective manner.</sentence>
<sentence>The identification of <cons lex="regulatory_protein" sem="G#protein_family_or_group">regulatory proteins</cons>, such as <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>, as molecular targets for <cons lex="oxidative_signalling" sem="G#other_name">oxidative signalling</cons> provides further evidence to implicate <cons lex="oxidative_signalling" sem="G#other_name">oxidative signalling</cons> as being intimately involved in the <cons lex="G0_to_G1_phase_transition" sem="G#other_name">G0 to G1 phase transition</cons> in <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:91175240</bibliomisc>
</articleinfo>
<title>
<sentence>Sex and age distribution of <cons lex="1,25(OH)2D3_receptors" sem="G#protein_family_or_group">1,25(OH)2D3 receptors</cons> in <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> from <cons lex="normal_human_subject" sem="G#multi_cell">normal human subjects</cons>.</sentence>
</title>
<abstract>
<sentence>Specific receptors for <cons lex="1,25_Dihydroxyvitamin_D3" sem="G#lipid">1,25 Dihydroxyvitamin D3</cons> have been described in human <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> (<cons lex="PBMC" sem="G#cell_type">PBMC</cons>).</sentence>
<sentence>We have tried to find out whether these receptors could show any difference in sex or age distribution.</sentence>
<sentence>Twenty two <cons lex="healthy_men" sem="G#multi_cell">healthy men</cons> aged 21-66 yr (mean +/- SD 41.0 +/- 13.6) and nineteen <cons lex="healthy_women" sem="G#multi_cell">healthy women</cons> aged 22-60 yr (38.9 +/- 13.9) have been studied.</sentence>
<sentence>The <cons lex="mean_dissociation_constant" sem="G#other_name">mean dissociation constant</cons> (<cons lex="Kd" sem="G#other_name">Kd</cons>) was similar in both sexes (1.35 +/- 0.70 x 10(-10) M in males, 1.13 +/- 0.66 x 10(-10) M in females), but the concentration of binding sites (Nmax) was significantly lower in <cons lex="female" sem="G#multi_cell">females</cons> (2.32 +/- 0.92 fmol/10(7) <cons lex="PBMC" sem="G#cell_type">PBMC</cons> vs 4.43 +/- 1.38 fmol/10(7) <cons lex="PBMC" sem="G#cell_type">PBMC</cons> in <cons lex="male" sem="G#multi_cell">males</cons>; p = 0.0001).</sentence>
<sentence>Neither Kd nor Nmax were significantly correlated with age.</sentence>
<sentence>No difference was found between <cons lex="(AND premenopausal_woman postmenopausal_woman)" sem="(AND G#multi_cell G#multi_cell)"><cons lex="pre*">pre</cons> and <cons lex="postmenopausal_women" sem="G#multi_cell"><cons lex="post*">post</cons><cons lex="*menopausal*">menopausal</cons> <cons lex="*woman">women</cons></cons></cons>.</sentence>
<sentence>Further studies are needed to elucidate if this <cons lex="sex_difference" sem="G#other_name">sex difference</cons> in <cons lex="PBMC_receptors" sem="G#protein_family_or_group"><cons lex="PBMC" sem="G#cell_type">PBMC</cons> receptors</cons> for 1.25 <cons lex="Dihydroxyvitamin_D3" sem="G#lipid">Dihydroxyvitamin D3</cons> is of any <cons lex="pathophysiological_relevance" sem="G#other_name">pathophysiological relevance</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96226053</bibliomisc>
</articleinfo>
<title>
<sentence>Expression of <cons lex="(AND Id2_mRNA Id3_mRNA)" sem="(AND G#RNA_N/A G#RNA_N/A)"><cons lex="Id2*">Id2</cons> and <cons lex="Id3*">Id3</cons> <cons lex="*mRNA">mRNA</cons></cons> in <cons lex="human_lymphocyte" sem="G#cell_type">human lymphocytes</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="helix-loop-helix_(HLH)_transcription_factor" sem="G#protein_family_or_group"><cons lex="helix-loop-helix" sem="G#protein_substructure">Helix-loop-helix</cons> (<cons lex="HLH" sem="G#protein_substructure">HLH</cons>) transcription factors</cons> are involved in <cons lex="cellular_growth" sem="G#other_name">cellular growth</cons> and <cons lex="differentiation" sem="G#other_name">differentiation</cons>.</sentence>
<sentence>The <cons lex="Id" sem="G#protein_family_or_group">Id</cons> (<cons lex="inhibitor_of_DNA_binding_and_differentiation" sem="G#other_name">inhibitor of DNA binding and differentiation</cons>) <cons lex="HLH_protein" sem="G#protein_family_or_group">HLH proteins</cons>, in a dominantly negative fashion, regulate <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activities</cons> of <cons lex="basic_HLH_protein" sem="G#protein_family_or_group">basic HLH proteins</cons>.</sentence>
<sentence>We examined by <cons lex="northern_hybridization" sem="G#other_name">northern hybridization</cons> the expression of <cons lex="(AND Id2_mRNA Id3_mRNA)" sem="(AND G#RNA_molecule G#RNA_molecule)"><cons lex="Id2*">Id2</cons> and <cons lex="Id3*">Id3</cons> <cons lex="*mRNA">mRNA</cons></cons> in <cons lex="human_leukemia/lymphoma_line" sem="G#cell_line">human leukemia/lymphoma lines</cons> and <cons lex="patient_sample" sem="G#other_name">patient samples</cons>, as well as resting and <cons lex="activated_normal_human_lymphocyte" sem="G#cell_line">activated normal human lymphocytes</cons> from <cons lex="peripheral_blood" sem="G#tissue">peripheral blood</cons> (<cons lex="PBL" sem="G#cell_type">PBL</cons>).</sentence>
<sentence>The <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons> mRNA</cons> was abundantly expressed in <cons lex="5/12_T-cell" sem="G#cell_line">5/12 T-cell</cons> and <cons lex="3/4_B-cell_line" sem="G#cell_line">3/4 B-cell lines</cons>, and <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons> was detected in <cons lex="4/12_T-cell" sem="G#cell_line">4/12 T-cell</cons> and <cons lex="3/4_B-cell_line" sem="G#cell_line">3/4 B-cell lines</cons>.</sentence>
<sentence>Interestingly, <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons></cons>, but not <cons lex="Id3_mRNA" sem="G#RNA_molecule"><cons lex="Id3" sem="G#protein_molecule">Id3</cons></cons>, mRNA was strongly expressed in <cons lex="4/5_T-cell_line" sem="G#cell_line">4/5 T-cell lines</cons> infected with <cons lex="(AND human_T-cell_leukemia_virus_type_I_(HTLV-I)_(ATL-1k,_MT-2,_S-LB1) human_T-cell_leukemia_virus_type_II_(Mo))" sem="(AND G#virus G#virus)"><cons lex="human_T-cell_leukemia_virus*">human T-cell leukemia virus</cons> <cons lex="*type_I_(HTLV-I)_(ATL-1k,_MT-2,_S-LB1)">type I (<cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>) (<cons lex="ATL-1k" sem="G#cell_line">ATL-1k</cons>, <cons lex="MT-2" sem="G#cell_line">MT-2</cons>, <cons lex="S-LB1" sem="G#cell_line">S-LB1</cons>)</cons> and <cons lex="*type_II_(Mo)">type II (<cons lex="Mo" sem="G#cell_line">Mo</cons>)</cons></cons>.</sentence>
<sentence>Another unexpected finding was that <cons lex="T-cell_leukemia" sem="G#other_name">T-cell leukemias</cons> and <cons lex="T-cell_line" sem="G#cell_line">T-cell lines</cons> often expressed either <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons></cons> or <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons>.</sentence>
<sentence>In addition, <cons lex="resting_PBL" sem="G#cell_type">resting <cons lex="PBL" sem="G#cell_type">PBL</cons></cons> constitutively expressed prominent levels of <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons> mRNA</cons>, but not <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons>.</sentence>
<sentence>Upon <cons lex="PHA-stimulation" sem="G#other_name"><cons lex="PHA" sem="G#protein_molecule">PHA</cons>-stimulation</cons>, <cons lex="Id2_expression" sem="G#other_name"><cons lex="Id2" sem="G#protein_molecule">Id2</cons> expression</cons> decreased and <cons lex="Id3_level" sem="G#other_name"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> levels</cons> increased with biphasic kinetics.</sentence>
<sentence>Taken together, our studies revealed three unexpected findings which require further analysis: (1) expression of <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons> mRNA</cons> is often associated with lymphocytic transformation by <cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> or -II; (2) T-cells usually express either <cons lex="Id2" sem="G#protein_molecule">Id2</cons> or <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons>, but B-cells often express both simultaneously; (3) non-dividing, normal <cons lex="PBL" sem="G#cell_type">PBL</cons> express high levels of <cons lex="Id2" sem="G#protein_molecule">Id2</cons> and no <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons>; and with the onset of cellular proliferation, levels of <cons lex="Id2_mRNA" sem="G#RNA_molecule"><cons lex="Id2" sem="G#protein_molecule">Id2</cons> mRNA</cons> decrease while levels of <cons lex="Id3_mRNA" sem="G#RNA_family_or_group"><cons lex="Id3" sem="G#protein_molecule">Id3</cons> mRNA</cons> increase, suggesting that regulation of expression of these closely related <cons lex="gene" sem="G#DNA_family_or_group">genes</cons> is disparate.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96082168</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="salicylate" sem="G#other_organic_compound">Salicylates</cons> inhibit <cons lex="lipopolysaccharide-induced_transcriptional_activation" sem="G#other_name"><cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons>-induced transcriptional activation</cons> of the tissue factor gene in <cons lex="human_monocytic_cell" sem="G#cell_type">human monocytic cells</cons>.</sentence>
</title>
<abstract>
<sentence>Binding of <cons lex="plasma_Factor_VII/VIIa" sem="G#protein_molecule">plasma Factor VII/VIIa</cons> to the <cons lex="tissue_factor_(TF)_receptor" sem="G#protein_family_or_group">tissue factor (TF) receptor</cons> initiates the <cons lex="coagulation_protease_cascade" sem="G#other_name"><cons lex="coagulation_protease" sem="G#protein_family_or_group">coagulation protease</cons> cascades</cons>.</sentence>
<sentence><cons lex="TF_expression" sem="G#other_name">TF expression</cons> by <cons lex="circulating_monocyte" sem="G#cell_type">circulating monocytes</cons> is associated with <cons lex="thrombotic_complication" sem="G#other_name">thrombotic</cons> and <cons lex="inflammatory_complication" sem="G#other_name">inflammatory complications</cons> in a variety of diseases.</sentence>
<sentence>Transcriptional activation of the <cons lex="human_TF_gene" sem="G#DNA_domain_or_region">human TF gene</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> exposed to <cons lex="bacterial_lipopolysaccharide" sem="G#lipid">bacterial <cons lex="lipopolysaccharide" sem="G#lipid">lipopolysaccharide</cons></cons> (<cons lex="LPS" sem="G#lipid">LPS</cons>) is mediated by binding of <cons lex="c-Rel/p65_heterodimer" sem="G#protein_complex">c-Rel/p65 heterodimers</cons> to a <cons lex="kappa_B_site" sem="G#DNA_domain_or_region">kappa B site</cons> in the <cons lex="TF_promoter" sem="G#DNA_domain_or_region">TF promoter</cons>.</sentence>
<sentence>Here, we report that a family of <cons lex="anti-inflammatory_agent" sem="G#other_name">anti-inflammatory agents</cons>, known as the salicylates, inhibited <cons lex="LPS" sem="G#lipid">LPS</cons> induction of <cons lex="TF_activity" sem="G#other_name">TF activity</cons> and <cons lex="TF_gene_transcription" sem="G#other_name"><cons lex="TF_gene" sem="G#DNA_domain_or_region">TF gene</cons> transcription</cons> in <cons lex="human_monocyte" sem="G#cell_type">human monocytes</cons> and <cons lex="monocytic_THP-1_cell" sem="G#cell_line">monocytic THP-1 cells</cons> at clinically relevant doses.</sentence>
<sentence>Furthermore, sodium salicylate blocked the <cons lex="LPS-induced_proteolytic_degradation" sem="G#other_name"><cons lex="LPS" sem="G#lipid">LPS</cons>-induced proteolytic degradation</cons> of <cons lex="I_kappa_B_alpha" sem="G#protein_molecule">I kappa B alpha</cons>, which prevented the <cons lex="nuclear_translocation" sem="G#other_name">nuclear translocation</cons> of <cons lex="c-Rel/p65_heterodimer" sem="G#protein_complex">c-Rel/p65 heterodimers</cons>.</sentence>
<sentence>In contrast, two other <cons lex="nonsteroidal_anti-inflammatory_drug" sem="G#other_name">nonsteroidal anti-inflammatory drugs</cons>, <cons lex="ibuprofen" sem="G#other_organic_compound">ibuprofen</cons> and <cons lex="indomethacin" sem="G#other_organic_compound">indomethacin</cons>, did not inhibit <cons lex="LPS" sem="G#lipid">LPS</cons> induction of the <cons lex="TF_gene" sem="G#DNA_domain_or_region">TF gene</cons>.</sentence>
<sentence>These results indicated that <cons lex="salicylate" sem="G#other_organic_compound">salicylates</cons> inhibited <cons lex="LPS" sem="G#lipid">LPS</cons> induction of <cons lex="TF_gene_transcription" sem="G#other_name"><cons lex="TF_gene" sem="G#DNA_domain_or_region">TF gene</cons> transcription</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons> by preventing <cons lex="nuclear_translocation" sem="G#other_name">nuclear translocation</cons> of <cons lex="c-Rel/p65_heterodimer" sem="G#protein_complex">c-Rel/p65 heterodimers</cons>.</sentence>
<sentence>The clinical benefits of <cons lex="salicylate" sem="G#other_organic_compound">salicylates</cons> in the treatment of several diseases, including <cons lex="atherosclerosis" sem="G#other_name">atherosclerosis</cons> and <cons lex="rheumatoid_arthritis" sem="G#other_name">rheumatoid arthritis</cons>, may be related to their ability to reduce <cons lex="monocyte_gene_expression" sem="G#other_name">monocyte gene expression</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96062272</bibliomisc>
</articleinfo>
<title>
<sentence>Activation of the <cons lex="signal_transducer" sem="G#other_name">signal transducer</cons> and <cons lex="transcription_(STAT)_signaling_pathway" sem="G#other_name">transcription (<cons lex="STAT" sem="G#protein_family_or_group">STAT</cons>) signaling pathway</cons> in a <cons lex="primary_T_cell_response" sem="G#other_name">primary T cell response</cons>.</sentence>
<sentence>Critical role for <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="T_cell_activation" sem="G#other_name">T cell activation</cons> is initiated by interaction of specific <cons lex="Ags" sem="G#protein_family_or_group">Ags</cons> with <cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>, followed by activation of <cons lex="intracellular_biochemical_event" sem="G#other_name">intracellular biochemical events</cons> leading to activation of several genes.</sentence>
<sentence>The activation of <cons lex="signal_transducer" sem="G#other_name">signal transducer</cons> and activator of <cons lex="transcription_(STAT)_protein" sem="G#protein_family_or_group">transcription (STAT) proteins</cons> in a <cons lex="primary_TCR-mediated_activation" sem="G#other_name">primary <cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-mediated activation</cons> of <cons lex="T_cell" sem="G#cell_type">T cells</cons> have been explored.</sentence>
<sentence>In <cons lex="purified_human_peripheral_blood_T_cell" sem="G#cell_type">purified human peripheral blood <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons>, <cons lex="nuclear_STAT_protein" sem="G#protein_family_or_group">nuclear STAT proteins</cons> were activated approximately 3 h after activation by cross-linked <cons lex="anti-CD3_Abs" sem="G#protein_family_or_group">anti-CD3 Abs</cons>.</sentence>
<sentence>These <cons lex="STAT_protein" sem="G#protein_family_or_group">STAT proteins</cons> were detected by using the <cons lex="IFN-gamma-activated_sequence" sem="G#DNA_domain_or_region">IFN-gamma-activated sequence</cons> (<cons lex="GAS" sem="G#DNA_domain_or_region">GAS</cons>) and related <cons lex="oligonucleotide" sem="G#polynucleotide">oligonucleotides</cons> as probes in <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assay</cons>.</sentence>
<sentence>Analysis of the <cons lex="nuclear_extract" sem="G#cell_component">nuclear extracts</cons> with <cons lex="anti-STAT_Ab" sem="G#protein_family_or_group">anti-STAT Abs</cons> indicated that they contained <cons lex="STAT-3" sem="G#protein_molecule">STAT-3</cons> and additional proteins crossreactive with the <cons lex="STAT_family" sem="G#protein_family_or_group">STAT family</cons>.</sentence>
<sentence>The induction of <cons lex="STAT_activity" sem="G#other_name"><cons lex="STAT" sem="G#protein_family_or_group">STAT</cons> activity</cons> was inhibited completely by pretreatment with either <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons> or <cons lex="cyclosporin_A" sem="G#other_organic_compound">cyclosporin A</cons>, thus indicating that the induction was due to a <cons lex="secondary_factor" sem="G#protein_family_or_group">secondary factor</cons> produced by the activated <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>As <cons lex="neutralizing_anti-IL-6_Abs" sem="G#protein_family_or_group">neutralizing anti-<cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> Abs</cons> effectively down-regulated the early induction of <cons lex="STAT_protein" sem="G#protein_family_or_group">STAT proteins</cons> and as exogenously added <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> rapidly activated DNA binding similar to <cons lex="TCR-mediated_binding" sem="G#other_name"><cons lex="TCR" sem="G#protein_family_or_group">TCR</cons>-mediated bindings</cons>, it can be concluded that <cons lex="IL-6" sem="G#protein_molecule">IL-6</cons> is the factor responsible for the activation of <cons lex="STAT_protein" sem="G#protein_family_or_group">STAT proteins</cons> in a <cons lex="primary_T_cell_response" sem="G#other_name">primary T cell response</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96046572</bibliomisc>
</articleinfo>
<title>
<sentence>The normal <cons lex="cell_cycle_activation_program" sem="G#other_name">cell cycle activation program</cons> is exploited during the infection of <cons lex="quiescent_B_lymphocyte" sem="G#cell_type">quiescent B lymphocytes</cons> by <cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons> in the <cons lex="peripheral_circulation" sem="G#other_name">peripheral circulation</cons> are maintained in a <cons lex="non-proliferative_state" sem="G#other_name">non-proliferative state</cons>.</sentence>
<sentence>Antigen recognition stimulates limited proliferation, whereas infection with <cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> (<cons lex="EBV" sem="G#virus">EBV</cons>) results in continual proliferation and the outgrowth of <cons lex="immortal_cell_line" sem="G#cell_line">immortal cell lines</cons>.</sentence>
<sentence>Because it is not clear at which point in cell cycle the <cons lex="peripheral_B_lymphocyte" sem="G#cell_type">peripheral <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons></cons> are arrested, we characterized the expression of several <cons lex="cell_cycle-associated_gene" sem="G#DNA_family_or_group">cell cycle-associated genes</cons> in <cons lex="(AND quiescent_cell stimulated_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="quiescent*">quiescent</cons> and <cons lex="stimulated*">stimulated</cons> <cons lex="*cell">cells</cons></cons>.</sentence>
<sentence>We show that the expression of four <cons lex="cell_gene" sem="G#DNA_family_or_group">cell genes</cons>, <cons lex="cdc-2" sem="G#DNA_domain_or_region">cdc-2</cons>, <cons lex="cyclin_E" sem="G#DNA_domain_or_region">cyclin E</cons>, <cons lex="CD23" sem="G#DNA_domain_or_region">CD23</cons>, and <cons lex="cyclin_D2" sem="G#DNA_domain_or_region">cyclin D2</cons>, are up-regulated approximately 100-fold as a result of <cons lex="EBV-mediated_immortalization" sem="G#other_name"><cons lex="EBV" sem="G#virus">EBV</cons>-mediated immortalization</cons>.</sentence>
<sentence>Because these genes play a positive role in cell proliferation, we suggest that this <cons lex="regulatory_switch" sem="G#other_name">regulatory switch</cons> contributes to controlling entry into the <cons lex="cell_cycle" sem="G#other_name">cell cycle</cons>.</sentence>
<sentence><cons lex="transient_stimulation" sem="G#other_name">Transient stimulation</cons> of <cons lex="quiescent_B_lymphocyte" sem="G#cell_type">quiescent <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons></cons> with either a cocktail of <cons lex="anti-CD40" sem="G#protein_family_or_group">anti-CD40</cons>, <cons lex="anti-IgM" sem="G#protein_family_or_group">anti-IgM</cons>, and <cons lex="IL4" sem="G#protein_molecule">IL4</cons>, or <cons lex="EBV" sem="G#virus">EBV</cons> results in the <cons lex="rapid_expression" sem="G#other_name">rapid expression</cons> of the same four genes, suggesting that, after infection, <cons lex="EBV" sem="G#virus">EBV</cons> exploits the normal program of <cons lex="B-lymphocyte_cell_cycle_activation" sem="G#other_name"><cons lex="B-lymphocyte" sem="G#cell_type">B-lymphocyte</cons> cell cycle activation</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96011839</bibliomisc>
</articleinfo>
<title>
<sentence>Expression of the <cons lex="chemokine_receptor" sem="G#protein_family_or_group">chemokine receptor</cons> <cons lex="BLR2/EBI1" sem="G#protein_molecule">BLR2/EBI1</cons> is specifically transactivated by <cons lex="Epstein-Barr_virus_nuclear_antigen_2" sem="G#protein_molecule"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> nuclear antigen 2</cons>.</sentence>
</title>
<abstract>
<sentence>In our attempt to identify <cons lex="chemokine_receptor" sem="G#protein_family_or_group">chemokine receptors</cons> that are related to <cons lex="Burkitt's_lymphoma_receptor_1" sem="G#protein_molecule">Burkitt's lymphoma receptor 1</cons> (<cons lex="BLR1" sem="G#protein_molecule">BLR1</cons>) and are expressed in <cons lex="activated_lymphocyte" sem="G#cell_type">activated lymphocytes</cons> we used <cons lex="RT-PCR" sem="G#other_name">RT-PCR</cons> resulting in the isolation of a cDNA encoding a <cons lex="seven_transmembrane_receptor" sem="G#protein_family_or_group">seven transmembrane receptor</cons> termed <cons lex="BLR2" sem="G#protein_molecule">BLR2</cons>.</sentence>
<sentence>The protein shows significant sequence similarities to the family of <cons lex="G-protein_coupled_chemokine_receptor" sem="G#protein_family_or_group"><cons lex="G-protein" sem="G#protein_family_or_group">G-protein</cons> coupled <cons lex="chemokine_receptor" sem="G#protein_family_or_group">chemokine receptors</cons></cons> and turned out to be identical to the recently described <cons lex="receptor_EBI1" sem="G#protein_molecule">receptor EBI1</cons>.</sentence>
<sentence>Northern blot analysis revealed that <cons lex="BLR2_mRNA" sem="G#RNA_molecule"><cons lex="BLR2" sem="G#protein_molecule">BLR2</cons> mRNA</cons> could be highly stimulated in <cons lex="(AND mitogen-treated_peripheral_blood_lymphocyte anti-CD3-treated_peripheral_blood_lymphocyte)" sem="(AND G#cell_line G#cell_line)"><cons lex="mitogen-*">mitogen-</cons> and <cons lex="anti-CD3-*">anti-CD3-</cons><cons lex="*treated_peripheral_blood_lymphocyte">treated peripheral blood lymphocytes</cons></cons>.</sentence>
<sentence><cons lex="BLR2-specific_mRNA" sem="G#RNA_family_or_group"><cons lex="BLR2" sem="G#protein_molecule">BLR2</cons>-specific mRNA</cons> could be detected in all <cons lex="Epstein-Barr_virus_positive_B_cell_line" sem="G#cell_line">Epstein-Barr virus positive B cell lines</cons>.</sentence>
<sentence>We show that transcription of the <cons lex="BLR2_gene" sem="G#DNA_domain_or_region"><cons lex="BLR2" sem="G#protein_molecule">BLR2</cons> gene</cons> could be specifically induced in <cons lex="Epstein-Barr_virus_negative_BL_41_cell" sem="G#cell_line"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> negative BL 41 cells</cons> via <cons lex="estrogen-mediated_activation" sem="G#other_name">estrogen-mediated activation</cons> of <cons lex="Epstein-Barr_virus_nuclear_antigen_2" sem="G#protein_molecule"><cons lex="Epstein-Barr_virus" sem="G#virus">Epstein-Barr virus</cons> nuclear antigen 2</cons>, a key regulator of <cons lex="viral_and_cellular_gene" sem="G#DNA_family_or_group"><cons lex="viral_gene" sem="G#DNA_family_or_group">viral</cons> and <cons lex="cellular_gene" sem="G#DNA_family_or_group">cellular genes</cons></cons> in <cons lex="immortalized_B_cell" sem="G#cell_line">immortalized B cells</cons>.</sentence>
<sentence>Our data suggest an involvement of <cons lex="BLR2" sem="G#protein_molecule">BLR2</cons> in the regulation of migration in <cons lex="activated_lymphocyte" sem="G#cell_type">activated lymphocytes</cons> and in <cons lex="viral_pathogenesis" sem="G#other_name">viral pathogenesis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:96009598</bibliomisc>
</articleinfo>
<title>
<sentence>A central role for a <cons lex="single_c-Myb_binding_site" sem="G#DNA_domain_or_region">single c-Myb binding site</cons> in a <cons lex="thymic_locus_control_region" sem="G#DNA_domain_or_region">thymic locus control region</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="locus_control_region" sem="G#DNA_domain_or_region">Locus control regions</cons> (<cons lex="LCR" sem="G#DNA_domain_or_region">LCRs</cons>) are powerful assemblies of <cons lex="cis_element" sem="G#DNA_family_or_group">cis elements</cons> that organize the actions of <cons lex="cell-type-specific_trans-acting_factor" sem="G#protein_family_or_group">cell-type-specific trans-acting factors</cons>.</sentence>
<sentence>A <cons lex="2.3-kb_LCR" sem="G#protein_molecule">2.3-kb LCR</cons> in the <cons lex="human_adenosine_deaminase_(ADA)_gene_first_intron" sem="G#DNA_domain_or_region"><cons lex="human_adenosine_deaminase_(ADA)_gene" sem="G#DNA_domain_or_region">human adenosine deaminase (ADA) gene</cons> first intron</cons>, which controls expression in <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons>, is composed of a <cons lex="200-bp_enhancer_domain" sem="G#DNA_domain_or_region">200-bp enhancer domain</cons> and extended flanking sequences that facilitate activation from within <cons lex="chromatin" sem="G#DNA_family_or_group">chromatin</cons>.</sentence>
<sentence>Prior analyses have demonstrated that the <cons lex="enhancer" sem="G#DNA_domain_or_region">enhancer</cons> contains a <cons lex="28-bp_core_region" sem="G#DNA_domain_or_region">28-bp core region</cons> and local adjacent augmentative <cons lex="cis_element" sem="G#DNA_family_or_group">cis elements</cons>.</sentence>
<sentence>We now show that the core contains a single critical <cons lex="c-Myb_binding_site" sem="G#DNA_domain_or_region">c-Myb binding site</cons>.</sentence>
<sentence>In both <cons lex="transiently_cotransfected_human_cell" sem="G#cell_line">transiently cotransfected human cells</cons> and stable <cons lex="chromatin-integrated_yeast_cell" sem="G#cell_line">chromatin-integrated yeast cells</cons>, <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> strongly <cons lex="transactivated_reporter_construct" sem="G#DNA_family_or_group">transactivated reporter constructs</cons> that contained <cons lex="polymerized_core_sequence" sem="G#DNA_domain_or_region">polymerized core sequences</cons>.</sentence>
<sentence><cons lex="c-Myb_protein" sem="G#protein_molecule"><cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> protein</cons> was strongly evident in <cons lex="T_lymphoblast" sem="G#cell_type">T lymphoblasts</cons> in which the <cons lex="enhancer" sem="G#DNA_domain_or_region">enhancer</cons> was active and was localized within discrete <cons lex="nuclear_structure" sem="G#cell_component">nuclear structures</cons>.</sentence>
<sentence><cons lex="Fetal_murine_thymus" sem="G#body_part">Fetal murine thymus</cons> exhibited a striking concordance of <cons lex="endogenous_c-myb_expression" sem="G#other_name">endogenous <cons lex="c-myb" sem="G#DNA_domain_or_region">c-myb</cons> expression</cons> with that of <cons lex="mouse_ADA" sem="G#DNA_domain_or_region">mouse ADA</cons> and <cons lex="human_ADA_LCR-directed_transgene_expression" sem="G#other_name"><cons lex="human_ADA_LCR" sem="G#DNA_domain_or_region">human ADA LCR</cons>-directed transgene expression</cons>.</sentence>
<sentence>Point mutation of the <cons lex="c-Myb_site" sem="G#DNA_domain_or_region"><cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> site</cons> within the intact <cons lex="2.3-kb_LCR" sem="G#protein_molecule">2.3-kb LCR</cons> severely attenuated <cons lex="enhancer_activity" sem="G#other_name">enhancer activity</cons> in transfections and <cons lex="LCR_activity" sem="G#other_name"><cons lex="LCR" sem="G#DNA_domain_or_region">LCR</cons> activity</cons> in <cons lex="transgenic_thymocyte" sem="G#cell_line">transgenic <cons lex="thymocyte" sem="G#cell_type">thymocytes</cons></cons>.</sentence>
<sentence>Within the context of a <cons lex="complex_enhancer" sem="G#DNA_domain_or_region">complex enhancer</cons> and <cons lex="LCR" sem="G#DNA_domain_or_region">LCR</cons>, <cons lex="c-Myb" sem="G#protein_molecule">c-Myb</cons> can act as an organizer of <cons lex="thymocyte-specific_gene_expression" sem="G#other_name"><cons lex="thymocyte-specific_gene" sem="G#DNA_domain_or_region">thymocyte-specific gene</cons> expression</cons> via a single binding site.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95403454</bibliomisc>
</articleinfo>
<title>
<sentence>A <cons lex="regulatory_element" sem="G#DNA_family_or_group">regulatory element</cons> in the <cons lex="human_interleukin_2_gene_promoter" sem="G#DNA_domain_or_region">human interleukin 2 gene promoter</cons> is a <cons lex="binding_site" sem="G#DNA_domain_or_region">binding site</cons> for the <cons lex="zinc_finger_protein" sem="G#protein_family_or_group">zinc finger proteins</cons> <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="EGR-1" sem="G#protein_molecule">EGR-1</cons>.</sentence>
</title>
<abstract>
<sentence>Activation of the <cons lex="interleukin_2_(IL-2)_gene" sem="G#DNA_domain_or_region"><cons lex="interleukin_2" sem="G#protein_molecule">interleukin 2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>) gene</cons> after <cons lex="antigen_recognition" sem="G#other_name">antigen recognition</cons> is a critical event for <cons lex="T_cell_proliferation" sem="G#other_name">T cell proliferation</cons> and effector function.</sentence>
<sentence>Prior studies have identified several <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> that contribute to the activity of the <cons lex="IL-2_promoter" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> promoter</cons> in <cons lex="stimulated_T_lymphocyte" sem="G#cell_type">stimulated T lymphocytes</cons>.</sentence>
<sentence>Here we describe a novel <cons lex="regulatory_element" sem="G#DNA_family_or_group">regulatory element</cons> within the <cons lex="IL-2_promoter" sem="G#DNA_domain_or_region">IL-2 promoter</cons> located immediately upstream of the <cons lex="nuclear_factor_of_activated_T_cells_(NFAT)_domain" sem="G#DNA_domain_or_region"><cons lex="nuclear_factor_of_activated_T_cells" sem="G#protein_family_or_group">nuclear factor of activated T cell</cons> (<cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons>) domain</cons>.</sentence>
<sentence>This region (termed the <cons lex="zinc_finger_protein_binding_region" sem="G#DNA_domain_or_region">zinc finger protein binding region</cons> (<cons lex="ZIP" sem="G#DNA_domain_or_region">ZIP</cons>)) serves as binding site for two differently regulated <cons lex="zinc_finger_protein" sem="G#protein_family_or_group">zinc finger proteins</cons>: the <cons lex="constitutively_expressed_transcription_factor" sem="G#protein_family_or_group">constitutively expressed transcription factor</cons> <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and the <cons lex="inducible_early_growth_response_protein" sem="G#protein_family_or_group">inducible early growth response protein</cons> <cons lex="EGR-1" sem="G#protein_molecule">EGR-1</cons>.</sentence>
<sentence>In <cons lex="unstimulated_cell" sem="G#cell_type">unstimulated cells</cons> which do not secrete <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>, only <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> binds to this region, while in <cons lex="stimulated_IL-2_secreting_cell" sem="G#cell_line">stimulated <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> secreting cells</cons> the <cons lex="inducible_EGR-1_protein" sem="G#protein_molecule">inducible <cons lex="EGR-1" sem="G#protein_molecule">EGR-1</cons> protein</cons> recognizes this element.</sentence>
<sentence>In <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons>, the <cons lex="ZIP_site" sem="G#DNA_domain_or_region"><cons lex="ZIP" sem="G#DNA_domain_or_region">ZIP</cons> site</cons> serves as an activator for <cons lex="IL-2_gene_expression" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> gene expression</cons>, and a combination of <cons lex="ZIP" sem="G#DNA_domain_or_region">ZIP</cons> and <cons lex="NFAT_binding_site" sem="G#DNA_domain_or_region"><cons lex="NFAT" sem="G#protein_family_or_group">NFAT</cons> binding sites</cons> is required for maximal <cons lex="IL-2_promoter_activity" sem="G#other_name"><cons lex="IL-2_promoter" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> promoter</cons> activity</cons>.</sentence>
<sentence>These results suggest a critical role of the <cons lex="ZIP_site" sem="G#DNA_domain_or_region">ZIP site</cons> for <cons lex="IL-2_promoter_activity" sem="G#other_name"><cons lex="IL-2_promoter" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> promoter</cons> activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95385995</bibliomisc>
</articleinfo>
<title>
<sentence>Activation of the <cons lex="HIV-1_enhancer" sem="G#DNA_domain_or_region">HIV-1 enhancer</cons> by the <cons lex="LEF-1_HMG_protein" sem="G#protein_molecule">LEF-1 HMG protein</cons> on <cons lex="nucleosome-assembled_DNA" sem="G#DNA_family_or_group">nucleosome-assembled DNA</cons> in vitro.</sentence>
</title>
<abstract>
<sentence><cons lex="lymphoid_enhancer-binding_factor_1" sem="G#protein_family_or_group">Lymphoid enhancer-binding factor 1</cons> (<cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons>) is a <cons lex="regulatory_high_mobility_group_(HMG)_protein" sem="G#protein_family_or_group">regulatory high mobility group (HMG) protein</cons> that activates the <cons lex="T_cell_receptor_alpha_(TCR_alpha)_enhancer" sem="G#DNA_domain_or_region"><cons lex="T_cell_receptor_alpha" sem="G#protein_molecule">T cell receptor alpha</cons> (<cons lex="TCR_alpha" sem="G#protein_molecule">TCR alpha</cons>) enhancer</cons> in a context-restricted manner in <cons lex="T_cell" sem="G#cell_type">T cells</cons>.</sentence>
<sentence>In this paper we demonstrate that the distal region of the <cons lex="human_immunodeficiency_virus-1_(HIV-1)_enhancer" sem="G#DNA_domain_or_region"><cons lex="human_immunodeficiency_virus-1" sem="G#virus">human immunodeficiency virus-1</cons> (<cons lex="HIV-1" sem="G#virus">HIV-1</cons>) enhancer</cons>, which contains <cons lex="DNA-binding_site" sem="G#DNA_domain_or_region">DNA-binding sites</cons> for <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons> and Ets-1, also provides a functional context for activation by <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons>.</sentence>
<sentence>First, we show that mutations in the <cons lex="LEF-1-binding_site" sem="G#DNA_domain_or_region"><cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons>-binding site</cons> inhibit the activity of <cons lex="multimerized_copy" sem="G#DNA_family_or_group">multimerized copies</cons> of the <cons lex="HIV-1_enhancer" sem="G#DNA_domain_or_region">HIV-1 enhancer</cons> in <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons>, and that <cons lex="LEF-1/GAL4" sem="G#protein_molecule"><cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons>/GAL4</cons> can activate a <cons lex="GAL4-substituted_HIV-1_enhancer" sem="G#DNA_domain_or_region">GAL4-substituted <cons lex="HIV-1_enhancer" sem="G#DNA_domain_or_region">HIV-1 enhancer</cons></cons> 80- to 100-fold in vivo.</sentence>
<sentence>Second, <cons lex="recombinant_LEF-1" sem="G#protein_family_or_group">recombinant <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons></cons> is shown to activate <cons lex="HIV-1_transcription" sem="G#other_name"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> transcription</cons> on <cons lex="chromatin-assembled_DNA" sem="G#DNA_family_or_group">chromatin-assembled DNA</cons> in vitro.</sentence>
<sentence>By using a <cons lex="nucleosome-assembly_system" sem="G#other_name"><cons lex="nucleosome" sem="G#protein_complex">nucleosome</cons>-assembly system</cons> derived from <cons lex="Drosophila_embryo" sem="G#multi_cell">Drosophila embryos</cons>, we find that the packaging of DNA into <cons lex="chromatin" sem="G#DNA_family_or_group">chromatin</cons> in vitro strongly represses <cons lex="HIV-1_transcription" sem="G#other_name"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> transcription</cons> and that repression can be counteracted efficiently by preincubation of the DNA with <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons> (or <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons> and <cons lex="Ets-1" sem="G#protein_molecule">Ets-1</cons>) supplemented with fractions containing the <cons lex="promoter-binding_protein" sem="G#protein_family_or_group">promoter-binding protein</cons>, <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons>.</sentence>
<sentence>Addition of <cons lex="TFE-3" sem="G#protein_molecule">TFE-3</cons>, which binds to an <cons lex="E-box_motif" sem="G#DNA_domain_or_region">E-box motif</cons> upstream of the <cons lex="(AND LEF-1_site Ets-1_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="LEF-1*">LEF-1</cons> and <cons lex="Ets-1*">Ets-1</cons> <cons lex="*site">sites</cons></cons>, further augments <cons lex="transcription" sem="G#other_name">transcription</cons> in this system.</sentence>
<sentence>Individually or collectively, none of the three <cons lex="enhancer-binding_protein" sem="G#protein_family_or_group">enhancer-binding proteins</cons> (<cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons>, <cons lex="Ets-1" sem="G#protein_molecule">Ets-1</cons>, and <cons lex="TFE-3" sem="G#protein_molecule">TFE-3</cons>) could activate transcription in the absence of <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons>.</sentence>
<sentence>A <cons lex="truncation_mutant" sem="G#protein_family_or_group">truncation mutant</cons> of <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons> (<cons lex="HMG-88" sem="G#protein_molecule">HMG-88</cons>), which contains the <cons lex="HMG_box" sem="G#protein_domain_or_region">HMG box</cons> but lacks the <cons lex="trans-activation_domain" sem="G#protein_domain_or_region">trans-activation domain</cons>, did not activate <cons lex="transcription" sem="G#other_name">transcription</cons> from <cons lex="nucleosomal_DNA" sem="G#DNA_family_or_group">nucleosomal DNA</cons>, indicating that bending of DNA by the <cons lex="HMG_domain" sem="G#protein_domain_or_region">HMG domain</cons> is not sufficient to activate <cons lex="transcription" sem="G#other_name">transcription</cons> in vitro.</sentence>
<sentence>We conclude that <cons lex="transcription_activation" sem="G#other_name">transcription activation</cons> by <cons lex="LEF-1" sem="G#protein_molecule">LEF-1</cons> in vitro is a <cons lex="chromatin-dependent_process" sem="G#other_name"><cons lex="chromatin" sem="G#DNA_family_or_group">chromatin</cons>-dependent process</cons> that requires a functional <cons lex="trans-activation_domain" sem="G#protein_domain_or_region">trans-activation domain</cons> in addition to the <cons lex="HMG_domain" sem="G#protein_domain_or_region">HMG domain</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:95370270</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="HIV-1_envelope_glycoprotein" sem="G#protein_family_or_group"><cons lex="HIV-1" sem="G#virus">HIV-1</cons> envelope glycoproteins</cons> induce activation of activated <cons lex="protein-1" sem="G#protein_molecule">protein-1</cons> in <cons lex="CD4+_T_cell" sem="G#cell_type">CD4+ <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> [published erratum appears in J Biol Chem 1995 Dec 1;270(48):29038]</sentence>
</title>
<abstract>
<sentence>Activation of <cons lex="CD4_positive_T_cell" sem="G#cell_type">CD4 positive <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> is a primary requirement for <cons lex="human_immunodeficiency_virus_(HIV)_entry" sem="G#other_name"><cons lex="human_immunodeficiency_virus" sem="G#virus">human immunodeficiency virus</cons> (<cons lex="HIV" sem="G#virus">HIV</cons>) entry</cons>, efficient <cons lex="HIV_replication" sem="G#other_name"><cons lex="HIV" sem="G#virus">HIV</cons> replication</cons>, and progression to <cons lex="AIDS" sem="G#other_name">AIDS</cons>, Utilizing <cons lex="CD4_positive_T_cell_line" sem="G#cell_line">CD4 positive T cell lines</cons> and <cons lex="purified_T_cell" sem="G#cell_type">purified <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> from <cons lex="normal_individual" sem="G#multi_cell">normal individuals</cons>, we have demonstrated that <cons lex="native_envelope_glycoprotein" sem="G#protein_family_or_group">native envelope glycoproteins</cons> of <cons lex="HIV" sem="G#virus">HIV</cons>, <cons lex="gp_160" sem="G#protein_molecule">gp 160</cons>, can induce activation of <cons lex="transcription_factor,_activated_protein-1" sem="G#protein_molecule">transcription factor, activated protein-1</cons> (<cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>).</sentence>
<sentence>The stimulatory effects of <cons lex="gp160" sem="G#protein_molecule">gp160</cons> are mediated through the <cons lex="CD4_molecule" sem="G#protein_molecule">CD4 molecule</cons>, since treatment of <cons lex="gp160" sem="G#protein_molecule">gp160</cons> with soluble <cons lex="CD4-IgG" sem="G#protein_molecule">CD4-IgG</cons> abrogates its activity, and <cons lex="CD4_negative_T_cell_line" sem="G#cell_line">CD4 negative T cell lines</cons> fail to be stimulated with <cons lex="gp160" sem="G#protein_molecule">gp160</cons>.</sentence>
<sentence>Immunoprecipitation of the <cons lex="gp_160-induced_nuclear_extract" sem="G#cell_component"><cons lex="gp_160" sem="G#protein_molecule">gp 160</cons>-induced <cons lex="nuclear_extract" sem="G#cell_component">nuclear extracts</cons></cons> with <cons lex="polyclonal_antibody" sem="G#protein_family_or_group">polyclonal antibodies</cons> to <cons lex="Fos" sem="G#protein_family_or_group">Fos</cons> and <cons lex="Jun_protein" sem="G#protein_family_or_group">Jun proteins</cons> indicates that <cons lex="AP-1_complex" sem="G#protein_complex"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> complex</cons> is comprised of members of these family of proteins.</sentence>
<sentence>The <cons lex="gp160-induced_AP-1_complex" sem="G#protein_complex"><cons lex="gp160" sem="G#protein_molecule">gp160</cons>-induced <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> complex</cons> is dependent upon <cons lex="protein_tyrosine_phosphorylation" sem="G#other_name">protein tyrosine phosphorylation</cons> and is <cons lex="protein_synthesis-independent" sem="G#other_name">protein synthesis-independent</cons>.</sentence>
<sentence>This stimulation can also be abolished by inhibitors of <cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons>, but it is unaffected by <cons lex="calcium_channel_blocker" sem="G#other_organic_compound">calcium channel blocker</cons> or <cons lex="cyclosporine_A" sem="G#other_organic_compound">cyclosporine A</cons>.</sentence>
<sentence>This <cons lex="gp160" sem="G#protein_molecule">gp160</cons> treatment adversely affects the functional capabilities of <cons lex="T_cell" sem="G#cell_type">T cells</cons>: pre-treatment of <cons lex="CD4+_T_cell" sem="G#cell_type">CD4+ <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> with <cons lex="gp160" sem="G#protein_molecule">gp160</cons> for 4 h at 37 degrees C inhibited <cons lex="anti-CD3-induced_interleukin-2_secretion" sem="G#other_name"><cons lex="anti-CD3" sem="G#protein_molecule">anti-CD3</cons>-induced <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> secretion</cons>.</sentence>
<sentence>Effects similar to <cons lex="gp160" sem="G#protein_molecule">gp160</cons> were seen with <cons lex="anti-CD4_mAb" sem="G#protein_molecule">anti-CD4 mAb</cons>.</sentence>
<sentence>The aberrant activation of <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> by <cons lex="gp160" sem="G#protein_molecule">gp160</cons> in <cons lex="CD4_positive_T_cell" sem="G#cell_type">CD4 positive <cons lex="T_cell" sem="G#cell_type">T cells</cons></cons> could result in up-regulation of <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons> containing <cons lex="AP-1_site" sem="G#DNA_domain_or_region"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> sites</cons>, e.g. <cons lex="interleukin-3" sem="G#protein_molecule">interleukin-3</cons> and <cons lex="granulocyte_macrophage_colony-stimulating_factor" sem="G#protein_molecule">granulocyte macrophage colony-stimulating factor</cons>, and concurrently lead to <cons lex="T_cell_unresponsiveness" sem="G#other_name"><cons lex="T_cell" sem="G#cell_type">T cell</cons> unresponsiveness</cons> by inhibiting <cons lex="interleukin-2_secretion" sem="G#other_name"><cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> secretion</cons>.</sentence>
</abstract>
</article>


<article>
<articleinfo>
<bibliomisc>MEDLINE:99098272</bibliomisc>
</articleinfo>
<title>
<sentence>Binding of <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> elicits structural changes in a silencer of the <cons lex="human_beta-globin_gene" sem="G#DNA_domain_or_region">human beta-globin gene</cons>.</sentence>
</title>
<abstract>
<sentence>Proteins involved in repression of the <cons lex="human_beta-globin_gene" sem="G#DNA_domain_or_region">human beta-globin gene</cons> may be useful in the treatment of <cons lex="sickle_cell_anemia" sem="G#other_name">sickle cell anemia</cons>, in conjunction with therapy to reactivate <cons lex="fetal_globin_gene" sem="G#DNA_family_or_group">fetal globin genes</cons>.</sentence>
<sentence>If there is a reciprocal elevation of <cons lex="gamma-globin_expression" sem="G#other_name"><cons lex="gamma-globin" sem="G#protein_family_or_group">gamma-globin</cons> expression</cons> upon repression, this approach could be useful in additional <cons lex="hemoglobinopathy" sem="G#other_name">hemoglobinopathies</cons>.</sentence>
<sentence>We previously showed that repression of the beta-globin gene appears to be mediated through two <cons lex="DNA_sequence" sem="G#DNA_domain_or_region">DNA sequences</cons>, <cons lex="(AND silencer_I silencer_II)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="silencer*">silencers</cons> <cons lex="*I">I</cons> and <cons lex="*II">II</cons></cons>, and identified a protein termed <cons lex="BP1" sem="G#protein_molecule">BP1</cons> which binds to both silencer sequences.</sentence>
<sentence>In this study, we cloned two <cons lex="cDNA" sem="G#DNA_family_or_group">cDNAs</cons> encoding proteins which bind to an <cons lex="oligonucleotide" sem="G#polynucleotide">oligonucleotide</cons> in <cons lex="silencer_I" sem="G#DNA_domain_or_region">silencer I</cons> containing a <cons lex="BP1" sem="G#protein_molecule">BP1</cons> binding site.</sentence>
<sentence>These <cons lex="cDNA" sem="G#DNA_family_or_group">cDNAs</cons> correspond to <cons lex="HMG-I" sem="G#protein_molecule">HMG-I</cons> and <cons lex="HMG-Y" sem="G#protein_molecule">HMG-Y</cons>, isoforms regarded as <cons lex="architectural_protein" sem="G#protein_family_or_group">architectural proteins</cons>.</sentence>
<sentence>We demonstrate that binding of <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> to this <cons lex="oligonucleotide" sem="G#polynucleotide">oligonucleotide</cons> causes bending/flexure of the DNA.</sentence>
<sentence><cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> also binds to a second <cons lex="oligonucleotide" sem="G#polynucleotide">oligonucleotide</cons> containing a <cons lex="BP1_binding_site" sem="G#DNA_domain_or_region"><cons lex="BP1" sem="G#protein_molecule">BP1</cons> binding site</cons> located in a <cons lex="negative_control_region" sem="G#DNA_domain_or_region">negative control region</cons> upstream of the <cons lex="delta-globin_gene" sem="G#DNA_domain_or_region">delta-globin gene</cons>, suggesting a role for <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> in repression of adult globin genes.</sentence>
<sentence>Expression studies revealed that <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> is ubiquitously expressed in human tissues that do not express <cons lex="beta-globin" sem="G#protein_molecule">beta-globin</cons>, being present in 48 of 50 tissues and six <cons lex="hematopoietic_cell_line" sem="G#cell_line">hematopoietic cell lines</cons> examined.</sentence>
<sentence>Furthermore, <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> expression is down-regulated during differentiation of <cons lex="primary_erythroid_cell" sem="G#cell_type">primary erythroid cells</cons>.</sentence>
<sentence>We present a model in which <cons lex="HMG-I(Y)" sem="G#protein_molecule">HMG-I(Y)</cons> alters <cons lex="DNA_conformation" sem="G#other_name">DNA conformation</cons> to allow binding of <cons lex="repressor_protein" sem="G#protein_family_or_group">repressor proteins</cons>, and in which the relative amount of HMG-I(Y) helps to determine the <cons lex="repressive_state" sem="G#other_name">repressive state</cons> of the <cons lex="beta-globin_gene" sem="G#DNA_domain_or_region">beta-globin gene</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99078032</bibliomisc>
</articleinfo>
<title>
<sentence>Interactions between the <cons lex="class_II_transactivator" sem="G#protein_molecule">class II transactivator</cons> and <cons lex="CREB_binding_protein" sem="G#protein_molecule">CREB binding protein</cons> increase transcription of <cons lex="major_histocompatibility_complex_class_II_gene" sem="G#DNA_family_or_group">major histocompatibility complex class II genes</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="class_II_major_histocompatibility_(class_II)_gene" sem="G#DNA_family_or_group">Class II major histocompatibility (class II) genes</cons> are regulated in a <cons lex="(AND B-cell-specific_fashion gamma_interferon-inducible_fashion)" sem="(AND G#other_name G#other_name)"><cons lex="B-cell-specific*">B-cell-specific</cons> and <cons lex="gamma_interferon-inducible*">gamma interferon-inducible</cons> <cons lex="*fashion">fashion</cons></cons>.</sentence>
<sentence>The master switch for the expression of these genes is the <cons lex="class_II_transactivator" sem="G#protein_molecule">class II transactivator</cons> (<cons lex="CIITA" sem="G#protein_molecule">CIITA</cons>).</sentence>
<sentence>In this report, we demonstrate that one of the functions of <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> is to recruit the <cons lex="CREB_binding_protein" sem="G#protein_molecule">CREB binding protein</cons> (<cons lex="CBP" sem="G#protein_molecule">CBP</cons>) to <cons lex="class_II_promoter" sem="G#DNA_family_or_group">class II promoters</cons>.</sentence>
<sentence>Not only functional but also specific binding interactions between <cons lex="CIITA" sem="G#protein_molecule">CIITA</cons> and <cons lex="CBP" sem="G#protein_molecule">CBP</cons> were demonstrated.</sentence>
<sentence>Moreover, a dominant negative form of <cons lex="CBP" sem="G#protein_molecule">CBP</cons> decreased the activity of <cons lex="class_II_promoter" sem="G#DNA_family_or_group">class II promoters</cons> and levels of <cons lex="class_II_determinant" sem="G#protein_family_or_group">class II determinants</cons> on the <cons lex="surface_of_cell" sem="G#cell_component">surface of cells</cons>.</sentence>
<sentence>Finally, the inhibition of <cons lex="class_II_gene_expression" sem="G#other_name"><cons lex="class_II_gene" sem="G#DNA_family_or_group">class II gene</cons> expression</cons> by the glucocorticoid hormone could be attributed to the squelching of <cons lex="CBP" sem="G#protein_molecule">CBP</cons> by the <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptor</cons>.</sentence>
<sentence>We conclude that <cons lex="CBP" sem="G#protein_molecule">CBP</cons>, a <cons lex="histone_acetyltransferase" sem="G#protein_family_or_group">histone acetyltransferase</cons>, plays an important role in the transcription of <cons lex="class_II_gene" sem="G#DNA_family_or_group">class II genes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98208264</bibliomisc>
</articleinfo>
<title>
<sentence>Role of <cons lex="cyclic_AMP_response_element-binding_protein" sem="G#protein_molecule"><cons lex="cyclic_AMP" sem="G#nucleotide">cyclic AMP</cons> response element-binding protein</cons> in <cons lex="cyclic_AMP_inhibition" sem="G#other_name"><cons lex="cyclic_AMP" sem="G#nucleotide">cyclic AMP</cons> inhibition</cons> of <cons lex="NF-kappaB-mediated_transcription" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-mediated transcription</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> family of transcription factors regulates the inducible expression of a variety of genes.</sentence>
<sentence>Recently, we showed that elevation of intracellular <cons lex="cyclic_AMP" sem="G#nucleotide">cyclic AMP</cons> inhibits <cons lex="NF-kappaB-mediated_transcription" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-mediated transcription</cons> in <cons lex="human_monocyte" sem="G#cell_type">human monocytes</cons> and <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> without preventing nuclear translocation of <cons lex="NF-kappaB_complex" sem="G#protein_complex"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> complexes</cons>.</sentence>
<sentence>The present study examined the molecular mechanism of this inhibition.</sentence>
<sentence>We hypothesized that activation of the <cons lex="protein_kinase_A_signaling_pathway" sem="G#other_name"><cons lex="protein_kinase_A" sem="G#protein_molecule">protein kinase A</cons> signaling pathway</cons> may inhibit <cons lex="NF-kappaB-mediated_transcription" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-mediated transcription</cons> by phosphorylating proteins, such as <cons lex="cAMP_response_element-binding_protein" sem="G#protein_molecule">cAMP response element-binding protein</cons> (<cons lex="CREB" sem="G#protein_molecule">CREB</cons>), which compete for limiting amounts of the coactivator <cons lex="CBP" sem="G#protein_molecule">CBP</cons>.</sentence>
<sentence>Here, we show that the <cons lex="amino-terminal_region" sem="G#protein_domain_or_region">amino-terminal region</cons> (<cons lex="amino_acids_1-450" sem="G#protein_domain_or_region">amino acids 1-450</cons>) of <cons lex="CBP" sem="G#protein_molecule">CBP</cons> specifically interacts with the <cons lex="carboxyl-terminal_region" sem="G#protein_domain_or_region">carboxyl-terminal region</cons> (<cons lex="amino_acids_286-551" sem="G#protein_domain_or_region">amino acids 286-551</cons>) of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> <cons lex="p65" sem="G#protein_subunit">p65</cons> (<cons lex="RelA" sem="G#protein_subunit">RelA</cons>) both in vitro and in vivo.</sentence>
<sentence>Functional studies using human <cons lex="endothelial_cell" sem="G#cell_type">endothelial cells</cons> demonstrated that overexpression of <cons lex="CBP" sem="G#protein_molecule">CBP</cons> rescued <cons lex="cAMP_inhibition" sem="G#other_name"><cons lex="cAMP" sem="G#nucleotide">cAMP</cons> inhibition</cons> of <cons lex="NF-kappaB-mediated_transcription" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-mediated transcription</cons> and transcription mediated by a <cons lex="chimeric_protein" sem="G#protein_family_or_group">chimeric protein</cons>, <cons lex="GAL4-p65(286-551)" sem="G#protein_molecule">GAL4-p65(286-551)</cons>, which contained the <cons lex="GAL4_DNA_binding_domain" sem="G#protein_domain_or_region">GAL4 DNA binding domain</cons> fused to the <cons lex="carboxyl-terminal_region" sem="G#protein_domain_or_region">carboxyl-terminal region</cons> of <cons lex="p65" sem="G#protein_subunit">p65</cons> (<cons lex="amino_acid_286-551" sem="G#protein_domain_or_region">amino acids 286-551</cons>).</sentence>
<sentence>In contrast, overexpression of <cons lex="CREB" sem="G#protein_molecule">CREB</cons> inhibited <cons lex="GAL4-p65(286-551)-mediated_transcription" sem="G#other_name"><cons lex="GAL4" sem="G#protein_molecule">GAL4</cons>-p65(286-551)-mediated transcription</cons>.</sentence>
<sentence>These results suggest that activation of the <cons lex="protein_kinase_A_pathway" sem="G#other_name"><cons lex="protein_kinase_A" sem="G#protein_molecule">protein kinase A</cons> pathway</cons> inhibits <cons lex="NF-kappaB_transcription" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> transcription</cons> by phosphorylating <cons lex="CREB" sem="G#protein_molecule">CREB</cons>, which competes with <cons lex="p65" sem="G#protein_subunit">p65</cons> for limiting amounts of <cons lex="CBP" sem="G#protein_molecule">CBP</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98133462</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">Glucocorticoid receptors</cons> in <cons lex="cord_blood_lymphocyte" sem="G#cell_type">cord blood lymphocytes</cons> of <cons lex="healthy_neonate" sem="G#multi_cell">healthy neonates</cons> and of <cons lex="preterm" sem="G#multi_cell">preterms</cons> suffering from <cons lex="respiratory_distress_syndrome" sem="G#other_name">respiratory distress syndrome</cons>.</sentence>
</title>
<abstract>
<sentence>We measured the number of <cons lex="glucocorticoid_receptor" sem="G#protein_family_or_group">glucocorticoid receptors</cons> (<cons lex="GR" sem="G#protein_family_or_group">GR</cons>) in <cons lex="cord_blood_lymphocyte" sem="G#cell_type">cord blood lymphocytes</cons> and the <cons lex="binding_affinity" sem="G#other_name">binding affinity</cons> (Kd) in 15 term and in 20 <cons lex="preterm_baby" sem="G#multi_cell">preterm babies</cons>.</sentence>
<sentence>Thirteen <cons lex="preterm" sem="G#multi_cell">preterms</cons> of the latter group received <cons lex="prenatal_steroid_treatment" sem="G#other_name">prenatal steroid treatment</cons>.</sentence>
<sentence>Seven <cons lex="preterm" sem="G#multi_cell">preterms</cons> developed <cons lex="neonatal_respiratory_distress_syndrome" sem="G#other_name">neonatal <cons lex="respiratory_distress_syndrome" sem="G#other_name">respiratory distress syndrome</cons></cons> (<cons lex="NRDS" sem="G#other_name">NRDS</cons>).</sentence>
<sentence>The number of <cons lex="GR" sem="G#protein_family_or_group">GR</cons> and the Kd were similar in the term and preterm (with and without <cons lex="NRDS" sem="G#other_name">NRDS</cons>) <cons lex="baby" sem="G#multi_cell">babies</cons>.</sentence>
<sentence>The maximum <cons lex="(3H)-thymidine" sem="G#nucleotide">(3H)-thymidine</cons> incorporation into DNA of <cons lex="cord_blood_lymphocyte" sem="G#cell_type">cord blood lymphocytes</cons> from all <cons lex="preterm" sem="G#multi_cell">preterms</cons>, with or without <cons lex="NRDS" sem="G#other_name">NRDS</cons> was suppressed when compared to that from term <cons lex="baby" sem="G#multi_cell">babies</cons> or adults.</sentence>
<sentence>This could partly be explained by the <cons lex="antenatal_steroid_treatment" sem="G#other_name">antenatal steroid treatment</cons>.</sentence>
<sentence>Sensitivity (ID50) of the <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> for the inhibitory effect of <cons lex="dexamethasone" sem="G#lipid">dexamethasone</cons> was the same in all groups.</sentence>
<sentence>In this study on the number and function of <cons lex="GR" sem="G#protein_family_or_group">GR</cons> in <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons>, we were unable to find a relation between the functionality of the <cons lex="GR" sem="G#protein_family_or_group">GR</cons> and the development of <cons lex="NRDS" sem="G#other_name">NRDS</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98104470</bibliomisc>
</articleinfo>
<title>
<sentence>Inefficient termination of antigen responses in <cons lex="NF-ATp-deficient_mouse" sem="G#other_artificial_source"><cons lex="NF-ATp" sem="G#protein_molecule">NF-ATp</cons>-deficient mice</cons>.</sentence>
</title>
<abstract>
<sentence>In order to elucidate the role of <cons lex="NF-ATp" sem="G#protein_molecule">NF-ATp</cons>, one of the most prominent members of family of <cons lex="NF-AT_transcription_factor" sem="G#protein_family_or_group">NF-AT transcription factors</cons> in <cons lex="peripheral_T_lymphocyte" sem="G#cell_type">peripheral <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons></cons>, in <cons lex="(AND T_cell_activation T_cell_differentiation)" sem="(AND G#other_name G#other_name)"><cons lex="T_cell*">T cell</cons> <cons lex="*activation">activation</cons> and <cons lex="*differentiation">differentiation</cons></cons> we created <cons lex="NF-ATp-deficient_mouse" sem="G#other_artificial_source"><cons lex="NF-ATp" sem="G#protein_molecule">NF-ATp</cons>-deficient mice</cons> by <cons lex="gene_targeting" sem="G#other_name">gene targeting</cons>.</sentence>
<sentence>Such <cons lex="NF-ATp-/-_mouse" sem="G#other_artificial_source"><cons lex="NF-ATp" sem="G#protein_molecule">NF-ATp</cons>-/- mice</cons> are born and appear to develop a <cons lex="normal_immune_system" sem="G#body_part">normal immune system</cons>.</sentence>
<sentence>Apart from clear-cut defects in the synthesis of <cons lex="mRNA" sem="G#RNA_family_or_group">mRNAs</cons> for <cons lex="Th2-type_lymphokine" sem="G#protein_family_or_group">Th2-type lymphokines</cons>, such as <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, <cons lex="IL-5" sem="G#protein_molecule">IL-5</cons>, <cons lex="IL-10" sem="G#protein_molecule">IL-10</cons> and <cons lex="IL-13" sem="G#protein_molecule">IL-13</cons>, in <cons lex="(AND primary_stimulation secondary_stimulation)" sem="(AND G#other_name G#other_name)"><cons lex="primary*">primary</cons> and <cons lex="secondary*">secondary</cons> <cons lex="*stimulation">stimulations</cons></cons> of <cons lex="spleen_cell" sem="G#cell_type">spleen cells</cons> in vitro, of a distinct impaired deletion of <cons lex="V_beta_11+/CD4+_T_lymphocyte" sem="G#cell_line">V beta 11+/CD4+ <cons lex="T_lymphocyte" sem="G#cell_type">T lymphocytes</cons></cons> from these <cons lex="mouse" sem="G#multi_cell">mice</cons> was detected after superantigen injection.</sentence>
<sentence>Moreover, <cons lex="NF-ATp-/-_mouse" sem="G#other_artificial_source"><cons lex="NF-ATp" sem="G#protein_molecule">NF-ATp</cons>-/- <cons lex="mouse" sem="G#multi_cell">mice</cons></cons> older than 6 weeks show an 2-5 fold increase in number of <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons>.</sentence>
<sentence>This is correlated with an increased expression of <cons lex="activation_marker" sem="G#protein_family_or_group">activation markers</cons> <cons lex="CD44" sem="G#protein_molecule">CD44</cons> and <cons lex="CD69" sem="G#protein_molecule">CD69</cons> and <cons lex="decreased_expression" sem="G#other_name">decreased expression</cons> of <cons lex="CD62" sem="G#protein_molecule">CD62</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99161827</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="(AND AML_protein Ets_protein)" sem="(AND G#protein_family_or_group G#protein_family_or_group)"><cons lex="AML*">AML</cons> and <cons lex="Ets*">Ets</cons> <cons lex="*protein">proteins</cons></cons> regulate the <cons lex="I_alpha1_germ-line_promoter" sem="G#DNA_domain_or_region">I alpha1 germ-line promoter</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="immunoglobulin_heavy_chain_(IgH)_class" sem="G#other_name"><cons lex="immunoglobulin_heavy_chain" sem="G#protein_family_or_group">immunoglobulin heavy chain</cons> (<cons lex="IgH" sem="G#protein_family_or_group">IgH</cons>) class</cons> switch recombination of <cons lex="B_lymphocyte" sem="G#cell_type">B lymphocytes</cons> preferentially targets unrearranged <cons lex="IgH_gene" sem="G#DNA_family_or_group">IgH genes</cons> that have already been rendered <cons lex="transcriptionally_active" sem="G#other_name">transcriptionally active</cons>.</sentence>
<sentence>Transcription of the <cons lex="germ-line_IgH_gene" sem="G#DNA_family_or_group">germ-line <cons lex="IgH_gene" sem="G#DNA_family_or_group">IgH genes</cons></cons> is controlled by <cons lex="intervening_(I)_region" sem="G#DNA_domain_or_region">intervening (I) regions</cons> upstream of their switch regions.</sentence>
<sentence>The I alpha1 promoter activates transcription of the <cons lex="human_germ-line_C_alpha1_gene" sem="G#DNA_domain_or_region">human germ-line C alpha1 gene</cons> for <cons lex="IgA1" sem="G#protein_molecule">IgA1</cons> and mediates the <cons lex="transforming_growth_factor_(TGF)-beta1_responsiveness" sem="G#other_name"><cons lex="transforming_growth_factor_(TGF)-beta1" sem="G#protein_molecule">transforming growth factor (TGF)-beta1</cons> responsiveness</cons> of this locus.</sentence>
<sentence>Here we show that the I alpha1 promoter contains several binding sites for the <cons lex="AML/PEBP2/CBF_family_of_transcription_factor" sem="G#protein_family_or_group"><cons lex="AML" sem="G#protein_family_or_group">AML</cons>/PEBP2/CBF family of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons></cons> and that <cons lex="(AND AML_protein Ets_protein)" sem="(AND G#protein_family_or_group G#protein_family_or_group)"><cons lex="AML*">AML</cons> and <cons lex="Ets*">Ets</cons> <cons lex="*protein">proteins</cons></cons> are major regulators of the <cons lex="(AND basal_promoter_activity TGF-beta-inducible_promoter_activity)" sem="(AND G#other_name G#other_name)"><cons lex="basal*">basal</cons> and <cons lex="TGF-beta-inducible*">TGF-beta-inducible</cons> <cons lex="*promoter_activity">promoter activity</cons></cons>.</sentence>
<sentence>Our data constitute a starting point for studies to elucidate the molecular mechanism by which <cons lex="TGF-beta" sem="G#protein_molecule">TGF-beta</cons> regulates <cons lex="IgA_production" sem="G#other_name"><cons lex="IgA" sem="G#protein_family_or_group">IgA</cons> production</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99150505</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="daidzein" sem="G#other_organic_compound">Daidzein</cons> and <cons lex="genistein" sem="G#other_organic_compound">genistein</cons> <cons lex="glucuronide" sem="G#other_organic_compound">glucuronides</cons> in vitro are weakly estrogenic and activate <cons lex="human_natural_killer_cell" sem="G#cell_type">human natural killer cells</cons> at nutritionally relevant concentrations.</sentence>
</title>
<abstract>
<sentence><cons lex="daidzein" sem="G#other_organic_compound">Daidzein</cons> and <cons lex="genistein" sem="G#other_organic_compound">genistein</cons> <cons lex="glucuronide" sem="G#other_organic_compound">glucuronides</cons> (<cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons>), major <cons lex="isoflavone_metabolite" sem="G#other_organic_compound">isoflavone metabolites</cons>, may be partly responsible for biological effects of <cons lex="isoflavone" sem="G#other_organic_compound">isoflavones</cons>, such as estrogen receptor binding and <cons lex="natural_killer_cell_(NK)_activation" sem="G#other_name"><cons lex="natural_killer_cell" sem="G#cell_type">natural killer cell</cons> (NK) activation</cons> or <cons lex="natural_killer_cell_inhibition" sem="G#other_name">inhibition</cons>.</sentence>
<sentence><cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons> were synthesized using <cons lex="3-methylcholanthrene-induced_rat_liver_microsome" sem="G#cell_component"><cons lex="3-methylcholanthrene" sem="G#other_organic_compound">3-methylcholanthrene</cons>-induced rat liver microsomes</cons>.</sentence>
<sentence>The Km and Vmax for <cons lex="daidzein" sem="G#other_organic_compound">daidzein</cons> and <cons lex="genistein" sem="G#other_organic_compound">genistein</cons> were 9.0 and 7.7 micromol/L, and 0.7 and 1.6 micromol/(mg protein. min), respectively.</sentence>
<sentence>The absence of <cons lex="ultraviolet_absorbance_maxima_shift" sem="G#other_name">ultraviolet absorbance maxima shifts</cons> in the presence of <cons lex="sodium_acetate" sem="G#other_organic_compound">sodium acetate</cons> confirmed that the synthesized products were 7-O-<cons lex="glucuronide" sem="G#other_organic_compound">glucuronides</cons>.</sentence>
<sentence><cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons> were further purified by a <cons lex="Sephadex_LH-20_column" sem="G#other_name">Sephadex LH-20 column</cons>.</sentence>
<sentence><cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons> competed with the binding of <cons lex="17beta-(3H)_estradiol" sem="G#lipid">17beta-(3H) estradiol</cons> to <cons lex="estrogen_receptor" sem="G#protein_family_or_group">estrogen receptors</cons> of <cons lex="B6D2F1_mouse_uterine_cytosol" sem="G#cell_component">B6D2F1 mouse uterine cytosol</cons>.</sentence>
<sentence>The concentrations required for 50% displacement of <cons lex="17beta-(3H)_estradiol" sem="G#lipid">17beta-(3H) estradiol</cons> (CB50) were: <cons lex="17beta-estradiol" sem="G#lipid">17beta-estradiol</cons>, 1.34 nmol/L; <cons lex="diethylstilbestrol" sem="G#lipid">diethylstilbestrol</cons>, 1.46 nmol/L; <cons lex="daidzein" sem="G#other_organic_compound">daidzein</cons>, 1.6 micromol/L; <cons lex="DG" sem="G#other_organic_compound">DG</cons>, 14.7 micromol/L; <cons lex="genistein" sem="G#other_organic_compound">genistein</cons>, 0.154 micromol/L; <cons lex="GG" sem="G#other_organic_compound">GG</cons>, 7.27 micromol/L.</sentence>
<sentence>In <cons lex="human_peripheral_blood_NK_cell" sem="G#cell_type">human peripheral blood NK cells</cons>, <cons lex="genistein" sem="G#other_organic_compound">genistein</cons> at &lt;0.5 micromol/L and <cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons> at 0.1-10 micromol/L enhanced <cons lex="NK_cell-mediated_K562_cancer_cell_killing" sem="G#other_name">NK cell-mediated <cons lex="K562_cancer_cell" sem="G#cell_line">K562 cancer cell</cons> killing</cons> significantly (P &lt; 0.05).</sentence>
<sentence>At &gt; 0.5 micromol/L, <cons lex="genistein" sem="G#other_organic_compound">genistein</cons> inhibited <cons lex="NK_cytotoxicity" sem="G#other_name">NK cytotoxicity</cons> significantly (P &lt; 0.05).</sentence>
<sentence>The <cons lex="glucuronide" sem="G#other_organic_compound">glucuronides</cons> only inhibited <cons lex="NK_cytotoxicity" sem="G#other_name">NK cytotoxicity</cons> at 50 micromol/L.</sentence>
<sentence>Isoflavones, and especially the isoflavone <cons lex="glucuronide" sem="G#other_organic_compound">glucuronides</cons>, enhanced activation of <cons lex="NK_cell" sem="G#cell_type">NK cells</cons> by <cons lex="interleukin-2" sem="G#protein_molecule">interleukin-2</cons> (<cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>), additively.</sentence>
<sentence>At physiological concentrations, <cons lex="DG" sem="G#other_organic_compound">DG</cons> and <cons lex="GG" sem="G#other_organic_compound">GG</cons> were weakly estrogenic, and they activated <cons lex="human_NK_cell" sem="G#cell_type">human <cons lex="NK_cell" sem="G#cell_type">NK cells</cons></cons> in nutritionally relevant concentrations in vitro, probably at a site different from <cons lex="IL-2_action" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> action</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99138943</bibliomisc>
</articleinfo>
<title>
<sentence>Cross-linking of <cons lex="CD44" sem="G#protein_molecule">CD44</cons> on <cons lex="rheumatoid_synovial_cell" sem="G#cell_type">rheumatoid synovial cells</cons> up-regulates <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="CD44" sem="G#carbohydrate">CD44</cons> is a ubiquitous molecule also known as <cons lex="hyaluronic_acid" sem="G#carbohydrate">hyaluronic acid</cons> or <cons lex="homing_receptor" sem="G#carbohydrate">homing receptor</cons>.</sentence>
<sentence>However, the <cons lex="cellular_function" sem="G#other_name">cellular functions</cons> and its role in inflammation, for example, rheumatoid synovitis, are currently unknown.</sentence>
<sentence>In this study, we propose a novel function for <cons lex="CD44" sem="G#carbohydrate">CD44</cons>.</sentence>
<sentence>Using synovial cells from <cons lex="rheumatoid_arthritis_(RA)_patient" sem="G#multi_cell"><cons lex="rheumatoid_arthritis" sem="G#other_name">rheumatoid arthritis</cons> (<cons lex="RA" sem="G#other_name">RA</cons>) patients</cons>, we demonstrated that <cons lex="CD44_cross-linking" sem="G#other_name"><cons lex="CD44" sem="G#carbohydrate">CD44</cons> cross-linking</cons> and binding to <cons lex="hyaluronan" sem="G#carbohydrate">hyaluronan</cons> augmented <cons lex="VCAM-1_expression" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> expression</cons> and subsequently <cons lex="VCAM-1-mediated_cell_adhesion" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>-mediated cell adhesion</cons>.</sentence>
<sentence>Briefly, we found that 1) <cons lex="rheumatoid_synovial_cell" sem="G#cell_type">rheumatoid synovial cells</cons> highly expressed <cons lex="CD44" sem="G#protein_molecule"><cons lex="CD44" sem="G#carbohydrate">CD44</cons></cons>; 2) cross-linking of <cons lex="CD44" sem="G#protein_molecule"><cons lex="CD44" sem="G#carbohydrate">CD44</cons></cons> markedly but transiently augmented <cons lex="VCAM-1_expression" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> expression</cons> and its <cons lex="mRNA_transcription" sem="G#other_name">mRNA transcription</cons> much more than did <cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> and TNF-alpha; 3) <cons lex="hyaluronan" sem="G#carbohydrate">hyaluronan</cons>, especially when fragmented, also up-regulated <cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>; 4) <cons lex="CD44" sem="G#protein_molecule"><cons lex="CD44" sem="G#carbohydrate">CD44</cons></cons> activated the transcription factor AP-1; and 5) the <cons lex="integrin-dependent_adhesive_function" sem="G#other_name"><cons lex="integrin" sem="G#protein_family_or_group">integrin</cons>-dependent adhesive function</cons> of <cons lex="RA_synovial_cell" sem="G#cell_type"><cons lex="RA" sem="G#other_name">RA</cons> synovial cells</cons> to <cons lex="T_cell" sem="G#cell_type">T cells</cons> was also amplified by <cons lex="CD44_cross-linking" sem="G#other_name"><cons lex="CD44" sem="G#carbohydrate"><cons lex="CD44" sem="G#protein_molecule">CD44</cons></cons> cross-linking</cons>.</sentence>
<sentence>These results indicate that the adhesion of <cons lex="RA_synovial_cell" sem="G#cell_type"><cons lex="RA" sem="G#other_name">RA</cons> synovial cells</cons> to matrices such as <cons lex="hyaluronic_acid" sem="G#carbohydrate">hyaluronic acid</cons> through <cons lex="CD44" sem="G#carbohydrate"><cons lex="CD44" sem="G#protein_molecule">CD44</cons></cons> could up-regulate <cons lex="VCAM-1_expression" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons> expression</cons> and <cons lex="VCAM-1-mediated_adhesion" sem="G#other_name"><cons lex="VCAM-1" sem="G#protein_molecule">VCAM-1</cons>-mediated adhesion</cons> to <cons lex="T_cell" sem="G#cell_type">T cells</cons>, which might in turn cause activation of <cons lex="T_cell" sem="G#cell_type">T cells</cons> and <cons lex="synovial_cell" sem="G#cell_type">synovial cells</cons> in <cons lex="RA_synovitis" sem="G#other_name"><cons lex="RA" sem="G#other_name">RA</cons> synovitis</cons>.</sentence>
<sentence>We therefore propose that such cross-talking among distinct <cons lex="adhesion_molecule" sem="G#other_organic_compound">adhesion molecules</cons> may be involved in the pathogenesis of <cons lex="inflammation" sem="G#other_name">inflammation</cons>, including <cons lex="RA_synovitis" sem="G#other_name"><cons lex="RA" sem="G#other_name">RA</cons> synovitis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99134363</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> is a critical regulator of <cons lex="human_granulocyte_apoptosis" sem="G#other_name">human granulocyte apoptosis</cons> in vitro.</sentence>
</title>
<abstract>
<sentence>During beneficial <cons lex="inflammation" sem="G#other_name">inflammation</cons>, potentially <cons lex="tissue-damaging_granulocyte" sem="G#cell_type">tissue-damaging granulocytes</cons> undergo <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> before being cleared by phagocytes in a <cons lex="non-phlogistic_manner" sem="G#other_name">non-phlogistic manner</cons>.</sentence>
<sentence>Here we show that the rate of constitutive <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> in <cons lex="human_neutrophil" sem="G#cell_type">human neutrophils</cons> and <cons lex="eosinophil" sem="G#cell_type">eosinophils</cons> is greatly accelerated in both a rapid and <cons lex="concentration-dependent_manner" sem="G#other_name">concentration-dependent manner</cons> by the <cons lex="fungal_metabolite_gliotoxin" sem="G#other_organic_compound">fungal metabolite <cons lex="gliotoxin" sem="G#other_organic_compound">gliotoxin</cons></cons>, but not by its inactive analog <cons lex="methylthiogliotoxin" sem="G#other_organic_compound">methylthiogliotoxin</cons>.</sentence>
<sentence>This induction of <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> was abolished by the <cons lex="caspase_inhibitor" sem="G#other_organic_compound">caspase inhibitor</cons> <cons lex="zVAD-fmk" sem="G#other_organic_compound">zVAD-fmk</cons>, correlated with the inhibition of <cons lex="nuclear_factor-kappa_B" sem="G#protein_complex">nuclear factor-kappa B</cons> (<cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>), and was mimicked by a <cons lex="cell_permeable_inhibitory_peptide" sem="G#peptide">cell permeable inhibitory peptide</cons> of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, <cons lex="SN-50" sem="G#peptide">SN-50</cons>; other <cons lex="NF-kappaB_inhibitor" sem="G#other_artificial_source"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> inhibitors</cons>, <cons lex="curcumin" sem="G#other_organic_compound">curcumin</cons> and <cons lex="pyrrolidine_dithiocarbamate" sem="G#other_organic_compound">pyrrolidine dithiocarbamate</cons>; and the <cons lex="proteasome_inhibitor" sem="G#other_organic_compound">proteasome inhibitor</cons>, <cons lex="MG-132" sem="G#other_organic_compound">MG-132</cons>.</sentence>
<sentence><cons lex="gliotoxin" sem="G#other_organic_compound">Gliotoxin</cons> also augmented dramatically the early (2-6 h) <cons lex="pro-apoptotic_effect" sem="G#other_name">pro-apoptotic effects</cons> of <cons lex="tumor_necrosis_factor-alpha" sem="G#protein_molecule">tumor necrosis factor-alpha</cons> (<cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>) in <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> and unmasked the ability of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> to induce <cons lex="eosinophil_apoptosis" sem="G#other_name"><cons lex="eosinophil" sem="G#cell_type">eosinophil</cons> <cons lex="apoptosis" sem="G#other_name">apoptosis</cons></cons>.</sentence>
<sentence>In <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons>, <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> caused a <cons lex="gliotoxin-inhibitable_activation" sem="G#other_name"><cons lex="gliotoxin" sem="G#other_organic_compound">gliotoxin</cons>-inhibitable activation</cons> of an inducible form of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, a response that may underlie the ability of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> to delay <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> at later times (12-24 h) and limit its <cons lex="early_killing_effect" sem="G#other_name">early killing effect</cons>.</sentence>
<sentence>Furthermore, <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons> displayed a similar capacity to enhance <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons> induced neutrophil <cons lex="apoptosis" sem="G#other_name">apoptosis</cons> even at time points when <cons lex="cycloheximide" sem="G#other_organic_compound">cycloheximide</cons> alone had no pro-apoptotic effect, suggesting that <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> may regulate the production of protein(s) which protect <cons lex="neutrophil" sem="G#cell_type">neutrophils</cons> from the <cons lex="cytotoxic_effect" sem="G#other_name">cytotoxic effects</cons> of <cons lex="TNF-alpha" sem="G#protein_molecule">TNF-alpha</cons>.</sentence>
<sentence>These data shed light on the biochemical and <cons lex="molecular_mechanism" sem="G#other_name">molecular mechanisms</cons> regulating <cons lex="human_granulocyte_apoptosis" sem="G#other_name">human granulocyte <cons lex="apoptosis" sem="G#other_name">apoptosis</cons></cons> and, in particular, indicate that the <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> plays a crucial role in regulating the <cons lex="physiological_cell_death_pathway" sem="G#other_name">physiological cell death pathway</cons> in <cons lex="granulocyte" sem="G#cell_type">granulocytes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99115672</bibliomisc>
</articleinfo>
<title>
<sentence>Role of <cons lex="Egr-2" sem="G#protein_molecule">Egr-2</cons> in up-regulation of <cons lex="Fas_ligand" sem="G#protein_family_or_group">Fas ligand</cons> in normal <cons lex="T_cell" sem="G#cell_type">T cells</cons> and <cons lex="(AND aberrant_double-negative_lpr_T_cell aberrant_double-negative_gld_T_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="aberrant_double-negative_lpr*">aberrant double-negative lpr</cons> and <cons lex="gld*">gld</cons> <cons lex="*T_cell">T cells</cons></cons>.</sentence>
</title>
<abstract>
<sentence>We previously identified a <cons lex="Fas_ligand_regulatory_element" sem="G#DNA_domain_or_region">Fas ligand regulatory element</cons> (<cons lex="FLRE" sem="G#DNA_domain_or_region">FLRE</cons>) in the <cons lex="Fas_ligand_(fasL)_promoter" sem="G#DNA_domain_or_region">Fas ligand (fasL) promoter</cons> that binds <cons lex="Egr_family_protein" sem="G#protein_family_or_group">Egr family proteins</cons> and demonstrated that <cons lex="Egr-3" sem="G#protein_molecule">Egr-3</cons> (<cons lex="PILOT" sem="G#protein_molecule">PILOT</cons>) but not <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> (<cons lex="NGFI-A" sem="G#protein_molecule">NGFI-A</cons>, <cons lex="Krox-24" sem="G#protein_molecule">Krox-24</cons>, <cons lex="Tis-8" sem="G#protein_molecule">Tis-8</cons>, and <cons lex="Zif-268" sem="G#protein_domain_or_region">Zif-268</cons>) induces transcription of <cons lex="fasL" sem="G#protein_molecule">fasL</cons>.</sentence>
<sentence>The <cons lex="aberrant_CD4(-)CD8(-)_T_cell" sem="G#cell_type">aberrant CD4(-)CD8(-) T cells</cons> from <cons lex="(AND lpr/lpr_mouse gld/gld_mouse)" sem="(AND G#other_artificial_source G#other_artificial_source)"><cons lex="lpr/lpr*">lpr/lpr</cons> and <cons lex="gld/gld*">gld/gld</cons> <cons lex="*mouse">mice</cons></cons>, which have mutations in the genes encoding <cons lex="Fas" sem="G#protein_molecule">Fas</cons> and <cons lex="FasL" sem="G#protein_molecule">FasL</cons>, respectively, have an activated phenotype and constitutively express high levels of <cons lex="fasL_mRNA" sem="G#RNA_molecule">fasL mRNA</cons>, prompting us to ask what role if any the <cons lex="FLRE" sem="G#DNA_domain_or_region">FLRE</cons> and <cons lex="Egr_family_protein" sem="G#protein_family_or_group">Egr family proteins</cons> have in this aberrant expression of <cons lex="fasL" sem="G#protein_molecule">fasL</cons>.</sentence>
<sentence>Unstimulated <cons lex="(AND MRL-lpr/lpr_T_cell C3H-gld/gld_CD4(-)CD8(-_)_T_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="MRL-lpr/lpr*">MRL-lpr/lpr</cons> and <cons lex="C3H-gld/gld_CD4(-)CD8(-_)*">C3H-gld/gld CD4(-)CD8(-)</cons> <cons lex="*T_cell">T cells</cons></cons> constitutively contained high levels of two proteins that bound to the <cons lex="FLRE" sem="G#DNA_domain_or_region">FLRE</cons>.</sentence>
<sentence>Supershift analysis revealed these proteins to be <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> and <cons lex="Egr-2" sem="G#protein_molecule">Egr-2</cons> (Krox-20); <cons lex="Egr-3" sem="G#protein_molecule">Egr-3</cons> was not detected.</sentence>
<sentence>Activation of <cons lex="normal_lymph_node_cell" sem="G#cell_type">normal lymph node cells</cons> resulted in increased expression of <cons lex="(AND Egr-1 Egr-2 Egr-3)" sem="(AND G#protein_molecule G#protein_molecule G#protein_molecule)"><cons lex="Egr*">Egr</cons><cons lex="*-1">-1</cons>, <cons lex="*-2">-2</cons>, and <cons lex="*-3">-3</cons></cons>.</sentence>
<sentence>As with <cons lex="egr-3" sem="G#DNA_domain_or_region">egr-3</cons>, expression of <cons lex="egr-2" sem="G#DNA_domain_or_region">egr-2</cons> was blocked by <cons lex="cyclosporin_A" sem="G#other_organic_compound">cyclosporin A</cons>.</sentence>
<sentence>Although overexpressed <cons lex="Egr-1" sem="G#protein_molecule">Egr-1</cons> was ineffective, overexpressed <cons lex="Egr-2" sem="G#protein_molecule">Egr-2</cons> was as potent as <cons lex="Egr-3" sem="G#protein_molecule">Egr-3</cons> in inducing <cons lex="fasL_promoter-dependent_reporter_constructs" sem="G#DNA_molecule"><cons lex="fasL" sem="G#protein_molecule">fasL</cons> promoter-dependent reporter constructs</cons> in T cell hybridomas and HeLa cells, and both up-regulated endogenous <cons lex="fasL_mRNA" sem="G#RNA_molecule">fasL mRNA</cons> in <cons lex="HeLa_cell" sem="G#cell_line">HeLa cells</cons>.</sentence>
<sentence><cons lex="FasL-dependent_reporter_construct" sem="G#DNA_molecule"><cons lex="FasL" sem="G#protein_molecule">FasL</cons>-dependent reporter constructs</cons> in <cons lex="(AND MRL-lpr/lpr_T_cell C3H-gld/gld_CD4(-)CD8(-)_T_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="MRL-lpr/lpr*">MRL-lpr/lpr</cons> and <cons lex="C3H-gld/gld_CD4(-)CD8(-)*">C3H-gld/gld CD4(-)CD8(-)</cons> <cons lex="*T_cell">T cells</cons></cons> were constitutively active, and this activity was largely prevented by mutation of the critical <cons lex="Egr_family_binding_element" sem="G#DNA_domain_or_region">Egr family binding element</cons>.</sentence>
<sentence>Thus, <cons lex="Egr-2" sem="G#protein_molecule">Egr-2</cons>, in addition to <cons lex="Egr-3" sem="G#protein_molecule">Egr-3</cons>, regulates <cons lex="FasL" sem="G#protein_molecule">FasL</cons> expression in activated normal <cons lex="T_cell" sem="G#cell_type">T cells</cons>, and <cons lex="Egr-2" sem="G#protein_molecule">Egr-2</cons> is likely to play a direct role in aberrant <cons lex="fasL_up-regulation" sem="G#other_name"><cons lex="fasL" sem="G#protein_molecule">fasL</cons> up-regulation</cons> in <cons lex="(AND lpr/lpr_T_cell gld/gld_CD4(-)CD8(-)_T_cell)" sem="(AND G#cell_line G#cell_line)"><cons lex="lpr/lpr*">lpr/lpr</cons> and <cons lex="gld/gld_CD4(-)CD8(-)*">gld/gld CD4(-)CD8(-)</cons> <cons lex="*T_cell">T cells</cons></cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99102381</bibliomisc>
</articleinfo>
<title>
<sentence>The activity of the <cons lex="CCAAT-box_binding_factor_NF-Y" sem="G#protein_molecule"><cons lex="CCAAT-box" sem="G#DNA_domain_or_region">CCAAT-box</cons> binding factor <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons></cons> is modulated through the regulated expression of its <cons lex="A_subunit" sem="G#protein_subunit">A subunit</cons> during <cons lex="monocyte_to_macrophage_differentiation" sem="G#other_name">monocyte to macrophage differentiation</cons>: regulation of <cons lex="tissue-specific_gene" sem="G#DNA_family_or_group">tissue-specific genes</cons> through a ubiquitous <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons>.</sentence>
</title>
<abstract>
<sentence>In this study, we analyzed the regulation of <cons lex="NF-Y_expression" sem="G#other_name"><cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> expression</cons> during human monocyte to <cons lex="macrophage_maturation" sem="G#other_name">macrophage maturation</cons>.</sentence>
<sentence><cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> is a ubiquitous and evolutionarily conserved <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> that binds specifically to the <cons lex="CCAAT_motif" sem="G#DNA_domain_or_region">CCAAT motif</cons> present in the <cons lex="5'_promoter_region" sem="G#DNA_domain_or_region">5' promoter region</cons> of a wide variety of genes.</sentence>
<sentence>We show here that in <cons lex="circulating_monocyte" sem="G#cell_type">circulating monocytes</cons>, <cons lex="NF-Y_binding_activity" sem="G#other_name"><cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> binding activity</cons> is not detected on the <cons lex="CCAAT_motif" sem="G#DNA_domain_or_region">CCAAT motif</cons> present in the <cons lex="promoter_of_gene" sem="G#DNA_domain_or_region">promoters of genes</cons> such as <cons lex="major_histocompatibility_complex_(MHC)_class_II" sem="G#DNA_family_or_group">major histocompatibility complex (MHC) class II</cons>, <cons lex="gp91-phox" sem="G#DNA_domain_or_region">gp91-phox</cons>, <cons lex="mig" sem="G#DNA_domain_or_region">mig</cons>, and fibronectin, whereas during <cons lex="macrophage_differentiation" sem="G#other_name">macrophage differentiation</cons>, a progressive increase in <cons lex="NF-Y_binding_activity" sem="G#other_name"><cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> binding activity</cons> is observed on these promoters.</sentence>
<sentence>Analysis of <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> subunit expression indicates that the absence of <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> activity in <cons lex="circulating_monocyte" sem="G#cell_type">circulating monocytes</cons> is caused by a lack of the <cons lex="A_subunit" sem="G#protein_subunit">A subunit</cons>.</sentence>
<sentence>Furthermore, addition of the recombinant <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons><cons lex="A_subunit" sem="G#protein_subunit">A subunit</cons> restores <cons lex="NF-Y_binding" sem="G#other_name"><cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> binding</cons>.</sentence>
<sentence>We show that the lack of <cons lex="NF-YA_protein" sem="G#protein_molecule">NF-YA protein</cons> is due to posttranscriptional regulation and not to a specific proteolytic activity.</sentence>
<sentence>In fact, <cons lex="NF-YA_mRNA" sem="G#RNA_molecule"><cons lex="NF-YA" sem="G#protein_molecule">NF-YA</cons> mRNA</cons> is present at the same level at all days of <cons lex="monocyte_cultivation" sem="G#other_name">monocyte cultivation</cons>, whereas the protein is absent in <cons lex="freshly_isolated_monocyte" sem="G#cell_type">freshly isolated monocytes</cons> but is progressively synthesized during the <cons lex="maturation_process" sem="G#other_name">maturation process</cons>.</sentence>
<sentence>We thus conclude that the <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons><cons lex="A_subunit" sem="G#protein_subunit">A subunit</cons> plays a relevant role in activating transcription of genes highly expressed in <cons lex="mature_monocyte" sem="G#cell_type">mature monocytes</cons>.</sentence>
<sentence>In line with this conclusion, we show that the <cons lex="cut/CDP_protein" sem="G#protein_molecule">cut/CDP protein</cons>, a transcriptional repressor that inhibits <cons lex="gpc91-phox_gene_expression" sem="G#other_name"><cons lex="gpc91-phox_gene" sem="G#DNA_domain_or_region">gpc91-phox gene</cons> expression</cons> by preventing <cons lex="NF-Y" sem="G#protein_molecule">NF-Y</cons> binding to the <cons lex="CAAT_box" sem="G#DNA_domain_or_region">CAAT box</cons>, is absent in <cons lex="monocyte" sem="G#cell_type">monocytes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99078033</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="interdomain_B" sem="G#protein_domain_or_region">Interdomain B</cons> in <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> regulates but is not required for <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> signaling function in <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons>.</sentence>
</title>
<abstract>
<sentence>The protein tyrosine kinase <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> plays an important role in <cons lex="T-cell_activation" sem="G#other_name">T-cell activation</cons> and <cons lex="T_cell_development" sem="G#other_name">development</cons>.</sentence>
<sentence>After <cons lex="T-cell_receptor_stimulation" sem="G#other_name"><cons lex="T-cell_receptor" sem="G#protein_family_or_group">T-cell receptor</cons> stimulation</cons>, <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> associates with the receptor and is phosphorylated on many <cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosines</cons>, including <cons lex="Y292" sem="G#amino_acid_monomer">Y292</cons>, <cons lex="Y315" sem="G#amino_acid_monomer">Y315</cons>, and <cons lex="Y319" sem="G#amino_acid_monomer">Y319</cons> within interdomain B.</sentence>
<sentence>Previously, we demonstrated that <cons lex="Y292" sem="G#amino_acid_monomer">Y292</cons> negatively regulates <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> function and that <cons lex="Y315" sem="G#amino_acid_monomer">Y315</cons> positively regulates <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> function by interacting with <cons lex="Vav" sem="G#protein_molecule">Vav</cons>.</sentence>
<sentence>Recent studies have suggested that <cons lex="Y319" sem="G#amino_acid_monomer">Y319</cons> also positively regulate <cons lex="ZAP-70_function" sem="G#other_name"><cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> function</cons>.</sentence>
<sentence>Paradoxically, removal of <cons lex="interdomain_B" sem="G#protein_domain_or_region">interdomain B</cons> (to create the construct designated <cons lex="Delta" sem="G#protein_molecule">Delta</cons>), containing the <cons lex="Y292" sem="G#amino_acid_monomer">Y292</cons>, <cons lex="Y315" sem="G#amino_acid_monomer"><cons lex="Y315" sem="G#amino_acid_monomer">Y315</cons></cons>, and <cons lex="Y319" sem="G#amino_acid_monomer">Y319</cons> sites, did not eliminate the ability of <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> to induce <cons lex="multiple_gene_reporter" sem="G#DNA_domain_or_region">multiple gene reporters</cons> in <cons lex="Syk-deficient_DT-40_B_cell" sem="G#cell_line">Syk-deficient DT-40 B cells</cons> and <cons lex="ZAP-70/Syk-deficient_Jurkat_cell" sem="G#cell_line"><cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons>/Syk-deficient Jurkat cells</cons>.</sentence>
<sentence>Here we show that <cons lex="Delta" sem="G#protein_molecule">Delta</cons> still utilizes the same pathways as wild-type <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> to mediate <cons lex="NF-AT_induction" sem="G#other_name"><cons lex="NF-AT" sem="G#protein_family_or_group">NF-AT</cons> induction</cons>.</sentence>
<sentence>This is manifested by the ability of <cons lex="Delta" sem="G#protein_molecule">Delta</cons> to restore induction of <cons lex="calcium_flux" sem="G#other_name"><cons lex="calcium" sem="G#atom">calcium</cons> fluxes</cons> and <cons lex="mitogen-activated_protein_kinase_activation" sem="G#other_name"><cons lex="mitogen-activated_protein_kinase" sem="G#protein_molecule">mitogen-activated protein kinase</cons> activation</cons> and by the ability of dominant negative <cons lex="Ras" sem="G#protein_molecule">Ras</cons> and <cons lex="FK506" sem="G#protein_molecule">FK506</cons> to block the induction of <cons lex="NF-AT_activity" sem="G#other_name"><cons lex="NF-AT" sem="G#protein_family_or_group">NF-AT</cons> activity</cons> mediated by <cons lex="Delta" sem="G#protein_molecule">Delta</cons>.</sentence>
<sentence>Biochemically we show that the stimulated <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="Vav" sem="G#protein_molecule">Vav</cons>, <cons lex="Shc" sem="G#protein_molecule">Shc</cons>, and <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> itself is diminished, whereas that of <cons lex="Slp-76" sem="G#protein_molecule">Slp-76</cons> is increased in cells reconstituted with <cons lex="Delta" sem="G#protein_molecule">Delta</cons>.</sentence>
<sentence>Deletion of <cons lex="interdomain_B" sem="G#protein_domain_or_region">interdomain B</cons> did not affect the ability of <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> to bind to the receptor.</sentence>
<sentence>The <cons lex="in_vitro_kinase_activity" sem="G#other_name">in vitro kinase activity</cons> of <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> lacking <cons lex="interdomain_B" sem="G#protein_domain_or_region">interdomain B</cons> was markedly reduced, but the kinase activity was still required for the protein's in vivo activity.</sentence>
<sentence>Based on these data, we concluded that <cons lex="interdomain_B" sem="G#protein_domain_or_region">interdomain B</cons> regulates but is not required for <cons lex="ZAP-70" sem="G#protein_molecule">ZAP-70</cons> signaling function leading to <cons lex="cellular_response" sem="G#other_name">cellular responses</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98208270</bibliomisc>
</articleinfo>
<title>
<sentence>Differential induction of <cons lex="DNA-binding_activity" sem="G#protein_family_or_group">DNA-binding activities</cons> following <cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linking in <cons lex="human_B_lineage_cell" sem="G#cell_type">human B lineage cells</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="B_cell-specific_cell_surface_molecule" sem="G#protein_family_or_group">B cell-specific cell surface molecule</cons> <cons lex="CD19" sem="G#protein_molecule">CD19</cons> is expressed at all stages of <cons lex="B_cell_development" sem="G#other_name">B cell development</cons>, including normal plasma cells, and mediates signal transduction via interaction with <cons lex="cytoplasmic_effector_protein" sem="G#protein_family_or_group">cytoplasmic effector proteins</cons>.</sentence>
<sentence>Cross-linking <cons lex="CD19" sem="G#protein_molecule">CD19</cons> on early <cons lex="human_B_lineage_cell" sem="G#cell_type">human B lineage cells</cons> induces the formation of a <cons lex="CD19/Vav/phosphatidylinositol-3_kinase_complex" sem="G#protein_complex"><cons lex="CD19" sem="G#protein_molecule">CD19</cons>/Vav/phosphatidylinositol-3 kinase complex</cons>, <cons lex="tyrosine_phosphorylation" sem="G#other_name"><cons lex="tyrosine" sem="G#amino_acid_monomer">tyrosine</cons> phosphorylation</cons> of <cons lex="CD19" sem="G#protein_molecule">CD19</cons> and <cons lex="Vav" sem="G#protein_molecule">Vav</cons>, and activation of the <cons lex="Ras_pathway" sem="G#other_name"><cons lex="Ras" sem="G#protein_molecule">Ras</cons> pathway</cons>.</sentence>
<sentence>To further explore the ramifications of <cons lex="CD19" sem="G#protein_molecule">CD19</cons> signaling, the current study examined whether phosphorylation of <cons lex="Elk-1" sem="G#protein_molecule">Elk-1</cons>, activation of <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons> (<cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>), or activation of nuclear factor-kappaB (<cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>) <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> occurred following <cons lex="CD19_cross-linking" sem="G#other_name"><cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linking</cons>.</sentence>
<sentence>The cells used were the <cons lex="BLIN-1_pre-B_cell_line" sem="G#cell_line">BLIN-1 pre-B cell line</cons> expressing low levels of <cons lex="cell_surface_mu_heavy_chain" sem="G#protein_subunit">cell surface mu heavy chain</cons> associated with <cons lex="surrogate_light_chain" sem="G#protein_subunit">surrogate light chain</cons> and the 1E8 immature B cell line expressing <cons lex="cell_surface_mu/kappa" sem="G#protein_molecule">cell surface mu/kappa</cons>.</sentence>
<sentence>Lysates from <cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linked <cons lex="1E8_cell" sem="G#cell_line">1E8 cells</cons> induced robust phosphorylation of an <cons lex="Elk-1_fusion_protein" sem="G#protein_molecule"><cons lex="Elk-1" sem="G#protein_molecule">Elk-1</cons> fusion protein</cons> in vitro, whereas no phosphorylation of <cons lex="Elk-1_fusion_protein" sem="G#protein_molecule"><cons lex="Elk-1" sem="G#protein_molecule">Elk-1</cons> fusion protein</cons> occurred using lysates from <cons lex="CD19_cross-linked_BLIN-1_cell" sem="G#cell_line"><cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linked BLIN-1 cells</cons>.</sentence>
<sentence>An <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assay</cons> employing <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> and <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> consensus <cons lex="oligonucleotide" sem="G#polynucleotide">oligonucleotides</cons> was used to demonstrate that <cons lex="AP-1_-binding_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> -binding activity</cons> increased, while constitutive <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>-binding activity was not enhanced, following 2 h of <cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linking in <cons lex="1E8_cell" sem="G#cell_line">1E8 cells</cons>. <cons lex="supershift_experiment" sem="G#other_name">Supershift experiments</cons> revealed that <cons lex="JunD" sem="G#protein_molecule">JunD</cons> and <cons lex="c-Fos_protein" sem="G#protein_molecule">c-Fos proteins</cons> mediated anti-<cons lex="CD19" sem="G#protein_molecule">CD19</cons> induced <cons lex="AP-1-binding_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>-binding activity</cons> in <cons lex="1E8_cell" sem="G#cell_line">1E8 cells</cons>.</sentence>
<sentence>In contrast, <cons lex="CD19" sem="G#protein_molecule">CD19</cons> cross-linking in <cons lex="BLIN-1_cell" sem="G#cell_line">BLIN-1 cells</cons> resulted in the induction of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>, but had no apparent effect on <cons lex="AP-1-binding_activity" sem="G#other_name"><cons lex="AP-1" sem="G#protein_molecule">AP-1</cons>-binding activity</cons>.</sentence>
<sentence>These data suggest that <cons lex="CD19-mediated_signal_transduction" sem="G#other_name"><cons lex="CD19" sem="G#protein_molecule">CD19</cons>-mediated signal transduction</cons> activates different <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> at juxtaposed stages of <cons lex="B_cell_development" sem="G#other_name">B cell development</cons> that may culminate in the activation or suppression of distinct sets of <cons lex="gene" sem="G#DNA_domain_or_region">genes</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98140255</bibliomisc>
</articleinfo>
<title>
<sentence>Oxidants, <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons>, and <cons lex="intestinal_inflammation" sem="G#other_name">intestinal inflammation</cons>.</sentence>
</title>
<abstract>
<sentence>It is now well appreciated that <cons lex="chronic_gut_inflammation" sem="G#other_name">chronic gut inflammation</cons> is characterized by enhanced production of <cons lex="reactive_metabolite" sem="G#other_organic_compound">reactive metabolites</cons> of <cons lex="oxygen" sem="G#atom">oxygen</cons> and <cons lex="nitrogen" sem="G#atom">nitrogen</cons>.</sentence>
<sentence>Some of these oxidants are known to modulate the expression of a variety of genes that are involved in the immune and <cons lex="inflammatory_response" sem="G#other_name">inflammatory responses</cons>.</sentence>
<sentence>For example, certain oxidants are known to activate the <cons lex="nuclear_transcription_factor_kappa_B" sem="G#protein_complex">nuclear <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> kappa B</cons>, which regulates the expression of a variety of different <cons lex="adhesion_molecule" sem="G#protein_family_or_group">adhesion molecules</cons>, <cons lex="cytokine" sem="G#protein_family_or_group">cytokines</cons>, and <cons lex="enzyme" sem="G#protein_family_or_group">enzymes</cons>.</sentence>
<sentence>Oxidants are also known to activate another <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons>, <cons lex="activator_protein-1" sem="G#protein_molecule">activator protein-1</cons>.</sentence>
<sentence>This <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> is composed of products from the <cons lex="fos_and_jun_proto-oncogene_family" sem="G#protein_family_or_group">fos and jun proto-oncogene family</cons> and is believed to be important in regulating <cons lex="cell_growth" sem="G#other_name">cell growth</cons> and <cons lex="proliferation" sem="G#other_name">proliferation</cons>.</sentence>
<sentence>Finally, <cons lex="oxidant" sem="G#inorganic">oxidants</cons> are believed to promote <cons lex="intestinal_epithelial_cell" sem="G#cell_type">intestinal epithelial cell</cons> <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>, and the <cons lex="B-cell_lymphoma/leukemia-2_gene_product" sem="G#protein_molecule">B-cell lymphoma/leukemia-2 gene product</cons> is believed to inhibit this phenomenon in an <cons lex="antioxidant-dependent_manner" sem="G#other_name">antioxidant-dependent manner</cons>.</sentence>
<sentence>Taken together, these observations suggest that <cons lex="nontoxic_concentration" sem="G#other_name">nontoxic concentrations</cons> of <cons lex="reactive_metabolite" sem="G#other_organic_compound">reactive metabolites</cons> of <cons lex="oxygen" sem="G#atom">oxygen</cons> and <cons lex="nitrogen" sem="G#atom">nitrogen</cons> play an important role in regulating the expression of genes involved in the <cons lex="inflammatory_response" sem="G#other_name">inflammatory response</cons> and in modulating <cons lex="apoptosis" sem="G#other_name">apoptosis</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98104475</bibliomisc>
</articleinfo>
<title>
<sentence>Identification of <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons> of the <cons lex="lymphoid-specific_transcription_factor_Oct2" sem="G#protein_molecule">lymphoid-specific <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> Oct2</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> is expressed predominantly in <cons lex="B_lymphocyte" sem="G#cell_type">B <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons></cons> and plays an essential role during the terminal phase of <cons lex="B_cell_differentiation" sem="G#other_name">B cell differentiation</cons>.</sentence>
<sentence>The <cons lex="regulatory_region" sem="G#DNA_domain_or_region">regulatory regions</cons> of several genes specifically expressed in <cons lex="B_cell" sem="G#cell_type">B cells</cons> contain <cons lex="functional_binding_site" sem="G#DNA_domain_or_region">functional binding sites</cons> for <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons>.</sentence>
<sentence>Nevertheless, none of the genes originally thought to be regulated by <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> were affected in their expression in <cons lex="Oct2-deficient_B_cell" sem="G#cell_line"><cons lex="Oct2" sem="G#protein_molecule">Oct2</cons>-deficient <cons lex="B_cell" sem="G#cell_type">B cells</cons></cons>.</sentence>
<sentence>In an attempt to find such elusive <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons> and to understand the molecular function of <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> in <cons lex="B_cell_development" sem="G#other_name">B cell development</cons>, we isolated <cons lex="cDNA" sem="G#DNA_family_or_group">cDNAs</cons> for <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons>.</sentence>
<sentence>So far, we have identified five potential targets for <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons>: the <cons lex="membrane_glycoprotein" sem="G#protein_family_or_group">membrane glycoprotein</cons> <cons lex="CD36" sem="G#protein_molecule">CD36</cons>, the <cons lex="cysteine-rich_secreted_protein_3" sem="G#protein_molecule">cysteine-rich secreted protein 3</cons> (<cons lex="CRISP-3" sem="G#protein_molecule">CRISP-3</cons>), a mouse homolog of the <cons lex="human_monocyte/neutrophil_elastase_inhibitor" sem="G#protein_molecule">human monocyte/neutrophil elastase inhibitor</cons> (<cons lex="mEI" sem="G#protein_molecule">mEI</cons>) and two unknown <cons lex="cDNA_sequence" sem="G#DNA_molecule">cDNA sequences</cons> <cons lex="Nov1" sem="G#DNA_molecule">Nov1</cons> and <cons lex="Nov2" sem="G#DNA_molecule">Nov2</cons>.</sentence>
<sentence>These <cons lex="target_gene" sem="G#DNA_family_or_group">target genes</cons> show quite distinct <cons lex="expression_pattern" sem="G#other_name">expression patterns</cons> demonstrating that <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> in addition to <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons> are involved in their regulation.</sentence>
<sentence>Whereas <cons lex="CD36" sem="G#protein_molecule">CD36</cons> and <cons lex="mEI" sem="G#protein_molecule">mEI</cons> were expressed in all <cons lex="hematopoetic_cell_line" sem="G#cell_line">hematopoetic cell lines</cons> containing <cons lex="Oct2" sem="G#protein_molecule">Oct2</cons>,.</sentence>
<sentence><cons lex="CRISP-3" sem="G#protein_molecule">CRISP-3</cons> is <cons lex="pre-B_cell-specific" sem="G#other_name">pre-B cell-specific</cons>, <cons lex="Nov1" sem="G#DNA_molecule">Nov1</cons> is <cons lex="plasma_B_cell-specific" sem="G#other_name">plasma B cell-specific</cons> and <cons lex="Nov2" sem="G#DNA_molecule">Nov2</cons> is <cons lex="B_cell-specifically_expressed" sem="G#other_name">B cell-specifically expressed</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99170284</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="RFX-B" sem="G#DNA_domain_or_region">RFX-B</cons> is the gene responsible for the most common cause of the <cons lex="bare_lymphocyte_syndrome" sem="G#other_name">bare lymphocyte syndrome</cons>, an <cons lex="MHC_class_II_immunodeficiency" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> immunodeficiency</cons> [published erratum appears in Immunity 1999 Mar;10(3):399]</sentence>
</title>
<abstract>
<sentence>The <cons lex="bare_lymphocyte_syndrome" sem="G#other_name">bare lymphocyte syndrome</cons> (<cons lex="BLS" sem="G#other_name">BLS</cons>) is characterized by the absence of <cons lex="MHC_class_II_transcription" sem="G#other_name"><cons lex="MHC_class_II" sem="G#protein_family_or_group">MHC class II</cons> transcription</cons> and <cons lex="(AND humoral-mediated_immune_response cellular-mediated_immune_response)" sem="(AND G#other_name G#other_name)"><cons lex="humoral-*">humoral-</cons> and <cons lex="cellular-*">cellular-</cons><cons lex="*mediated_immune_response">mediated immune responses</cons></cons> to foreign antigens.</sentence>
<sentence>Three of the four <cons lex="BLS" sem="G#other_name">BLS</cons> genetic complementation groups have defects in the activity of the <cons lex="MHC_class_II_transcription_factor" sem="G#protein_family_or_group">MHC class II transcription factor</cons> <cons lex="RFX" sem="G#protein_molecule">RFX</cons>.</sentence>
<sentence>We have purified the <cons lex="RFX_complex" sem="G#protein_complex"><cons lex="RFX" sem="G#protein_molecule">RFX</cons> complex</cons> and sequenced its three subunits.</sentence>
<sentence>The sequence of the smallest subunit describes a novel gene, termed <cons lex="RFX-B" sem="G#DNA_domain_or_region">RFX-B</cons>.</sentence>
<sentence><cons lex="RFX-B" sem="G#DNA_domain_or_region">RFX-B</cons> complements the predominant <cons lex="BLS_complementation_group" sem="G#protein_family_or_group"><cons lex="BLS" sem="G#other_name">BLS</cons> complementation group</cons> (<cons lex="group_B" sem="G#protein_family_or_group">group B</cons>) and was found to be mutant in <cons lex="cell_line" sem="G#cell_line">cell lines</cons> from this <cons lex="BLS_group" sem="G#multi_cell"><cons lex="BLS" sem="G#other_name">BLS</cons> group</cons>.</sentence>
<sentence>The protein has no known <cons lex="DNA-binding_domain" sem="G#protein_domain_or_region">DNA-binding domain</cons> but does contain three ankyrin repeats that are likely to be important in <cons lex="protein-protein_interaction" sem="G#other_name">protein-protein interactions</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99158164</bibliomisc>
</articleinfo>
<title>
<sentence>Binding of <cons lex="c-Rel" sem="G#protein_molecule">c-Rel</cons> to <cons lex="STAT5_target_sequence" sem="G#DNA_domain_or_region">STAT5 target sequences</cons> in <cons lex="HTLV-I-transformed_T_cell" sem="G#cell_type">HTLV-I-transformed T cells</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="type_I_human_T-cell_leukemia_virus" sem="G#virus">type I human T-cell leukemia virus</cons> (<cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>) induces abnormal growth and subsequent transformation of <cons lex="T_cell" sem="G#cell_type">T cells</cons>, which is associated with the development of an <cons lex="acute_T-cell_malignancy" sem="G#other_name">acute T-cell malignancy</cons> termed <cons lex="adult_T-cell_leukemia" sem="G#other_name">adult T-cell leukemia</cons>.</sentence>
<sentence>A characteristic of <cons lex="HTLV-I-transformed_T_cell" sem="G#cell_type"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-transformed T cells</cons> is the constitutive nuclear expression of <cons lex="NF-kappaB/Rel_family" sem="G#protein_family_or_group">NF-kappaB/Rel family</cons> of transcription factors, which appears to be essential for the growth of these <cons lex="transformed_cell" sem="G#cell_type">transformed cells</cons>.</sentence>
<sentence>Although <cons lex="NF-kappaB/Rel_factor" sem="G#protein_family_or_group">NF-kappaB/Rel factors</cons> are known to induce the expression of <cons lex="T-cell_growth_factor_interleukin_(IL)-2" sem="G#protein_molecule">T-cell growth factor interleukin (IL)-2</cons>, it is unclear how they participate in the <cons lex="IL-2-independent_growth" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-independent growth</cons> of <cons lex="HTLV-I-_transformed_cell" sem="G#cell_line"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons><cons lex="transformed_cell" sem="G#cell_type">-transformed cells</cons></cons>.</sentence>
<sentence>In this study, we show that certain <cons lex="NF-kappaB/Rel_member" sem="G#protein_family_or_group">NF-kappaB/Rel members</cons>, predominantly <cons lex="c-Rel" sem="G#protein_molecule">c-Rel</cons>, interact with enhancer sequences for <cons lex="STAT5" sem="G#protein_molecule">STAT5</cons>, a key transcription factor mediating <cons lex="IL-2-induced_T-cell_proliferation" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons>-induced T-cell proliferation</cons>.</sentence>
<sentence>Reporter gene assays reveal that the binding of <cons lex="c-Rel" sem="G#protein_molecule">c-Rel</cons> to the <cons lex="STAT5" sem="G#protein_molecule">STAT5</cons> site present in the <cons lex="Fc_gammaR1_gene" sem="G#DNA_domain_or_region">Fc gammaR1 gene</cons> leads to potent transactivation of this enhancer.</sentence>
<sentence>Binding of <cons lex="c-Rel" sem="G#protein_molecule">c-Rel</cons> to the <cons lex="Fc_gammaR1_STAT_site" sem="G#DNA_domain_or_region">Fc gammaR1 STAT site</cons> also occurs in human <cons lex="peripheral_blood_T_cell" sem="G#cell_type">peripheral blood T cells</cons> immortalized with <cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> in vitro and is correlated with enhanced levels of proliferation of these cells.</sentence>
<sentence>These results raise the possibility that <cons lex="NF-kappaB/Rel" sem="G#protein_family_or_group">NF-kappaB/Rel</cons> may participate in the growth control of <cons lex="HTLV-I-transformed_T_cell" sem="G#cell_line"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-transformed T cells</cons> by regulating genes driven by both <cons lex="kappaB_enhancer" sem="G#DNA_domain_or_region">kappaB</cons> and certain <cons lex="STAT_enhancer" sem="G#DNA_domain_or_region">STAT enhancers</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99147045</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="activation-dependent_transcriptional_regulation" sem="G#other_name">Activation-dependent transcriptional regulation</cons> of the <cons lex="human_Fas_promoter" sem="G#DNA_domain_or_region">human Fas promoter</cons> requires <cons lex="NF-kappaB_p50-p65_recruitment" sem="G#other_name"><cons lex="NF-kappaB_p50-p65" sem="G#protein_complex">NF-kappaB p50-p65</cons> recruitment</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="Fas" sem="G#protein_molecule">Fas</cons> (<cons lex="CD95" sem="G#protein_molecule">CD95</cons>) and <cons lex="Fas_ligand" sem="G#protein_molecule">Fas ligand</cons> (<cons lex="CD95L" sem="G#protein_molecule">CD95L</cons>) are an interacting <cons lex="receptor-ligand_pair" sem="G#protein_N/A">receptor-ligand pair</cons> required for <cons lex="immune_homeostasis" sem="G#other_name">immune homeostasis</cons>.</sentence>
<sentence><cons lex="lymphocyte_activation" sem="G#other_name">Lymphocyte activation</cons> results in the upregulation of <cons lex="Fas_expression" sem="G#other_name"><cons lex="Fas" sem="G#protein_molecule">Fas</cons> expression</cons> and the acquisition of sensitivity to <cons lex="FasL-mediated_apoptosis" sem="G#other_name"><cons lex="FasL" sem="G#protein_molecule">FasL</cons>-mediated apoptosis</cons>.</sentence>
<sentence>Although Fas upregulation is central to the preservation of immunologic tolerance, little is known about the <cons lex="molecular_machinery" sem="G#other_name">molecular machinery</cons> underlying this process.</sentence>
<sentence>To investigate the events involved in activation-induced <cons lex="Fas_upregulation" sem="G#other_name"><cons lex="Fas" sem="G#protein_molecule">Fas</cons> upregulation</cons>, we have examined <cons lex="mRNA_accumulation" sem="G#other_name">mRNA accumulation</cons>, <cons lex="fas_promoter_activity" sem="G#other_name">fas promoter activity</cons>, and <cons lex="protein_expression" sem="G#other_name">protein expression</cons> in the <cons lex="Jurkat_T-cell_line" sem="G#cell_line">Jurkat T-cell line</cons> treated with <cons lex="phorbol_myristate_acetate" sem="G#other_organic_compound">phorbol myristate acetate</cons> and <cons lex="ionomycin" sem="G#other_organic_compound">ionomycin</cons> (<cons lex="P/I" sem="G#other_organic_compound">P/I</cons>), pharmacological mimics of <cons lex="T-cell_receptor_activation" sem="G#other_name"><cons lex="T-cell_receptor" sem="G#protein_family_or_group">T-cell receptor</cons> activation</cons>.</sentence>
<sentence>Although <cons lex="resting_Jurkat_cell" sem="G#cell_line">resting Jurkat cells</cons> express <cons lex="Fas" sem="G#protein_molecule">Fas</cons>, <cons lex="Fas_mRNA" sem="G#RNA_molecule"><cons lex="Fas" sem="G#protein_molecule">Fas</cons> mRNA</cons> was induced approximately 10-fold in 2 h upon <cons lex="P/I" sem="G#other_organic_compound">P/I</cons> stimulation.</sentence>
<sentence>Using <cons lex="sequential_deletion_mutant" sem="G#DNA_family_or_group">sequential deletion mutants</cons> of the <cons lex="human_fas_promoter" sem="G#DNA_domain_or_region">human fas promoter</cons> in transient transfection assays, we identified a <cons lex="47-bp_sequence" sem="G#DNA_domain_or_region">47-bp sequence</cons> (<cons lex="positions_-306_to_-260" sem="G#DNA_domain_or_region">positions -306 to -260</cons> relative to the <cons lex="ATG" sem="G#polynucleotide">ATG</cons>) required for <cons lex="activation-driven_fas_upregulation" sem="G#other_name">activation-driven fas upregulation</cons>.</sentence>
<sentence><cons lex="sequence_analysis" sem="G#other_name">Sequence analysis</cons> revealed the presence of a previously <cons lex="unrecognized_composite_binding_site" sem="G#DNA_domain_or_region">unrecognized composite binding site</cons> for both the <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> at <cons lex="position_-295_to_-286" sem="G#DNA_domain_or_region">positions -295 to -286</cons>.</sentence>
<sentence><cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">Electrophoretic mobility shift assay</cons> (<cons lex="EMSA" sem="G#other_name">EMSA</cons>) and supershift analyses of this region documented constitutive binding of <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> in unactivated nuclear extracts and inducible binding of <cons lex="p50-p65_NF-kappaB_heterodimer" sem="G#protein_complex">p50-p65 <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> heterodimers</cons> after <cons lex="P/I" sem="G#other_organic_compound">P/I</cons> activation.</sentence>
<sentence><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> <cons lex="transcription_factor_binding" sem="G#other_name">transcription factor binding</cons> was shown to be mutually exclusive by <cons lex="EMSA_displacement_study" sem="G#other_name"><cons lex="EMSA" sem="G#other_name">EMSA</cons> displacement studies</cons> with purified recombinant <cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> and recombinant <cons lex="p50" sem="G#protein_subunit">p50</cons>.</sentence>
<sentence>The functional contribution of the <cons lex="kappaB-Sp1_composite_site" sem="G#DNA_domain_or_region">kappaB-<cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> composite site</cons> in <cons lex="P/I-inducible_fas_promoter_activation" sem="G#other_name"><cons lex="P/I-inducible_fas_promoter" sem="G#DNA_domain_or_region"><cons lex="P/I" sem="G#other_organic_compound">P/I</cons>-inducible fas promoter</cons> activation</cons> was verified by using kappaB-<cons lex="Sp1_concatamer" sem="G#polynucleotide"><cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> concatamers</cons> (<cons lex="-295_to_-286" sem="G#DNA_domain_or_region">-295 to -286</cons>) in a <cons lex="thymidine_kinase_promoter-driven_reporter_construct" sem="G#DNA_molecule">thymidine kinase promoter-driven reporter construct</cons> and <cons lex="native_promoter_construct" sem="G#DNA_family_or_group">native promoter constructs</cons> in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> overexpressing <cons lex="IkappaB-alpha" sem="G#protein_molecule">IkappaB-alpha</cons>.</sentence>
<sentence>Site-directed mutagenesis of the critical <cons lex="guanine_nucleotide" sem="G#nucleotide">guanine nucleotides</cons> in the <cons lex="kappaB-Sp1_element" sem="G#DNA_domain_or_region">kappaB-<cons lex="Sp1" sem="G#protein_molecule">Sp1</cons> element</cons> documented the essential role of this site in <cons lex="activation-dependent_fas_promoter_induction" sem="G#other_name">activation-dependent fas promoter induction</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99138825</bibliomisc>
</articleinfo>
<title>
<sentence>Evidence for repression of <cons lex="IL-2_gene_activation" sem="G#other_name"><cons lex="IL-2_gene" sem="G#DNA_domain_or_region">IL-2 gene</cons> activation</cons> in <cons lex="anergic_T_cell" sem="G#cell_type">anergic T cells</cons>.</sentence>
</title>
<abstract>
<sentence>The induction of <cons lex="clonal_anergy" sem="G#other_name">clonal anergy</cons> in a T cell inhibits <cons lex="IL-2_secretion" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> secretion</cons> because of the development of a <cons lex="proximal_signal_transduction_defect" sem="G#other_name">proximal signal transduction defect</cons>.</sentence>
<sentence>Fusion of <cons lex="anergic_murine_T_cell" sem="G#cell_type">anergic murine T cells</cons> to <cons lex="human_Jurkat_T_leukemia_cell" sem="G#cell_type">human Jurkat T leukemia cells</cons> and formation of <cons lex="heterokaryon" sem="G#cell_line">heterokaryons</cons> failed to result in a complementation of this signaling defect and restoration of <cons lex="murine_IL-2_mRNA" sem="G#RNA_molecule">murine IL-2 mRNA</cons> inducibility.</sentence>
<sentence>Instead, signal transduction to the human <cons lex="IL-2_gene" sem="G#DNA_domain_or_region">IL-2 gene</cons> became disrupted.</sentence>
<sentence><cons lex="heterokaryon" sem="G#cell_line">Heterokaryons</cons> formed by the fusion of <cons lex="anergic_murine_T_cell" sem="G#cell_type">anergic murine T cells</cons> to <cons lex="normal_murine_T_cell" sem="G#cell_type">normal murine T cells</cons> also failed to accumulate <cons lex="intracellular_IL-2_protein" sem="G#protein_molecule">intracellular IL-2 protein</cons> in response to stimulation either with the combination of <cons lex="CD3" sem="G#protein_molecule"><cons lex="CD3_mAb" sem="G#protein_family_or_group">CD3</cons></cons> and <cons lex="CD28_mAb" sem="G#protein_family_or_group">CD28 mAbs</cons> or with <cons lex="ionomycin" sem="G#other_organic_compound">ionomycin</cons> plus a <cons lex="protein_kinase_C-activating_phorbol_ester" sem="G#other_organic_compound"><cons lex="protein_kinase_C" sem="G#protein_molecule">protein kinase C</cons>-activating phorbol ester</cons>.</sentence>
<sentence>The results argue against a loss-of-function signaling defect as the sole basis for <cons lex="clonal_anergy" sem="G#other_name">clonal anergy</cons> induction and document the presence of a <cons lex="dominant-acting_repressor_molecule" sem="G#protein_family_or_group">dominant-acting repressor molecule</cons> that inhibits signal transduction to the <cons lex="IL-2_gene" sem="G#DNA_domain_or_region">IL-2 gene</cons> within viable <cons lex="anergic_T_cell" sem="G#cell_type">anergic T cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99125803</bibliomisc>
</articleinfo>
<title>
<sentence>Comparison of <cons lex="(AND HTLV-I_basal_transcription HTLV-I_expression)" sem="(AND G#other_name G#other_name)"><cons lex="HTLV-I*">HTLV-I</cons> <cons lex="*basal_transcription">basal transcription</cons> and <cons lex="*expression">expression</cons></cons> of <cons lex="CREB/ATF-1/CREM_family_member" sem="G#protein_family_or_group">CREB/ATF-1/CREM family members</cons> in <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> and <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> is the etiologic agent of <cons lex="adult_T-cell_leukemia/lymphoma" sem="G#other_name"><cons lex="adult_T-cell_leukemia" sem="G#other_name">adult T-cell leukemia</cons>/lymphoma</cons> and is associated with <cons lex="tropical_spastic_paraparesis/HTLV-I-associated_myelopathy" sem="G#other_name">tropical spastic paraparesis/<cons lex="HTLV-I" sem="G#virus">HTLV-I</cons>-associated myelopathy</cons>.</sentence>
<sentence>Following integration into the <cons lex="host_cell_genome" sem="G#other_name">host cell genome</cons>, <cons lex="HTLV-I_replication" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> replication</cons> is regulated by both host and viral mechanisms that control transcription.</sentence>
<sentence>Low levels of <cons lex="viral_transcription" sem="G#other_name">viral transcription</cons> (<cons lex="basal_transcription" sem="G#other_name">basal transcription</cons>) occur before expression of the <cons lex="virally_encoded_Tax_protein" sem="G#protein_molecule">virally encoded Tax protein</cons> (<cons lex="Tax-mediated_transcription" sem="G#other_name"><cons lex="Tax" sem="G#protein_molecule">Tax</cons>-mediated transcription</cons>).</sentence>
<sentence>Members of the <cons lex="cyclic_adenosine_monophosphate_(cAMP)_response_element_binding_(CREB)/activating_transcription_factor_1_(ATF-1)_family" sem="G#protein_family_or_group"><cons lex="cyclic_adenosine_monophosphate_(cAMP)_response_element" sem="G#DNA_domain_or_region"><cons lex="cyclic_adenosine_monophosphate" sem="G#nucleotide">cyclic adenosine monophosphate</cons> (<cons lex="cAMP" sem="G#nucleotide">cAMP</cons>) response element</cons> binding (CREB)/activating transcription factor 1 (<cons lex="ATF-1" sem="G#protein_molecule">ATF-1</cons>) family</cons> of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> bind three <cons lex="21-bp_repeat" sem="G#DNA_domain_or_region">21-bp repeats</cons> (<cons lex="Tax-responsive_element-1" sem="G#DNA_domain_or_region">Tax-responsive element-1</cons>, or <cons lex="TRE-1" sem="G#DNA_domain_or_region">TRE-1</cons>) within the <cons lex="viral_promoter" sem="G#DNA_domain_or_region">viral promoter</cons> and are important for <cons lex="(AND basal_transcription Tax-mediated_transcription)" sem="(AND G#other_name G#other_name)"><cons lex="basal*">basal</cons> and <cons lex="Tax-mediated*">Tax-mediated</cons> <cons lex="*transcription">transcription</cons></cons>.</sentence>
<sentence>Using mitogen stimulated and quiescent <cons lex="peripheral_blood_mononuclear_cell" sem="G#cell_type">peripheral blood mononuclear cells</cons> (<cons lex="PBMC" sem="G#cell_type">PBMC</cons>) and <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>, we compared differences in <cons lex="basal_transcription" sem="G#other_name">basal transcription</cons> and amounts and binding of <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factors</cons> with <cons lex="TRE-1" sem="G#DNA_domain_or_region">TRE-1</cons>.</sentence>
<sentence>We demonstrate that amounts of transcriptionally active <cons lex="phosphorylated_CREB_protein" sem="G#protein_molecule">phosphorylated CREB protein</cons> (<cons lex="P-CREB" sem="G#protein_molecule">P-CREB</cons>) differ between activated <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons>.</sentence>
<sentence>Following stimulation, <cons lex="P-CREB_level" sem="G#other_name"><cons lex="P-CREB" sem="G#protein_molecule">P-CREB</cons> levels</cons> remain elevated in <cons lex="PBMC" sem="G#cell_type">PBMC</cons> for up to 24 hours whereas CREB is dephosphorylated in <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> within 4 hours following stimulation.</sentence>
<sentence>The differences in <cons lex="P-CREB_level" sem="G#other_name"><cons lex="P-CREB" sem="G#protein_molecule">P-CREB</cons> levels</cons> between <cons lex="PBMC" sem="G#cell_type">PBMC</cons> and <cons lex="Jurkat_cell" sem="G#cell_line">Jurkat cells</cons> were directly correlated with <cons lex="basal_transcription" sem="G#other_name">basal transcription</cons> of <cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> in the two cell types.</sentence>
<sentence>Using <cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">electrophoretic mobility shift assays</cons>, we determined that the pattern of band migration differed between the two cell types.</sentence>
<sentence>These data demonstrate that <cons lex="PBMC" sem="G#cell_type">PBMC</cons> differentially regulate basal <cons lex="HTLV-I_transcription" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> transcription</cons> compared with <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons>, and this differential regulation is due, in part to differential phosphorylation and binding of <cons lex="CREB/ATF-1" sem="G#protein_molecule">CREB/ATF-1</cons> to <cons lex="TRE-1" sem="G#DNA_domain_or_region">TRE-1</cons> in the <cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> promoter.</sentence>
<sentence>We demonstrate the utility of using <cons lex="primary_lymphocyte_model" sem="G#other_name">primary lymphocyte models</cons> to study <cons lex="HTLV-I_transcription" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> transcription</cons> in the context of cell signaling and suggest that activated <cons lex="PBMC" sem="G#cell_type">PBMC</cons> maintain elevated levels of <cons lex="P-CREB" sem="G#protein_molecule">P-CREB</cons>, which promote basal <cons lex="HTLV-I_transcription" sem="G#other_name"><cons lex="HTLV-I" sem="G#virus">HTLV-I</cons> transcription</cons> and enhance <cons lex="viral_persistence" sem="G#other_name">viral persistence</cons> in vivo.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99115412</bibliomisc>
</articleinfo>
<title>
<sentence>Anoxia/reoxygenation-induced tolerance with respect to <cons lex="polymorphonuclear_leukocyte_adhesion" sem="G#other_name">polymorphonuclear leukocyte adhesion</cons> to <cons lex="cultured_endothelial_cell" sem="G#cell_line">cultured endothelial cells</cons>.</sentence>
<sentence>A <cons lex="nuclear_factor-kappaB-mediated_phenomenon" sem="G#other_name"><cons lex="nuclear_factor-kappaB" sem="G#protein_complex">nuclear factor-kappaB</cons>-mediated phenomenon</cons>.</sentence>
</title>
<abstract>
<sentence>Exposing <cons lex="human_umbilical_vein_endothelial_cell" sem="G#cell_line">human umbilical vein endothelial cells</cons> (<cons lex="HUVEC" sem="G#cell_line">HUVECs</cons>) to <cons lex="anoxia/reoxygenation" sem="G#other_name">anoxia/reoxygenation</cons> (<cons lex="A/R" sem="G#other_name">A/R</cons>) results in an increase in <cons lex="polymorphonuclear_leukocyte_(PMN)_adhesion" sem="G#other_name">polymorphonuclear leukocyte (<cons lex="PMN" sem="G#cell_type">PMN</cons>) adhesion</cons> to <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons>.</sentence>
<sentence>This <cons lex="A/R" sem="G#other_name">A/R</cons>-induced hyperadhesion is completely prevented by a previous (24 hours earlier) exposure of <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> to <cons lex="A/R" sem="G#other_name">A/R</cons>.</sentence>
<sentence>This phenomenon has been termed "<cons lex="A/R_tolerance" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> tolerance</cons>."</sentence>
<sentence>Exposing <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> to <cons lex="A/R" sem="G#other_name">A/R</cons> induces an increase in <cons lex="nuclear_factor_kappaB" sem="G#protein_complex">nuclear factor kappaB</cons> (<cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>) in <cons lex="HUVEC_nuclei" sem="G#cell_component">HUVEC nuclei</cons> within 4 hours.</sentence>
<sentence>Interfering with either <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> (<cons lex="proteasome_inhibitor" sem="G#other_name"><cons lex="proteasome" sem="G#protein_complex">proteasome</cons> inhibitor</cons>) or translocation (<cons lex="double-stranded_oligonucleotide" sem="G#polynucleotide">double-stranded oligonucleotides</cons> containing <cons lex="NF-kappaB_binding_sequence" sem="G#DNA_domain_or_region"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding sequence</cons>) prevents the development of <cons lex="A/R_tolerance" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> tolerance</cons> (ie, the increase in <cons lex="A/R-induced_PMN_adhesion" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons>-induced <cons lex="PMN_adhesion" sem="G#other_name">PMN adhesion</cons></cons> to <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> is the same after the first and second <cons lex="A/R_challenge" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> challenges</cons>).</sentence>
<sentence>NO production by <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> is increased after the second <cons lex="A/R" sem="G#other_name">A/R</cons> challenge, but not after the first <cons lex="A/R_challenge" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> challenge</cons>.</sentence>
<sentence>Inhibition of <cons lex="NO_synthase" sem="G#protein_molecule">NO synthase</cons> (<cons lex="NOS" sem="G#protein_molecule">NOS</cons>) during the second <cons lex="A/R_challenge" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> challenge</cons> prevents the development of <cons lex="A/R" sem="G#other_name">A/R</cons> tolerance with respect to <cons lex="PMN_adhesion" sem="G#other_name">PMN adhesion</cons>.</sentence>
<sentence>However, while <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons> contained endothelial <cons lex="NOS_protein" sem="G#protein_molecule">NOS protein</cons>, no inducible <cons lex="NOS" sem="G#protein_molecule">NOS</cons> was detected in either tolerant or <cons lex="nontolerant_cell" sem="G#cell_type">nontolerant cells</cons>.</sentence>
<sentence>Further studies indicated that inhibition of <cons lex="GTP-cyclohydrolase_I" sem="G#protein_molecule">GTP-cyclohydrolase I</cons> (an enzyme involved in de novo synthesis of an important cofactor for <cons lex="NOS_activity" sem="G#other_name"><cons lex="NOS" sem="G#protein_molecule">NOS</cons> activity</cons>, tetrahydrobiopterin) prevented the generation of <cons lex="NO" sem="G#inorganic">NO</cons> in <cons lex="A/R-tolerant_cell" sem="G#cell_line"><cons lex="A/R" sem="G#other_name">A/R</cons>-tolerant cells</cons>.</sentence>
<sentence>Extracellular generation of <cons lex="NO" sem="G#inorganic">NO</cons> (<cons lex="NO" sem="G#inorganic">NO</cons> donor) did not effect the hyperadhesion response induced by the initial <cons lex="A/R_challenge" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> challenge</cons>.</sentence>
<sentence><cons lex="A/R" sem="G#other_name">A/R</cons> also induced an oxidant stress in naive <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons>, but not in <cons lex="A/R-tolerant_HUVEC" sem="G#cell_line"><cons lex="A/R" sem="G#other_name">A/R</cons>-tolerant <cons lex="HUVEC" sem="G#cell_line">HUVECs</cons></cons>.</sentence>
<sentence>Inhibition of <cons lex="NOS" sem="G#protein_molecule">NOS</cons> during the second <cons lex="A/R" sem="G#other_name">A/R</cons> insult results in the generation of an <cons lex="oxidant_stress" sem="G#other_name">oxidant stress</cons> similar to that observed after the first <cons lex="A/R_challenge" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> challenge</cons>.</sentence>
<sentence>Taken together, the findings of the present study are consistent with a role for <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> in the development of <cons lex="A/R_tolerance" sem="G#other_name"><cons lex="A/R" sem="G#other_name">A/R</cons> tolerance</cons> (with respect to <cons lex="PMN_adhesion" sem="G#other_name"><cons lex="PMN" sem="G#cell_type">PMN</cons> adhesion</cons>), perhaps by transcriptional regulation of <cons lex="GTP-cyclohydrolase" sem="G#protein_molecule"><cons lex="GTP" sem="G#nucleotide">GTP</cons>-cyclohydrolase</cons>.</sentence>
<sentence>The increased <cons lex="NO" sem="G#inorganic">NO</cons> production during the second <cons lex="A/R" sem="G#other_name">A/R</cons> insult reduces <cons lex="PMN_adhesion" sem="G#other_name">PMN adhesion</cons> most likely by reducing the <cons lex="intracellular_oxidant_stress" sem="G#other_name">intracellular oxidant stress</cons> induced by <cons lex="A/R" sem="G#other_name">A/R</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99102085</bibliomisc>
</articleinfo>
<title>
<sentence>Mildly oxidized <cons lex="low-density_lipoprotein" sem="G#protein_family_or_group">low-density lipoproteins</cons> decrease early production of <cons lex="interleukin_2" sem="G#protein_molecule">interleukin 2</cons> and <cons lex="nuclear_factor_kappaB" sem="G#protein_complex">nuclear factor kappaB</cons> binding to DNA in <cons lex="activated_T-lymphocyte" sem="G#cell_type">activated T-lymphocytes</cons>.</sentence>
</title>
<abstract>
<sentence>Activated T-lymphocytes are found early in <cons lex="atherosclerosis_lesion" sem="G#tissue">atherosclerosis lesions</cons>, but little is known about their role.</sentence>
<sentence>Oxidized <cons lex="low-density_lipoprotein" sem="G#protein_family_or_group">low-density lipoproteins</cons> (<cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons>) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons> inhibit not only <cons lex="interleukin_(IL)-2-receptor_expression" sem="G#other_name"><cons lex="interleukin_(IL)-2-receptor" sem="G#protein_molecule">interleukin (IL)-2-receptor</cons> expression</cons> on the surface of in vitro-activated T-lymphocytes but also their proliferation.</sentence>
<sentence>We have now investigated the effect of <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons> on <cons lex="blast_differentiation" sem="G#other_name">blast differentiation</cons>, on <cons lex="IL-2_synthesis" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> synthesis</cons> and on the activation of the <cons lex="nuclear_factor_kappaB_(NF-kappaB)_system" sem="G#other_name"><cons lex="nuclear_factor_kappaB" sem="G#protein_complex">nuclear factor kappaB</cons> (<cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>) system</cons> in activated lymphocytes.</sentence>
<sentence>Mildly <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons> (50 and 100 microgram/ml) decreased the number of <cons lex="lymphoblast" sem="G#cell_type">lymphoblasts</cons> and the level of IL-2 concentration in the culture supernatants after activation of <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons> by <cons lex="phytohaemagglutinin" sem="G#protein_molecule">phytohaemagglutinin</cons> and <cons lex="PMA+ionomycin" sem="G#other_organic_compound">PMA+<cons lex="ionomycin" sem="G#other_organic_compound">ionomycin</cons></cons>.</sentence>
<sentence>The inhibition of <cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> production was observed in the <cons lex="CD3(+)_T-lymphocyte_cytoplasm" sem="G#cell_component"><cons lex="CD3" sem="G#protein_molecule">CD3</cons>(+) T-lymphocyte cytoplasm</cons> as early as 4 h after activation by <cons lex="PMA+ionomycin" sem="G#other_organic_compound">PMA+<cons lex="ionomycin" sem="G#other_organic_compound">ionomycin</cons></cons>.</sentence>
<sentence>The study of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> showed that <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons> led to a decrease of <cons lex="activation-induced_p65/p50" sem="G#protein_complex">activation-induced p65/<cons lex="p50" sem="G#protein_subunit">p50</cons></cons> <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of <cons lex="p50_dimer" sem="G#protein_complex"><cons lex="p50" sem="G#protein_subunit">p50</cons> dimer</cons> was unchanged.</sentence>
<sentence>This was correlated with an unchanged level of the active form of the <cons lex="cytosolic_inhibitor_protein" sem="G#protein_family_or_group">cytosolic inhibitor protein</cons> <cons lex="IkappaB-alpha" sem="G#protein_molecule">IkappaB-alpha</cons>.</sentence>
<sentence>Taken together, these observations suggest that the immunosuppressive effect of <cons lex="oxLDL" sem="G#protein_family_or_group">oxLDLs</cons> might operate via a <cons lex="dysregulation" sem="G#other_name">dysregulation</cons> of the <cons lex="T-lymphocyte_activation_mechanisms" sem="G#other_name"><cons lex="T-lymphocyte" sem="G#cell_type">T-lymphocyte</cons> activation mechanisms</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99077977</bibliomisc>
</articleinfo>
<title>
<sentence>The <cons lex="B29_(immunoglobulin_beta-chain)_gene" sem="G#DNA_domain_or_region">B29 (<cons lex="immunoglobulin_beta-chain" sem="G#protein_subunit">immunoglobulin beta-chain</cons>) gene</cons> is a genetic target for <cons lex="early_B-cell_factor" sem="G#protein_molecule">early B-cell factor</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="early_B-cell_factor" sem="G#protein_molecule">Early B-cell factor</cons> (<cons lex="EBF" sem="G#protein_molecule">EBF</cons>) is a <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> suggested as essential for <cons lex="early_B-lymphocyte_development" sem="G#other_name">early <cons lex="B-lymphocyte" sem="G#cell_type">B-lymphocyte</cons> development</cons> by findings in <cons lex="mouse" sem="G#body_part">mice</cons> where the coding gene has been inactivated by <cons lex="homologous_disruption" sem="G#other_name">homologous disruption</cons>.</sentence>
<sentence>This makes the identification of genetic targets for this <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> pertinent for the understanding of <cons lex="early_B-cell_development" sem="G#other_name">early B-cell development</cons>.</sentence>
<sentence>The lack of <cons lex="B29_transcript" sem="G#RNA_family_or_group">B29 transcripts</cons>, coding for the <cons lex="beta_subunit" sem="G#protein_subunit">beta subunit</cons> of the B-cell receptor complex, in <cons lex="pro-B_cell" sem="G#cell_type">pro-B cells</cons> from <cons lex="EBF-deficient_mouse" sem="G#other_artificial_source"><cons lex="EBF" sem="G#protein_molecule">EBF</cons>-deficient <cons lex="mouse" sem="G#body_part">mice</cons></cons> suggested that B29 might be a genetic target for <cons lex="EBF" sem="G#protein_molecule">EBF</cons>.</sentence>
<sentence>We here present data suggesting that <cons lex="EBF" sem="G#protein_molecule">EBF</cons> interacts with three independent sites within the <cons lex="mouse_B29_promoter" sem="G#DNA_domain_or_region">mouse <cons lex="B29_promoter" sem="G#DNA_domain_or_region">B29 promoter</cons></cons>.</sentence>
<sentence>Furthermore, <cons lex="ectopic_expression" sem="G#other_name">ectopic expression</cons> of <cons lex="EBF" sem="G#protein_molecule">EBF</cons> in <cons lex="HeLa_cell" sem="G#cell_line">HeLa cells</cons> activated a <cons lex="B29_promoter-controlled_reporter_construct" sem="G#DNA_molecule"><cons lex="B29_promoter" sem="G#DNA_domain_or_region"><cons lex="B29" sem="G#DNA_domain_or_region">B29</cons> promoter</cons>-controlled reporter construct</cons> 13-fold and induced a low level of expression from the <cons lex="endogenous_B29_gene" sem="G#DNA_domain_or_region">endogenous <cons lex="B29" sem="G#DNA_domain_or_region">B29</cons> gene</cons>.</sentence>
<sentence>Finally, mutations in the <cons lex="EBF" sem="G#protein_molecule">EBF</cons> binding sites diminished <cons lex="B29_promoter_activity" sem="G#other_name"><cons lex="B29_promoter" sem="G#DNA_domain_or_region"><cons lex="B29" sem="G#DNA_domain_or_region">B29</cons> promoter</cons> activity</cons> in <cons lex="pre-B_cell" sem="G#cell_type">pre-B cells</cons> while the same mutations did not have as striking an effect on the <cons lex="promoter_function" sem="G#other_name">promoter function</cons> in <cons lex="B-cell_line" sem="G#cell_line">B-cell lines</cons> of later differentiation stages.</sentence>
<sentence>These data suggest that the <cons lex="B29_gene" sem="G#DNA_domain_or_region"><cons lex="B29" sem="G#DNA_domain_or_region">B29</cons> gene</cons> is a genetic target for <cons lex="EBF" sem="G#protein_molecule">EBF</cons> in <cons lex="early_B-cell_development" sem="G#other_name">early B-cell development</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98208262</bibliomisc>
</articleinfo>
<title>
<sentence>Delta-opioid receptors expressed by <cons lex="Jurkat_T_cell" sem="G#cell_line">Jurkat T cells</cons> enhance <cons lex="IL-2_secretion" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> secretion</cons> by increasing <cons lex="AP-1_complex" sem="G#protein_complex">AP-1 complexes</cons> and activity of the <cons lex="NF-AT/AP-1-binding_promoter_element" sem="G#DNA_domain_or_region">NF-AT/AP-1-binding promoter element</cons>.</sentence>
</title>
<abstract>
<sentence>Recent molecular evidence points to transient and/or stage-specific expression of <cons lex="(AND delta-opioid_receptor kappa-opioid_receptor)" sem="(AND G#protein_family_or_group G#protein_family_or_group)"><cons lex="delta-*">delta-</cons> and <cons lex="kappa-*">kappa-</cons><cons lex="*opioid_receptor">opioid receptors</cons></cons> by <cons lex="(AND thymic_T_lymphocyte peripheral_T_lymphocyte)" sem="(AND G#cell_type G#cell_type)"><cons lex="thymic*">thymic</cons> and <cons lex="peripheral*">peripheral</cons> <cons lex="*T_lymphocyte">T lymphocytes</cons></cons>.</sentence>
<sentence>Since medical treatments or stress commonly increase <cons lex="opioid_level" sem="G#other_name">opioid levels</cons>, it is important to understand the mechanisms by which <cons lex="opioid" sem="G#other_organic_compound">opioids</cons> affect <cons lex="T_lymphocyte_function" sem="G#other_name">T lymphocyte functions</cons>.</sentence>
<sentence>We therefore created and studied a <cons lex="T_cell_line" sem="G#cell_line">T cell line</cons> expressing the <cons lex="cloned_delta-opioid_receptor" sem="G#protein_molecule">cloned delta-opioid receptor</cons> (<cons lex="DOR1" sem="G#protein_molecule">DOR1</cons>).</sentence>
<sentence><cons lex="DOR1_ligation" sem="G#other_name"><cons lex="DOR1" sem="G#protein_molecule">DOR1</cons> ligation</cons> by a specific <cons lex="DOR1_agonist" sem="G#other_name"><cons lex="DOR1" sem="G#protein_molecule">DOR1</cons> agonist</cons>, <cons lex="deltorphin" sem="G#other_organic_compound">deltorphin</cons>, augmented <cons lex="IL-2_secretion" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> secretion</cons> by synergizing with signals from <cons lex="TCR-CD3" sem="G#protein_molecule">TCR-<cons lex="CD3" sem="G#protein_molecule">CD3</cons></cons> and <cons lex="CD28" sem="G#protein_molecule">CD28</cons>.</sentence>
<sentence>Reporter gene constructs were used to map this effect of <cons lex="deltorphin" sem="G#other_organic_compound">deltorphin</cons> to the <cons lex="(AND AP-1-binding_site NF-AT/AP-1-binding_site)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="AP-1-*">AP-1-</cons> and <cons lex="NF-AT/AP-1-*">NF-AT/AP-1-</cons><cons lex="*binding_site">binding sites</cons></cons> of the <cons lex="IL-2_promoter" sem="G#DNA_domain_or_region"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> promoter</cons>.</sentence>
<sentence>Although <cons lex="DOR1" sem="G#protein_molecule">DOR1</cons> signaling increased <cons lex="[Ca2+]i" sem="G#other_name">[<cons lex="Ca2+" sem="G#atom">Ca2+</cons>]i</cons>, <cons lex="deltorphin" sem="G#other_organic_compound">deltorphin</cons> enhanced transcriptional activity of the <cons lex="NF-AT/AP-1-binding_site" sem="G#DNA_domain_or_region">NF-AT/AP-1-binding site</cons> via a mechanism independent of <cons lex="calcineurin" sem="G#protein_molecule">calcineurin</cons> and distinct from the effects of elevated <cons lex="[Ca2+]i" sem="G#other_name">[<cons lex="Ca2+" sem="G#atom">Ca2+</cons>]i</cons>.</sentence>
<sentence>Deltorphin also increased accumulation of <cons lex="AP-1_transcription_factor_complex" sem="G#protein_complex">AP-1 <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons> complexes</cons>, suggesting that <cons lex="DOR1" sem="G#protein_molecule">DOR1</cons> augments <cons lex="IL-2_secretion" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> secretion</cons> by increasing the <cons lex="AP-1_component" sem="G#protein_molecule">AP-1 component</cons> of the <cons lex="NF-AT/AP-1_transcription_factor" sem="G#protein_complex">NF-AT/AP-1 <cons lex="transcription_factor" sem="G#protein_family_or_group">transcription factor</cons></cons>.</sentence>
<sentence>These results advance the molecular understanding of opioid effects on <cons lex="lymphocyte" sem="G#cell_type">lymphocytes</cons>, and in addition, demonstrate regulation of <cons lex="IL-2_synthesis" sem="G#other_name"><cons lex="IL-2" sem="G#protein_molecule">IL-2</cons> synthesis</cons> and secretion by the novel mechanism of <cons lex="receptor-mediated_AP-1_induction" sem="G#other_name">receptor-mediated <cons lex="AP-1" sem="G#protein_molecule">AP-1</cons> induction</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:98124483</bibliomisc>
</articleinfo>
<title>
<sentence>Induction of <cons lex="interleukin-12" sem="G#protein_molecule">interleukin-12</cons> <cons lex="p40_transcript" sem="G#RNA_molecule"><cons lex="p40" sem="G#protein_molecule">p40</cons> transcript</cons> by <cons lex="CD40_ligation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation</cons> via activation of <cons lex="nuclear_factor-kappaB" sem="G#protein_complex">nuclear factor-kappaB</cons>.</sentence>
</title>
<abstract>
<sentence><cons lex="interleukin-12" sem="G#protein_molecule">Interleukin-12</cons> is produced in response to <cons lex="infection" sem="G#other_name">infection</cons> with <cons lex="bacteria" sem="G#mono_cell">bacteria</cons> or <cons lex="parasite" sem="G#mono_cell">parasites</cons> or to <cons lex="bacterial_constituent" sem="G#other_organic_compound">bacterial constituents</cons> such as <cons lex="LPS" sem="G#lipid">LPS</cons> in <cons lex="monocytes/macrophage" sem="G#cell_type">monocytes/macrophages</cons> and <cons lex="dendritic_cell" sem="G#cell_type">dendritic cells</cons>, and also generated by the interaction between <cons lex="activated_T_cell" sem="G#cell_type">activated T cells</cons> and <cons lex="antigen-presenting_cell" sem="G#cell_type">antigen-presenting cells</cons> via <cons lex="CD40-CD40_ligand" sem="G#protein_molecule"><cons lex="CD40" sem="G#protein_molecule">CD40</cons><cons lex="CD40" sem="G#protein_molecule">-CD40</cons> ligand</cons> (<cons lex="CD40L" sem="G#protein_molecule">CD40L</cons>).</sentence>
<sentence>So far, transcriptional analyses of <cons lex="p40" sem="G#protein_molecule">p40</cons> have been carried out only using <cons lex="bacterial_constituent" sem="G#other_organic_compound">bacterial constituents</cons> such as <cons lex="LPS" sem="G#lipid">LPS</cons> as stimuli.</sentence>
<sentence>In the present study, we have characterized the <cons lex="transcriptional_induction" sem="G#other_name">transcriptional induction</cons> of <cons lex="p40" sem="G#protein_molecule">p40</cons> by <cons lex="CD40_ligation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation</cons> in a <cons lex="human_B_lymphoblastoid_cell_line" sem="G#cell_line">human B lymphoblastoid cell line</cons>, <cons lex="Daudi" sem="G#cell_line">Daudi</cons>, and a <cons lex="human_acute_monocytic_leukemia_cell_line" sem="G#cell_line">human acute monocytic leukemia cell line</cons>, <cons lex="THP-1" sem="G#cell_line">THP-1</cons>.</sentence>
<sentence>These cells, stimulated by an agonistic monoclonal antibody against <cons lex="CD40" sem="G#protein_molecule">CD40</cons> or by transfection with a <cons lex="CD40L_expression_vector" sem="G#DNA_molecule"><cons lex="CD40L" sem="G#protein_molecule">CD40L</cons> expression vector</cons>, secreted <cons lex="p40" sem="G#protein_molecule">p40</cons> and showed enhanced <cons lex="p40_mRNA_expression" sem="G#other_name"><cons lex="p40_mRN" sem="G#RNA_molecule"><cons lex="p40" sem="G#protein_molecule">p40</cons> mRNA</cons> expression</cons>.</sentence>
<sentence><cons lex="sequence_analysis" sem="G#other_name">Sequence analysis</cons> of the <cons lex="p40_promoter_region" sem="G#DNA_domain_or_region"><cons lex="p40" sem="G#protein_molecule">p40</cons> promoter region</cons> identified two <cons lex="potential_nuclear_factor_(NF)-kappaB_binding_site" sem="G#DNA_domain_or_region">potential nuclear factor (NF)-kappaB binding sites</cons> conserved between mouse and human.</sentence>
<sentence><cons lex="electrophoretic_mobility_shift_assay" sem="G#other_name">Electrophoretic mobility shift assay</cons> revealed that the potential <cons lex="NF-kappaB_binding_sequence" sem="G#DNA_domain_or_region"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding sequence</cons> which is located around <cons lex="120_bp_upstream" sem="G#DNA_domain_or_region">120 bp upstream</cons> of the <cons lex="transcription_initiation_site" sem="G#DNA_domain_or_region">transcription initiation site</cons> in <cons lex="(AND murine_p40_gene human_p40_gene)" sem="(AND G#DNA_family_or_group G#DNA_family_or_group)"><cons lex="murine*">murine</cons> and <cons lex="human*">human</cons> <cons lex="*p40_gene">p40 genes</cons></cons> formed an <cons lex="NF-kappaB_complex" sem="G#protein_complex"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> complex</cons> with nuclear extract from <cons lex="Daudi_cell" sem="G#cell_line">Daudi cells</cons> stimulated by <cons lex="CD40_ligation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation</cons>.</sentence>
<sentence>Moreover, transfection of <cons lex="Daudi_cell" sem="G#cell_line">Daudi cells</cons> with the polymerized <cons lex="NF-kappaB_binding_sequence" sem="G#DNA_domain_or_region"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding sequence</cons> ligated to a <cons lex="thymidine_kinase/chloramphenicol_acetyltransferase_(CAT)_reporter_plasmid" sem="G#DNA_molecule"><cons lex="thymidine_kinase" sem="G#protein_molecule">thymidine kinase</cons><cons lex="chloramphenicol_acetyltransferase" sem="G#protein_molecule">/chloramphenicol acetyltransferase</cons> (<cons lex="CAT" sem="G#protein_molecule">CAT</cons>) reporter plasmid</cons> greatly induced <cons lex="CAT_activity" sem="G#other_name"><cons lex="CAT" sem="G#protein_molecule">CAT</cons> activity</cons>, but transfection with the <cons lex="polymerized_mutated_NF-kappaB_binding_sequence" sem="G#DNA_domain_or_region">polymerized mutated <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding sequence</cons> did not.</sentence>
<sentence>These results suggest that the <cons lex="NF-kappaB_binding_site" sem="G#DNA_domain_or_region"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> binding site</cons> located around 120 bp upstream of the <cons lex="transcription_initiation_site" sem="G#DNA_domain_or_region">transcription initiation site</cons> in <cons lex="(AND murine_p40_promoter_region human_p40_promoter_region)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="murine*">murine</cons> and <cons lex="human*">human</cons> <cons lex="*p40_promoter_region">p40 promoter regions</cons></cons> could be important for the <cons lex="p40_induction" sem="G#other_name"><cons lex="p40" sem="G#protein_molecule">p40</cons> induction</cons> by <cons lex="CD40_ligation" sem="G#other_name"><cons lex="CD40" sem="G#protein_molecule">CD40</cons> ligation</cons> via activation of <cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99168501</bibliomisc>
</articleinfo>
<title>
<sentence>High frequency of <cons lex="germ-line_BRCA2_mutations" sem="G#other_name">germ-line <cons lex="BRCA2" sem="G#DNA_domain_or_region">BRCA2</cons> mutations</cons> among <cons lex="hungarian_male_breast_cancer_patient" sem="G#multi_cell">Hungarian male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons> patients</cons> without family history.</sentence>
</title>
<abstract>
<sentence>To determine the contribution of <cons lex="BRCA1" sem="G#DNA_domain_or_region">BRCA1</cons> and <cons lex="BRCA2" sem="G#DNA_domain_or_region">BRCA2</cons> <cons lex="mutation" sem="G#other_name">mutations</cons> to the pathogenesis of male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons> in Hungary, the country with the highest male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons> mortality rates in continental Europe, a series of 18 male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons> patients and three patients with <cons lex="gynecomastia" sem="G#other_name">gynecomastia</cons> was analyzed for <cons lex="germ-line_mutation" sem="G#other_name">germ-line mutations</cons> in both <cons lex="BRCA1" sem="G#DNA_domain_or_region">BRCA1</cons> and <cons lex="BRCA2" sem="G#DNA_domain_or_region">BRCA2</cons>.</sentence>
<sentence>Although no <cons lex="germ-line_BRCA1_mutation" sem="G#other_name">germ-line <cons lex="BRCA1" sem="G#DNA_domain_or_region">BRCA1</cons> mutation</cons> was observed, 6 of the 18 male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons> cases (33%) carried <cons lex="truncating_mutation" sem="G#other_name">truncating mutations</cons> in the <cons lex="BRCA2" sem="G#DNA_domain_or_region">BRCA2</cons> gene.</sentence>
<sentence>Unexpectedly, none of them reported a family history for <cons lex="breast/ovarian_cancer" sem="G#other_name">breast/ovarian cancer</cons>.</sentence>
<sentence>Four of six <cons lex="truncating_mutation" sem="G#other_name">truncating mutations</cons> were novel, and two mutations were recurrent.</sentence>
<sentence>Four <cons lex="patient" sem="G#multi_cell">patients</cons> (22%) had a family history of <cons lex="breast/ovarian_cancer" sem="G#other_name">breast/ovarian cancer</cons> in at least one first- or second-degree relative; however, no <cons lex="BRCA2_mutation" sem="G#other_name"><cons lex="BRCA2" sem="G#DNA_domain_or_region">BRCA2</cons> mutation</cons> was identified among them.</sentence>
<sentence>No mutation was identified in either of the genes in the <cons lex="gynecomastia" sem="G#other_name">gynecomastias</cons>.</sentence>
<sentence>These results provide evidence for a strong genetic component of <cons lex="male_breast_cancer" sem="G#other_name">male <cons lex="breast_cancer" sem="G#other_name">breast cancer</cons></cons> in Hungary.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99156941</bibliomisc>
</articleinfo>
<title>
<sentence><cons lex="T-cell_expression" sem="G#other_name">T-cell expression</cons> of the <cons lex="human_GATA-3_gene" sem="G#DNA_domain_or_region">human GATA-3 gene</cons> is regulated by a <cons lex="non-lineage-specific_silencer" sem="G#DNA_domain_or_region">non-lineage-specific silencer</cons>.</sentence>
</title>
<abstract>
<sentence>The <cons lex="GATA-3_transcription_factor" sem="G#protein_molecule">GATA-3 transcription factor</cons> is required for development of the <cons lex="T-cell_lineage" sem="G#cell_line">T-cell lineage</cons> and <cons lex="Th2_cytokine_gene_expression" sem="G#other_name"><cons lex="Th2_cytokine_gene" sem="G#DNA_domain_or_region">Th2 cytokine gene</cons> expression</cons> in <cons lex="CD4_T-cell" sem="G#cell_type">CD4 T-cells</cons>.</sentence>
<sentence>We have mapped the <cons lex="DNase-I-hypersensitive_(HS)_regions" sem="G#DNA_domain_or_region">DNase-I-hypersensitive (HS) regions</cons> of the <cons lex="human_GATA-3_gene" sem="G#DNA_domain_or_region">human GATA-3 gene</cons> in <cons lex="T-cell" sem="G#cell_type">T-cells</cons> and <cons lex="non-T-cell" sem="G#cell_type">non-T-cells</cons> and studied their <cons lex="transcriptional_activity" sem="G#other_name">transcriptional activities</cons>.</sentence>
<sentence><cons lex="HS_I-III" sem="G#DNA_domain_or_region">HS I-III</cons>, located 5' from the <cons lex="transcriptional_initiation_site" sem="G#DNA_domain_or_region">transcriptional initiation site</cons>, were found in <cons lex="(AND hematopoietic_cell non-hematopoietic_cell)" sem="(AND G#cell_type G#cell_type)"><cons lex="hematopoietic*">hematopoietic</cons> and <cons lex="non-hematopoietic*">non-hematopoietic</cons> <cons lex="*cell">cells</cons></cons>, whereas <cons lex="HS_IV-VII" sem="G#DNA_domain_or_region">HS IV-VII</cons>, located 3' from the <cons lex="transcriptional_start_site" sem="G#DNA_domain_or_region">transcriptional start site</cons>, were exclusively observed in <cons lex="T-cell" sem="G#cell_type">T-cells</cons>.</sentence>
<sentence>Among these <cons lex="hypersensitive_site" sem="G#DNA_domain_or_region">hypersensitive sites</cons>, two <cons lex="transcriptional_control_element" sem="G#DNA_domain_or_region">transcriptional control elements</cons> were found, one in the <cons lex="first_intron" sem="G#DNA_domain_or_region">first intron</cons> of the <cons lex="GATA-3_gene" sem="G#DNA_domain_or_region">GATA-3 gene</cons> and the other <cons lex="between_8.3_and_5.9_kilobases" sem="G#DNA_domain_or_region">between 8.3 and 5.9 kilobases</cons> 5' from the <cons lex="GATA-3_transcriptional_initiation_site" sem="G#DNA_domain_or_region">GATA-3 <cons lex="transcriptional_initiation_site" sem="G#DNA_domain_or_region">transcriptional initiation site</cons></cons>.</sentence>
<sentence>The <cons lex="first_intron" sem="G#DNA_domain_or_region">first intron</cons> acted as a strong <cons lex="transcriptional_activator" sem="G#other_name">transcriptional activator</cons> in a position-dependent manner and with no <cons lex="cell-type_specificity" sem="G#other_name">cell-type specificity</cons>.</sentence>
<sentence>The <cons lex="upstream_regulatory_element" sem="G#DNA_domain_or_region">upstream regulatory element</cons> could confer <cons lex="T-cell_specificity" sem="G#other_name">T-cell specificity</cons> to the <cons lex="GATA-3_promoter_activity" sem="G#other_name"><cons lex="GATA-3_promoter" sem="G#DNA_domain_or_region">GATA-3 promoter</cons> activity</cons>, and analysis of this region revealed a <cons lex="707-base_pair_silencer" sem="G#DNA_domain_or_region">707-base pair silencer</cons> that drastically inhibited <cons lex="GATA-3_promoter_activity" sem="G#other_name"><cons lex="GATA-3_promoter" sem="G#DNA_domain_or_region">GATA-3 promoter</cons> activity</cons> in <cons lex="non-T-cell" sem="G#cell_type">non-<cons lex="T-cell" sem="G#cell_type">T-cells</cons></cons>.</sentence>
<sentence>Two <cons lex="CAGGTG_E-box" sem="G#DNA_substructure">CAGGTG E-boxes</cons>, located at the <cons lex="(AND 5'-end 3'-end)" sem="(AND G#DNA_domain_or_region G#DNA_domain_or_region)"><cons lex="5'-*">5'-</cons> and <cons lex="3'-*">3'-</cons><cons lex="*end">ends</cons></cons> of the silencer, were necessary for this <cons lex="silencer_activity" sem="G#other_name">silencer activity</cons>.</sentence>
<sentence>The <cons lex="3'-CAGGTG_E-box" sem="G#DNA_domain_or_region">3'-CAGGTG E-box</cons> could bind <cons lex="USF_protein" sem="G#protein_molecule">USF proteins</cons>, the <cons lex="ubiquitous_repressor" sem="G#protein_family_or_group">ubiquitous repressor</cons> <cons lex="ZEB" sem="G#protein_molecule">ZEB</cons>, or the <cons lex="basic_helix-loop-helix_protein" sem="G#protein_family_or_group">basic helix-loop-helix proteins</cons> <cons lex="E2A" sem="G#protein_molecule">E2A</cons> and <cons lex="HEB" sem="G#protein_molecule">HEB</cons>, and we showed that a competition between <cons lex="ZEB" sem="G#protein_molecule">ZEB</cons> and <cons lex="E2A/HEB_protein" sem="G#protein_molecule"><cons lex="E2A" sem="G#protein_molecule">E2A</cons>/HEB proteins</cons> is involved in the <cons lex="silencer_activity" sem="G#other_name">silencer activity</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99147030</bibliomisc>
</articleinfo>
<title>
<sentence>Reactive oxygen intermediate-dependent <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> by <cons lex="interleukin-1beta" sem="G#protein_molecule">interleukin-1beta</cons> requires <cons lex="5-lipoxygenase" sem="G#protein_molecule">5-lipoxygenase</cons> or <cons lex="NADPH_oxidase_activity" sem="G#other_name"><cons lex="NADPH" sem="G#other_organic_compound">NADPH</cons> oxidase activity</cons>.</sentence>
</title>
<abstract>
<sentence>We previously reported that the role of <cons lex="reactive_oxygen_intermediate" sem="G#inorganic">reactive oxygen intermediates</cons> (<cons lex="ROI" sem="G#inorganic">ROIs</cons>) in <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> by <cons lex="proinflammatory_cytokine" sem="G#protein_family_or_group">proinflammatory cytokines</cons> was cell specific.</sentence>
<sentence>However, the sources for <cons lex="ROI" sem="G#inorganic">ROIs</cons> in various cell types are yet to be determined and might include <cons lex="5-lipoxygenase" sem="G#protein_molecule">5-lipoxygenase</cons> (<cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons>) and <cons lex="NADPH" sem="G#other_organic_compound">NADPH</cons> oxidase.</sentence>
<sentence><cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> and <cons lex="5-LOX_activating_protein" sem="G#protein_molecule"><cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> activating protein</cons> (<cons lex="FLAP" sem="G#protein_molecule">FLAP</cons>) are coexpressed in <cons lex="lymphoid_cell" sem="G#cell_type">lymphoid cells</cons> but not in <cons lex="(OR monocytic_cell epithelial_cell)" sem="(OR G#cell_type G#cell_type)"><cons lex="monocytic*">monocytic</cons> or <cons lex="epithelial*">epithelial</cons> <cons lex="*cell">cells</cons></cons>.</sentence>
<sentence>Stimulation of <cons lex="lymphoid_cell" sem="G#cell_type">lymphoid cells</cons> with <cons lex="interleukin-1beta" sem="G#protein_molecule">interleukin-1beta</cons> (<cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons>) led to ROI production and <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons>, which could both be blocked by antioxidants or <cons lex="FLAP" sem="G#protein_molecule">FLAP</cons> inhibitors, confirming that <cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> was the source of <cons lex="ROI" sem="G#inorganic">ROIs</cons> and was required for <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> in these cells.</sentence>
<sentence><cons lex="IL-1beta_stimulation" sem="G#other_name"><cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> stimulation</cons> of <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons> did not generate any <cons lex="ROI" sem="G#inorganic">ROIs</cons> and <cons lex="NF-kappaB_induction" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> induction</cons> was not influenced by <cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> inhibitors.</sentence>
<sentence>However, reintroduction of a functional <cons lex="5-LOX_system" sem="G#other_name"><cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> system</cons> in these cells allowed <cons lex="ROI_production" sem="G#other_name">ROI production</cons> and <cons lex="5-LOX-dependent_NF-kappaB_activation" sem="G#other_name"><cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons>-dependent <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons></cons>.</sentence>
<sentence>In <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons>, <cons lex="IL-1beta_treatment" sem="G#other_name"><cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> treatment</cons> led to a production of <cons lex="ROI" sem="G#inorganic">ROIs</cons> which is independent of the <cons lex="5-LOX_enzyme" sem="G#protein_molecule"><cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> enzyme</cons> but requires the <cons lex="NADPH_oxidase_activity" sem="G#other_name"><cons lex="NADPH" sem="G#other_organic_compound">NADPH</cons> oxidase activity</cons>.</sentence>
<sentence>This pathway involves the <cons lex="Rac1" sem="G#protein_molecule">Rac1</cons> and <cons lex="Cdc42" sem="G#protein_molecule">Cdc42</cons> <cons lex="GTPase" sem="G#protein_family_or_group">GTPases</cons>, two enzymes which are not required for <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> by <cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons> in <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons>.</sentence>
<sentence>In conclusion, three different <cons lex="cell-specific_pathway" sem="G#other_name">cell-specific pathways</cons> lead to <cons lex="NF-kappaB_activation" sem="G#other_name"><cons lex="NF-kappaB" sem="G#protein_complex">NF-kappaB</cons> activation</cons> by <cons lex="IL-1beta" sem="G#protein_molecule">IL-1beta</cons>: a pathway dependent on <cons lex="ROI_production" sem="G#other_name">ROI production</cons> by <cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons> in <cons lex="lymphoid_cell" sem="G#cell_type">lymphoid cells</cons>, an <cons lex="ROI-_and_5-LOX-independent_pathway" sem="G#other_name">ROI- and <cons lex="5-LOX" sem="G#protein_molecule">5-LOX</cons>-independent pathway</cons> in <cons lex="epithelial_cell" sem="G#cell_type">epithelial cells</cons>, and a pathway requiring ROI production by <cons lex="NADPH_oxidase" sem="G#protein_molecule"><cons lex="NADPH" sem="G#other_organic_compound">NADPH</cons> oxidase</cons> in <cons lex="monocytic_cell" sem="G#cell_type">monocytic cells</cons>.</sentence>
</abstract>
</article>

<article>
<articleinfo>
<bibliomisc>MEDLINE:99138796</bibliomisc>
</articleinfo>
<title>
<sentence>Cutting edge: dominant effect of <cons lex="Ile50Val_variant" sem="G#protein_subunit">Ile50Val variant</cons> of the <cons lex="human_IL-4_receptor_alpha-chain" sem="G#protein_subunit">human IL-4 receptor alpha-chain</cons> in <cons lex="IgE_synthesis" sem="G#other_name"><cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> synthesis</cons>.</sentence>
</title>
<abstract>
<sentence>Two variants of the <cons lex="IL-4R_alpha-chain_(IL-4Ralpha)_gene" sem="G#DNA_domain_or_region"><cons lex="IL-4R_alpha-chain" sem="G#protein_subunit">IL-4R alpha-chain</cons> (<cons lex="IL-4Ralpha" sem="G#protein_subunit">IL-4Ralpha</cons>) gene</cons> have been recently identified in association with different <cons lex="atopic_disorder" sem="G#other_name">atopic disorders</cons>.</sentence>
<sentence>To clarify the etiological relationship between the two variants, we analyzed responsiveness to <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> of <cons lex="transfectant" sem="G#other_name">transfectants</cons> with four kinds of <cons lex="IL-4Ralpha" sem="G#protein_subunit">IL-4Ralpha</cons> carrying either <cons lex="Val" sem="G#amino_acid_monomer">Val</cons> or <cons lex="Ile" sem="G#amino_acid_monomer">Ile</cons> at <cons lex="50" sem="G#protein_domain_or_region">50</cons> and either <cons lex="Gln" sem="G#amino_acid_monomer">Gln</cons> or <cons lex="Arg" sem="G#amino_acid_monomer">Arg</cons> at <cons lex="551" sem="G#protein_domain_or_region">551</cons>.</sentence>
<sentence>The substitution of Ile for <cons lex="Val" sem="G#amino_acid_monomer">Val</cons> augmented <cons lex="STAT6_activation" sem="G#other_name"><cons lex="STAT6" sem="G#protein_molecule">STAT6</cons> activation</cons>, proliferation, and <cons lex="transcription_activity" sem="G#other_name">transcription activity</cons> of the <cons lex="Iepsilon_promoter" sem="G#DNA_domain_or_region">Iepsilon promoter</cons> by <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons>, whereas that of <cons lex="Arg" sem="G#amino_acid_monomer">Arg</cons> for <cons lex="Gln" sem="G#amino_acid_monomer">Gln</cons> did not change these <cons lex="IL-4_signal" sem="G#other_name"><cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> signals</cons>.</sentence>
<sentence><cons lex="Arg551" sem="G#amino_acid_monomer">Arg551</cons> was not associated with <cons lex="atopic_asthma" sem="G#other_name">atopic asthma</cons> in the <cons lex="Japanese_population" sem="G#multi_cell">Japanese population</cons>.</sentence>
<sentence><cons lex="CD23_expression" sem="G#other_name"><cons lex="CD23" sem="G#protein_molecule">CD23</cons> expression</cons> and <cons lex="IgE_synthesis" sem="G#other_name"><cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> synthesis</cons> by <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> were augmented in <cons lex="Ile50-bearing_PBMC" sem="G#cell_line"><cons lex="Ile50" sem="G#amino_acid_monomer">Ile50</cons>-bearing PBMC</cons>, compared with those bearing <cons lex="Val50" sem="G#amino_acid_monomer">Val50</cons>.</sentence>
<sentence>Taken together, substitution of <cons lex="Arg551" sem="G#amino_acid_monomer">Arg551</cons> does not enhance the <cons lex="IL-4" sem="G#protein_molecule">IL-4</cons> signal for generation of germline epsilon transcript, whereas the substitution of <cons lex="Ile50" sem="G#amino_acid_monomer">Ile50</cons> contributes to enhancement of <cons lex="IgE_synthesis" sem="G#other_name"><cons lex="IgE" sem="G#protein_family_or_group">IgE</cons> synthesis</cons>.</sentence>
</abstract>
</article>



</set>